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Stellingen bij het proefschrift van W.G. Balvers. 
I 
De door Dutton et al. aangevoerde literatuur levert geen bewijs voor hun 
veronderstelling dat het semichinonimine-radicaal van resorufïne wordt 
geprotoneerd op de stikstof en niet op de zuurstof. 
Dutton, D.R., Reed, G.A. & Parkinson, A. (1989) ArchBiochem.Biophys. 268: 605-
616 
II 
Het bewijs van Bayerl et al. voor hun conclusie dat er een specifieke 
interactie bestaat tussen cytochroom P450 en fosfatidylethanolamine (PE) 
is onvoldoende en sluit niet uit dat er specifieke interacties bestaan tussen 
cytochroom P450 en fosfatidylserine (PS) en/of fosfatidylinositol (PI). 
Bayerl, T., Klose, G., Ruckpaul, K. & Schwarze, W. (1985) BiochimMiophysActa 
812: 437-446 
III 
Het vergelijken van de resultaten van gepubliceerde studies over de rol 
van fosfolipiden in het cytochroom P450 enzym systeem is nagenoeg 
onmogelijk door de grote verscheidenheid aan gereconstitueerde 
systemen die zijn gebruikt. 
Dit proefschrift (hoofdtuk 2 t/m 5) 
IV 
De manier van incorporatie van cytochroom P450 enzymen in 
gereconstitueerde modelsystemen is vergelijkbaar met de wijze van 
inbouw in het microsomale membraan 
Dit proefschrift (hoofdstuk 2) 
MO computerberekeningen zijn een zeer bruikbaar hulpmiddel bij het 
onderzoek naar de reactiemechanismen in de biochemie zolang de 
uitkomsten worden gebruikt op relatieve wijze. 
VI 
Door de onzekerheid in de correlatietijd (TC) en de spintoestand van de 
Fe3+ in de heem cofactor van cytochroom P450 zijn de met behulp van 
NMR-Ti relaxatie metingen bepaalde afstanden tussen substraat atomen 
en het Fe3+-atoom minder absoluut dan ze doorgaans worden 
gepresenteerd. 
van de Straat, R., de Vries, J., de Boer, H.J.R., Vromans, R.M. & Vermeulen, N.P.E. 
(1987) Xenobiotica 17: 1-9 
Castro-Maderal, L. & Sullivan , P.D. (1992) FEBS Lelt. 296: 249-253 
Myers, G.T., Thummel, K.E., Kalhorn, T.F. & Nelson, S.D. (1994) JMed.Ckem. 37: 
860-867 
VII 
Het vait te betwijfelen of je eiwitten zoals cytochroom P450 en NADPH-
cytochroom reductase, waarvan meer dan 85% van het eiwit zich in het 
cytoplasma bevindt nog wel integrale membraan eiwitten moet noemen. 
Black, S.D. (1992) FASEB J. 6: 680-685 
VIII 
Wanneer de jacht op de walvis voor wetenschappelijke doeleinden 
doorgaat, zal dit dier de twijfelachtige eer te beurt vallen de eerste 
uitgestorven diersoort te zijn waarvan we alles weten. 
IX 
Bij de claim van de zuivelfabrikanten dat rechtsdraaiend melkzuur 
gezonder is dan linksdraaiend melkzuur wordt ook de waarheid 
'verdraaid'. 
Chemisch Magazine (april 1992) 
X 
Het 'voetje' dat wasmiddelenfabrikanten proberen te halen bij de 
consument is altijd witter dan wit. 
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Chapter 1 
General introduction 
A: The cytochrome P450 enzyme system 
B: The importance of phospholipids in the 
cytochrome P450 enzyme system 
(\c^S\ 
Al.l Introduction 
Living organisms are exposed to an ever increasing number of 
xenobiotics (i.e. chemicals foreign to the body) such as drugs, food 
additives, preservatives, pesticides and other agrochemicals and 
environmental contaminants. The body is equipped with metabolic 
pathways which can convert these foreign compounds as well as various 
endogenous substrates like steroids, fatty acids, Prostaglandines and 
ketones to metabolites that can be excluded from the body. In a process 
called biotransformation the water solubility of xenobiotics is increased 
to make them readily excretable through urine or bile. The 
biotransformation of foreign chemicals is generally divided into two 
phases. Phase I metabolism involves the modification of the xenobiotic 
through oxidation, reduction or hydrolysis. In Phase II metabolism a 
polar xenobiotic or a product from Phase I metabolism is conjugated with 
small endogenous molecules (e.g. glucuronic acid, glutathione, sulphate, 
acetate, glycin etc.). Generally, the biotransformation leads to 
detoxification of the xenobiotics. However, in some cases the 
biotransformation can give rise to the formation of reactive intermediates 
and/or metabolites which are more toxic than the parent molecule 
(bioactivation). These toxic metabolites can cause cell damage. 
An important Phase I enzyme system is the cytochrome P450 
dependent monooxygenase. Over the last three decades the cytochrome 
P450 enzyme system has been intensively studied. A complete 
understanding of the mechanism of action of the cytochrome P450 
enzyme system is very important for toxicological research, for example 
in determining the bioactivation and detoxification of a xenobiotic. But 
also in the pharmacological and medical field a good knowledge of this 
enzyme system is of great importance especially because the P450 
enzyme system is to a certain extent responsible for the residence time of 
drugs in the body and thus for the required dosage of medication. 
Currently pharmaceutical laboratories screen potential drugs on the 
formation of possible metabolites in in vitro systems using the 
cytochrome P450 enzyme system. Furthermore, the use of the P450 
enzyme system has also been suggested in organic chemistry, especially 
in the synthesis of stereo- and / or regio selective chemicals, and in the 
battle against the ever increasing environmental contamination [1,2]. 
The following paragraphs describe in more detail important general 
features of the cytochrome P450 enzyme system like cytochrome P450 
multiplicity and inducibility, the structure of the individual protein 
constituents of the enzyme system and the catalytic cycle. 
A1.2 Occurence and cellular location of the 
cytochrome P450 enzyme system 
The cytochromes P450 enzyme system occurs in biological systems as 
diverse as microorganisms, plants, animals and man. Of all mammalian 
tissues, the liver is the organ containing the highest P450 amounts, 
although cytochromes P450 are also found in the lungs, skin, kidneys, 
nose, spleen, testes, intestines and other tissues but in relatively low 
amounts |3-6|. 
The mammalian cytochrome P450 enzyme system is associated 
with the membrane of the smooth endoplasmatic reticulum. The enzyme 
system belongs to the class of oxygen activating enzymes that catalyse 
biological oxidations by transferring electrons from NADPH to molecular 
oxygen. The enzyme system is a multi-enzyme complex composed of (i) 
cytochromes P450, hemoproteins that catalyse the final electron transfer 
to molecular oxygen and the insertion of an oxygen atom into the 
substrate, (ii) NADPH-cytochrome reductase, a flavoprotein that transfers 
electrons from NADPH to cytochrome P450 or cytochrome b$, (iii) 
cytochrome h$, a hemoprotein that takes part in the transfer of electrons 
to cytochrome P450 for some substrate conversions [7] and (iv) NADH-
cytochrome reductase, a flavoprotein that tranfers electrons from NADH 
to cytochrome bv A schematic presentation of the electron flow through 
the mammalian cytochrome P450 enzyme system from the endoplasmatic 
reticulum is presented in Figure ALL 
For mitochondrial and bacterial cytochromes P450 the electrons 
are transferred from NADH via a flavoprotein (for example adrenodoxin 
reductase for mitochondrial cytochrome P450 and putidaredoxin 
reductase for bacterial cytochrome P450 from Pseudomonas putida) and 
a ferredoxin (an iron-sulfur ([2Fe-2S]) protein; adrenodoxin and 
putidaredoxin for respectively mitochondrial and bacterial cytochrome 
P450) to molecular oxygen [8,9]. 
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Figure Al .1 : Electron flow through the mammalian cytochrome P450 enzyme 
system 
A1.3 Cytochrome P450 multiplicity 
One of the most characteristic features of the P450 enzyme system is its 
ability to metabolise in addition to endogenous substrates like steroids, 
fatty acids, Prostaglandines and ketones, an almost unlimited number of 
biologically occurring and xenobiotic substances (currently estimated to 
be more than 250,000 different compounds) [10-14]. This characteristic 
originates from the existence of multiple cytochrome P450 enzymes. 
Upto now, more than 150 different cytochrome P450 forms have been 
characterised [2j. In rats at least 38 different P450 enzymes were 
described [11. When the existence of multiple cytochrome P450 forms 
was first demonstrated [15] it was not known whether different species 
and tissues would have similar forms. Research, done in the seventies and 
early eighties, on different forms of cytochrome P450 resulted in a 
confusing variety of trivial names that were based on, for example, the 
animal from which the cytochrome P450 form was isolated, chemicals 
that were used to pretreate the animal prior to isolation of the cytochrome 
P450 form, a substrate metabolised by the P450 form or a specific 
reaction catalysed by the isolated cytochrome P450 form. In some cases 
numbers or letters were assigned in series. Nebert et al. [16,17] 
introduced a systematic nomenclature in which the individual P450 
proteins were devided into families and subfamilies depending on the 
alignment and percent of similarity of the nucleotide sequences of their 
genes. Those P450 proteins from all sources with 40% or greater 
sequence identity are included in the same family, presented by a Roman 
number, and those with greater than 55% identity are then included in the 
same subfamily, presented by a capital letter. The individual genes are 
then arbitrarily given an additional Arabic number. This nomenclature is 
now generally accepted and examples for some different forms of rat 
cytochrome P450 together with their trivial names as presented in earlier 
studies are presented in Table ALL 
Table A 1.1: Example of different nomenclatures of some different forms of rat 
cytochrome P450 
nomenclature 
Nebert 
[16,171 
IA1 
IA2 
IIA1 
IIB1 
IIB2 
I1C6 
IIC7 
HCl 1 
HCl 2 
HCl 3 
HEI 
IIIA1 
nomenclature 
Guengerich 
[12,181 
ßNF-B 
1SF-G 
UT-F 
PB-B 
PB-D 
PB-C 
-
UT-A 
UT-I 
-
-
PCN-E 
nomenclature 
Ryan 
[12] 
c 
d 
a 
b 
e 
k 
f 
h 
i 
g 
j 
P 
nomenclature 
Waxman 
[12] 
-
-
PB-3 
PB-4 
PB-5 
PB-1 
2c 
2d 
-
PB-2a 
nomenclature 
Schenkman 
[12] 
-
-
RLM2b 
PBRLM5 
PBRLM6 
PBRLM4 
RLM5b 
RLM5 
fRLM4 
RLM3 
RLM6 
-
A1.4 Cytochrome P450 induction 
The level of many forms of cytochrome P450 in the different organs of 
the body can be increased by exposure to a chemical agent. So far 3 
major classes of cytochrome P450 inducers are known which increase the 
level of different families of P450 forms; (i) the phénobarbital type, 
inducing families IIB and to a minor extent IIC, (ii) the 3-
methylcholanthrene type (polycyclic, aromatic hydrocarbons), inducing 
families IA and to a minor extent IIA and (iii) the steroid type (for 
example pregnenolone-16oc-carbonitrile (PCN)), inducing family IIIA 
[18]. In addition to these three major classes, two minor classes of 
inducible P450 forms have been identified; the ethanol-inducible P-450's 
(family HE) and clofibrate-inducible P-450's (family IVA) [18]. 
The mechanism by which inducers elevate the level of specific 
cytochrome P450 forms is not yet fully understood but it is believed to be 
different for individual forms of cytochrome P450. The induction of 
cytochrome P450 IA by polycyclic aromatic hydrocarbons is supposed to 
involve a cytoplasmatic Ah (Aryl hydrocarbon) receptor [19-21]. After 
binding to the receptor, the inducer-receptor complex (AhR) is 
translocated to the nucleus. In the ligand-free form the receptor is bound 
to a 90 kDa "Heat shock Protein" (HsP90) similar to steroid hormon 
receptors [221. Furthermore, the protein complex is believed to contain a 
metalion, probably molybdenum. Upon binding the inducer, the receptor 
is activated. During the process of receptor activation, HsP90 dissociates 
from the inducer-receptor complex thereby liberating the DNA binding 
domain on the receptor [23]. Recently it was demonstrated that another 
protein is involved in the translocation of the activated AhR to the 
nucleus, namely the Ah receptor nuclear translocator (Arnt) [24]. The 
interaction of the AhR protein with DNA involves socalled "zinkfingers" 
in the DNA binding site [25] which make contact with the "major 
groove" of the DNA. The binding stimulates the transcription of the P450 
IA gene. The transport of mRNA from the nucleus to the cytosol, which 
is suggested to be the rate-limitting step of biosynthesis of the protein 
[26], then results in the selective biosynthesis of the enzyme into which 
mitochondrially derived heme is inserted to form the holoenzyme. 
Isosafrole and other methylenedioxyphenyl inducers which are also 
capable of inducing cytochrome P450 IA do not appear to act via the Ah 
receptor [27]. From computer graphic studies of the molecular 
dimensions and electronic structures of inducers of cytochrome P450 IA 
and specific substrates and inhibitors of cytochrome P450 IA, the 
conformation of the cytosolic receptor was demonstrated to resemble that 
of the active site of the enzyme [28]. For further information on 
cytochrome P450 IA regulation the reader is referred to papers of Fujii-
Kuriyama et al. (29) and Bresnick and Houser [30]. 
Phénobarbital induction of cytochrome P450 IIB is suggested to 
result from increased levels of P450 IIB mRNA [31,32] resulting from 
increased transcription of the corresponding P450 IIB gene. Recognition 
of the inducer is suggested to be mediated by a phénobarbital type 
receptor [33,34j although receptor-independent mechanisms have also 
been postulated [32|. 
The induction of cytochrome P450 HE proceeds primarily by 
stabilization of the protein and its mRNA [35,36]. Binding of the 
substrate (for example ethanol or acetone) or its metabolite has been 
suggested to protect the P450 HE protein from rapid degradation. 
The mechanisms of induction of cytochrome P450 IIIA were 
shown to be diverse. Induction by pregnenolone- 16oc-carbonitrile (PCN) 
and dexamethasone was demonstrated to result from an increase in P450 
III mRNA [37,381 whereas endogenous glucocortecoid mediated 
induction of this enzyme involves a cytosolic receptor [39]. 
The induction of cytochrome P450 IVA by Clofibrate has been 
reported to be mediated by a receptor, activated by a peroxisome 
proliferating compound [40,41]. Upon Clofibrate administration the gene 
transcription is suggested to increase rapidly, followed by an elevated 
cytochrome P450 IVA mRNA and protein level [42]. 
A1.5 Structure of the various protein constituents of 
the cytochrome P450 enzyme system 
In the following paragraph the structure of the individual protein 
components of the enzyme system will be discussed in more detail. 
Special attention will be given to structural aspects that might be of 
importance for membrane incorporation and protein-protein interactions 
in the P450 system. 
A 1.5.1 Cytochrome P450 
Currently, the only direct method for the determination of the three-
dimensional structure of high molecular weight proteins like the 
cytochromes P450 (± 50 kDa) is through high-resolution X-ray 
crystallography. For the bacterial, camphor metabolising, soluble 
cytochrome P450 CAM from Pseudomonas putida a three dimensional 
structure, obtained from high-resolution X-ray crystallography, has been 
reported [43] and more recently, the three dimensional structure of 
another bacterial cytochrome P450, P450 BM-3 from Bacillus 
megarerium, was elucidated [44]. In contrast, the information on the three 
dimensional structure of mammalian cytochromes P450 (50 kDa) is 
limited because these proteins have not (yet) been succesfully 
crystalysed. This is mainly due to the fact that, unlike cytochrome P450 
CAM, mammalian cytochromes P450 are membrane bound resulting in 
protein preparations containing disturbing surfactants and phospholipids 
and / or irregular protein aggregates. 
Several models for the incorporation of vertebrate cytochrome 
P450 into the membrane have been proposed over the last decade. Early 
models suggested cytochrome P450 to be an intrinsic membrane protein, 
deeply embedded in the phospholipid bilayer with multiple a-helices 
spanning the membrane [45-49]. Recent experiments using site-specific 
antibodies and chimeric proteins however, demonstrated this model to be 
unlikely and a new model on the topology of membrane bound 
cytochrome P450 was proposed with an anchoring domain of one [50-59] 
maybe two [60-63] membrane spanning helices at the N-terminus and a 
large hydrophilic domain exposed to the cytosol which may have one or 
two additional peripheral membrane contacts [62, 64,65]. Based on gene 
analogy of mammalian and bacterial cytochrome P-450 the hydrophilic 
domain is suggested to resemble the overall shape of P450 CAM; a 
triangular prism, 30 Â thick, with sides of 55 to 60 Â [66]. This domain 
contains the heme group and the binding sites for NADPH-cytochrome 
reductase and cytochrome b5. Lysine residues located on the surface of 
the hydrophilic domain of the cytochromes P450 are suggested to play an 
important role in the interaction of the cytochromes P450 with NADPH-
cytochrome reductase and cytochrome b$ [67-69]. A model presenting 
membrane associated cytochrome P450 with one membrane spanning 
helix is presented in Figure A 1.2. The heme orientation of cytochrome 
P450 in relation to the plane of the membrane is at present not 
conclusively established. The opinions on this subject vary from a 
parallel orientation [61 ] to a perpendicular orientation with respect to the 
plane of the membrane [57 j. 
Cytosol 
Membrane 
*Hm 11111 r i I s ^ ^ \ I r \ 11 ! i i i NI r> I r Y \ 1i_ — — — — 
Lumen 
Figure Al .2: Membrane topology of mammalian cytochrome P450 
A 1.5.2 NADPH-cytochrome reductase 
NADPH-cytochrome reductase is a membrane bound flavoprotein and 
the primary electron donor for the cytochrome P450 enzymes although it 
is also capable of reducing cytochromes c and b5- In addition NADPH-
cytochrome reductase is capable of reducing artificial electron acceptors 
such as ferricyanide, 2,6-dichlorophenolindophenol and a great number 
of low molecular weight compounds with suitable redox potentials such 
as, for example, quinones [70]. The protein has a molecular mass of about 
76 kDa and is anchored to the membrane by a membrane spanning 
binding domain of 6-10 kDa at the acetylated N-terminus [71]. Without 
this membrane binding domain the protein is unable to reduce 
cytochrome P450 172,73]. The large hydrophilic C-terminal domain is 
exposed to the cytosol. 
The enzyme contains two prosthetic groups per polypeptide chain; 
one FAD and one FMN [74] which are responsible for the electron 
transport to cytochrome P450. The midpoint potentials of the two flavin 
molecules are presented in Table A1.2 [75,76]. 
Table Al .2: Redox potentials of the different redox couples in NADPH-cytochrome 
reductase 
redox couple 
FAD ^ FADH0 
FADH* » FADH2 
FMN <=> FMNH' 
FMNH' ^ FMNH2 
redox potential (mV) 
-290 
-365 
-110 
-270 
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Based on a study using NADPH-cytochrome reductase which was free of 
FMN the following sequence of electron transfer in the cytochrome P450 
enzyme system was proposed [77]; 
NADPH => FAD => FMN =* Cytochrome P450 
The low redox potential of FAD enables it to accept two electrons from 
NADPH. A sulfhydryl group and an e-amino group (perhaps of lysine) 
[78] located in the vicinity of the NADPH binding site are suggested to 
be involved in the interaction with NADPH. Upon accepting the electrons 
from NADPH, FAD transports the electrons to FMN which in its turn, 
when fully reduced, can transfer the electrons, one at a time, to 
cytochrome P450. Adjacent to the FMN binding region there is a cluster 
of 6 carboxyl groups which are part of the possible site of electrostatic 
interaction with cytochromes c and P450 [79,80]. Selective 
methylamidation of these carboxyl groups suppresses the ability of 
NADPH-cytochrome reductase to reduce cytochromes P450 and c but 
stimulates the reduction of cytochrome b5 by NADPH-cytochrome 
reductase [80] indicating that the mechanism of interaction of reductase 
with cytochromes P450 and c is different from that with cytochrome b5-
A 1.5.3 Cytochrome D5 
Cytochrome b5 is an amphipatic, heme containing enzyme of 16 kDa and 
composed of at least two domains. Proteolytic treatment leads to a heme 
containing, hydrophilic catalytically active fragment with a molecular 
weight of about 11 kDa. This catalytically active part was obtained in 
crystalline form and its structure was determined by X-ray analysis and 
NMR [81,82] as a spherical ellipsoid with a diameter of 31 Â and a 
height of 38 Â. The heme group has two histidines as axial ligands and 
two propionate residues from the heme are exposed to the water phase. 
Carboxyl residues located on the surface of the catalytic domain of 
cytochrome 115, together with the propionate groups participate directly in 
the interaction with NADPH-cytochrome reductase and NADH-
cytochrome reductase [83,84]. 
The hydrophilic part is connected to a hydrophobic, membrane 
incorporated part by a flexible region of about 10 amino acids which 
allows a high mobility of the hydrophilic part [85]. Probably due to this 
flexible region the heme group of cytochrome b5 has no definite 
orientation with respect to the plane of the membrane [86]. The 
membrane fragment is a C-terminal fragment of about 40 amino acids 
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[85]. Together with the carboxyl residues on the hydrophilic domain, the 
hydrophobic part is essential for interaction with the other proteins of the 
enzyme system. 
A 1.5.4 NADH-cytochrome reductase 
The primary electron donor of cytochrome 05 is NADH-cytochrome 
reductase. It is a membrane bound, flavin (FAD) containing protein of 
about 33 kDa with the active site located at the cytosolic side of the 
endoplasmatic reticulum membrane [66]. The redox potential of this 
flavin containing protein was determined to be -280 mV [87] and it can 
use both NADH and NADPH as electron source although the latter is 
actually used much less frequent. The hydrophilic and hydrophobic parts 
are, like in cytochrome b$, assumed to be connected by a short, extremely 
flexible region [88] which enables the enzyme to serve as an electron 
carrier to various acceptors. The membrane binding domain is a strongly 
hydrophobic N-terminal fragment. The amino-terminal glycine is 
acylated by myristic acid [89]. 
A1.6 The cytochrome P450 catalytic cycle 
The cytochrome P450 enzyme system is capable of catalysing a variety of 
reactions, including oxidative and reductive dehalogenation, oxidative 
deamination, aliphatic-, aromatic- and N-hydroxylation, N-oxidation, 
epoxidation and O-, N- and S-dealkylation. Most of these reactions are so 
called monooxygenase reactions in which one of the atoms of molecular 
oxygen is transfered to the substrate and the other atom is incorporated in 
a watermolecule. 
R + 0 2 + 2e- + 2H+ => RO + H 2 0 
The catalytic mechanism of the cytochrome P450 dependent 
monooxygenase reaction is depicted in Figure A1.3. The individual steps 
in the catalytic cycle are discussed in detail hereafter. 
Al.6.1 Cytochrome P450 Fe3+ 
The catalytic site of the enzyme system contains an Fe^+-protoporphyrin 
IX as the prosthetic group [90-92], whose ferrous-carbon monoxide 
complex exhibits a characteristic light absorption peak around 450 nm. 
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(RO)FeJ (R)Fe 3+ 
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(R)Fei+(022) 2H+ H202 T 
O, 
(R)Fe2+(02) 
(R)Fe2+((y) (R)Fe3+(0/) 
Figure A 1.3: Catalytic mechanism of the cytochrome P450 monooxy'genäse reaction 
The iron atom of the ironporphyrin functions as an Fe2+/Fe3+ redox 
couple in the catalytic cycle. The four N-atoms from the porphyrin 
molecule act as the planar ligands of the Fe3+. The fifth ligand of the iron 
heme is a cysteinyl thiolate group [93] which in the bacterial cytochrome 
P450 CAM originates from Cys 357 [43]. This axial cysteine ligand 
contributes to the specific function of cytochrome P450 compared to 
oxygen binding hemoproteins like myoglobin and hemoglobin, in which 
the fifth coordinate position is occupied by a histidine residue. The 
typical light absorption peak at 450 nm also originates from this axial 
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cysteine ligand. Denaturation of the protein shifts this absorption band 
from 450 to 420 nm as a result of either a distorted iron-thiolate bond 
[94] or a replacement of the thiolate by another ligand [95]. It has been 
suggested that in the denatured state an imidazole is coordinated to the 
iron instead of a thiolate [96]. The other axial ligand of cytochrome P450 
might be an OH-containing group - probably originating from tyrosine or 
a water molecule - resulting in the hexacoordinated, low spin (S=l/2) 
Fe3+ form with the iron in the plane of the porphyrin ring. However, the 
sixth ligand position can also remain unoccupied, resulting in the 
pentacoordinated, high spin (S=5/2) Fe3+ form, with the iron atom 
slightly lifted out of the plane of the porphyrin molecule (Figure A1.4). 
The high and low spin conformers of the heme group are in equilibrium 
with each other and the position of this equilibrium is dependent on the 
cytochrome P450 form, the temperature and the ionic strength of the 
solvent[971. 
Low-spin High-spin 
Figure A 1.4: Low and high spin form of cytochrome P450 
Al.6.2 Cytochrome P450 Fe3+ + R => cytochrome P450 Fe3+(R) 
The binding of substrate to cytochrome P450 is generally accompanied 
by a shift in the spin equilibrium. This change in the spin equilibrium 
results in characteristic spectral changes of the heme chromophore. The 
spectral changes can be divided into three categories. The majority of the 
substrates (mainly hydrophobic substrates) induce a difference spectrum 
which is characterised by a peak at 387 nm and a trough at 421 nm. This 
is denoted as a type I difference spectrum and explained as a shift in the 
spin equilibrium from low-spin to high-spin cytochrome P450 (Figure 
A 1.5). Type 1 difference spectra have also been observed upon addition to 
cytochromes P450 of NADPH-cytochrome reductase [98], phospholipids 
[98-100], cytochrome b5 [101-104] and free fatty acids [105]. Other 
substrates (for example alcohols and ketones) produce a reverse type I 
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difference spectrum with a peak at ±420 nm and a trough at 385-390 nm. 
This is interpreted as a shift towards the low-spin conformer. Finally a 
group of substrates (nitrogen containing compounds) induce a type II 
difference spectrum with a maximum between 425 and 445 nm and a 
minimum between 390 and 420 nm. It is assumed that type I substrates 
(mainly hydrophobic molecules) bind to a hydrophobic site near the heme 
group of cytochrome P450, while type II substrates occupy the sixth axial 
ligand position [106-107]. 
< 
< 
360 380 400 420 440 
Wavelength (nm) 
460 
Figure Al .5: Type I difference spectra of cytochrome P450 IIBl in the presence of 
increasing concentrations of ethoxycoumarin 
The substrate binding site has been reported to be facing (or partly buried 
in) the membrane [49,108], although this is contradicted by others [57]. 
Because of the lipophilic character of most substrates, the active sites of 
the cytochromes P450 are assumed to be hydrophobic domains located 
near the heme [109-111]. Experiments involving the chemical 
modification of tyrosines suggest that Tyr 380 is located in the active site 
of cytochrome P450 LM2 (cytochrome P450 IIB1 new nomenclature) and 
involved in substrate binding together with Phe 377 [45,112]. 
For some cytochrome P450 enzymes a change in the spin 
equilibrium in favor of the high spin state results in a significant increase 
in the redox potential. For instance, upon camphor binding, the redox 
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potential of bacterial cytochrome P450 CAM has been reported to 
increase from -303 mV to -173 mV [97,113] which would facilitate its 
reduction. Although an increase in the redox potential upon substrate 
binding was not observed for other P450 enzymes [114] it is generally 
assumed that substrate binding can facilitate the reduction of cytochrome 
P450. 
Al.6.3 Cytochrome P450 Fe3+(R) + e- => cytochrome P450 Fe2+(R) 
In the next step of the reaction cycle cytochrome P450 becomes one-
electron reduced. For mitochondrial and bacterial cytochromes P450, the 
electron comes from NADH via a flavoprotein and a ferredoxin (an [2Fe-
2S]-protein) [8,9] whereas for mammalian cytochrome P450 systems the 
first electron for the reaction comes from NADPH via NADPH-
cytochrome reductase. 
Because pyridine nucleotides are two electron donors and 
cytochrome P450 can only accept one electron at a time, NADPH-
cytochrome reductase must be a two electron acceptor and a one electron 
donor. This means that during the electron transfer process the reductase 
must be able to store a radical electron in a form which is insensitive to 
molecular oxygen. This oxygen stable semiquinone form is most likely 
FAD-FMNH« [76]. The exact mechanism by which electrons are 
transported from NADPH to cytochrome P450 is at present still unclear 
but a possible mechanism was suggested by Iyanagi et al. [76] (Figure 
Al.6). In a "priming" reaction the low potential flavin, FAD, accepts two 
electrons from NADPH [115]. Through intramolecular transfer the 
electrons are transported to the high potential flavin, FMN. The FAD-
FMNH2 then transfers one electron to cytochrome P450, resulting in the 
formation of the oxygen stable semiquinone form, FAD/FMNH». This 
semiquinone form is rapidly reduced by NADPH to the three electron 
reduced form, FADHi-FMNH«. Through intramolecular electron transfer 
an electron is again transported to FMN, leading to the formation of 
FAD'-FMNIh, which also can donate an electron to cytochrome P450. 
The remaining FAD«-FMN* is converted through intramolecular electron 
transfer to FAD-FMNH2 which can enter a new cycle. 
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FADH« - FMNH FADH2 - FMNH« 
Figure A 1.6: The catalytic cycle of NADPH-cytochrome reductase 
Stopped flow studies with purified proteins have provided evidence 
for the fact that the reduction of cytochrome P450 in the first electron 
transfer process is a biphasic reaction, composed of two independent 
first-order partial reactions [116]. Since the majority of the cytochromes 
P450 is reduced in the rapid partial phase, this one is considered to be the 
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physiologically relevant process [97]. Several reaction models were 
proposed for the reduction of cytochrome P450 by NADPH-cytochrome 
reductase. 
1 .The first model is the "statistical collision model" in which both 
cytochrome P450 and NADPH-cytochrome reductase are randomly 
distributed over the membrane. The rate of reduction is supposed to be 
determined by the lateral mobility of the proteins in the membrane. 
This model, however, does not explain the biphasic character of the 
reduction of cytochrome P450 [117-121]. 
2.In the so-called "sequential spin state model", the high- and low-spin 
form of the cytochrome P450 are supposed to exhibit specific 
reactivities. Reduction of the high-spin fraction is suggested to be 
related to the rapid partial reaction, whereas the reduction of the low-
spin fraction is supposed to represent the slow partial reaction. The 
slow reduction of the low-spin fraction is supposed to occur via the rate 
limiting relaxation into the high-spin conformation [122-124]. 
However, the relaxation of the spin equilibrium was demonstrated to 
proceed in the nanosecond region [125,126], thereby excluding rate 
limitation by this step. As an alternative an additional conformational 
change, being spectrally invisible, has been proposed to represent the 
rate limiting step responsible for the slow reduction phase [124]. 
3.In the "redox state control model" cytochrome P450 reduction is 
suggested to occur by the biphasic kinetics due to its reduction by 
NADPH-cytochrome reductase with different redox states [127]. This 
model is based on a dependency of the phase distribution of the 
reduction process on the NADPH concentration, but it is questioned 
because of the occurence of the biphasic character of the reduction 
process even under conditions of high NADPH and reductase 
concentration. 
4.The fourth model, the so-called "cluster model" is based on the high 
ratio of cytochrome P450 to reductase (15 to 30) in the endoplasmatic 
reticulum membrane [128]. According to this model, the reductase is 
surrounded by a cluster of cytochrome P450 molecules. This 
organisation implies a sweet contact between the cytochrome P450 and 
the reductase enabling efficient electron transfer. Therefore, reduction 
of the cytochromes P450 in this cluster is proposed to correspond to the 
fast partial reduction. The slow partial reduction would correspond to 
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the reduction of non-associated cytochrome P450 molecules after a 
rate-limiting exchange with clustered cytochromes P450 [129-132]. 
Al.6.4 Cytochrome P450 Fe2+(R) + 0 2 => cytochrome P450 
Fe2+(02)(R) <=> Fe3+(02')(R) 
After the first one electron reduction oxygen binds to the enzyme, 
occupying the sixth coordinate, thus forming the hexacoördinated 
Fe2 +(02)(RH). Through electron transfer from Fe2 + to 0 2 the 
Fe3+(02*)(RH) is formed [8]. At this stage the cycle can derail by the 
release of a superoxide anion and the return of the enzyme to the 
Fe3+(RH) state. The superoxide anion is reactive and might inactivate 
cytochrome P450 by oxidizing the heme group [133-137]. Furthermore, 
the superoxide anion can undergo an iron-catalysed Haber-Weiss reaction 
Fe2+/3+ 
02- + H 2 0 2 => OH- + OH* + 0 2 
yielding the highly reactive hydroxyl radical (HO»). This hydroxyl radical 
may inactivate P-450 and other proteins and / or initiate peroxidation by 
hydrogen abstraction from a polyunsaturated fatty acid of a membrane 
phospholipid (138]. 
Al.6.5 Cytochrome P450 Fe3+(02s)(R) + e- => cytochrome P450 
Fe2+(02')(R) « Fe3+(022-)(R) 
A major difference between the introduction of the first and second 
electron is that the first electron is donated almost exclusively by 
NADPH via NADPH-cytochrome reductase, whereas the second electron 
can be donated by both NADPH via NADPH-cytochrome reductase and 
NADH via NADH-cytochrome reductase and cytochrome b$ [9,139]. A 
contribution of the cytochrome b$ electron donating system to the second 
electron reduction process is, however, not observed for all substrates 
[7,140,141]. For mitochondrial and bacterial cytochromes P450 the first 
and second electron are both donated by the NADH-flavoprotein-
ferredoxin system [8|. 
After the second electron reduction the catalytic cycle can derail, 
namely by the release of hydrogen peroxide from which in a Haber-Weiss 
reaction - as indicated above - hydroxyl radicals are formed which might 
inactivate cytochrome P450 and initiate lipid peroxidation [138]. 
Although the exact electron density distribution within the 2-
electron reduced oxygen bound P-450 complex is not yet known, it is 
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suggested that a second electron transfer to molecular oxygen occurs 
followed by protonation of the terminal oxygen atom resulting in 
formation of a Fe-^ +CC^H") intermediate. This process is supposed to 
facilitate the next step in the catalytic cycle [142]. 
Al.6.6 Cytochrome P450 Fe3+(022-)(R) + 2H+ => cytochrome P450 
(FeO)3+(R) + H 2 0 
It is generally assumed that the heterolytic cleavage of the 0 - 0 bond in 
the Fe3+(02-")R intermediate results in the formation of a high valency 
iron-oxo complex. The exact distribution of the electrons in this reactive 
intermediate is still under debate but all hypotheses include the removal 
of two elections from the iron (forming Fe5+) by oxygen (forming 02_) 
resulting in a high valency iron-oxo center with a formal charge of 3 + . 
Possible distributions of the electrons in this intermediate might be: 
- Fe 5 + (02 2 ) [142-145], with an iron that has a valency of five 
(perferryl). However, upto now such a perferryl iron has not yet been 
observed in any hemoprotein. 
- Fe4+(02-) [142,143,146]. This distribution explains the radical 
character of the iron-oxo species, which is in accordance with the 
radical mechanism suggested for several cytochrome P450 dependent 
biotransformations (see below). 
- (protein/porphyrin)+(Fe4+)(022") with a porphyrin or protein centered 
radical because the iron-oxo species is suggested to have extracted an 
electron from the porphyrin ring or (perhaps) from the protein 
|142,146|. Although the role of the protein or the porphyrin in the 
iron-oxo complex remains to be proven, the porphyrin ring, protein 
chain and / or cysteine ligand might be important in the reactive 
intermediate by stabilizing the highly electrophilic iron-oxo species by 
(partial) electron donation. 
Al.6.7 Cytochrome P450 (FeO)3+(R) => cytochrome P450 Fe3+(RO) 
In this step of the catalytic cycle the substrate is converted to product by 
transfer of the oxygen atom from the (FeO)3+ species to the substrate. 
This results in, for example, alifatic- or aromatic hydroxylation, 
epoxidation or heteroatom oxidation. Some generally accepted 
mechanisms and some hypotheses for cytochrome P450(FeO)3 + 
catalysed substrate conversions are presented in Figure A1.7 [142-150] 
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After release of the product the ferric form of the enzyme is ready to 
enter the next reaction cycle. 
A1.7 An additional component of the cytochrome P-
450 enzyme system 
In this thesis so far, the properties of the individual protein constituents 
of the enzyme system and their role in cytochrome P450 substrate 
conversions have been discussed. However, after the first succesful 
reconstitution of the cytochrome P450 enzyme system in 1968 it was 
demonstrated that in addition to cytochrome P450, NADPH-cytochrome 
reductase, cytochrome b$ and NADH-cytochrome reductase a fifth, non-
protein component was also of importance to generate a reconstituted 
cytochrome P450 enzyme system with optimal catalytic activity. This 
fifth component, later demonstrated to be the phospholipids of the 
endoplasmatic reticulum membrane, has been shown to influence 
cytochrome P450 dependent activities. The role of phospholipids in the 
cytochrome P450 enzyme system and the interactions of phospholipids 
with cytochrome P450 and NADPH-cytochrome reductase will be 
discussed in more detail in Chapter IB. 
Aliphatic hydrocarbon hydroxylation 
(FeO)3+ + H-CR3 „ . „ _ „ „ » „ (FeOH)3+ + «CR, , O H r e h » d Fe3+ + HO-CR3 H* abstraction 
Heteroatoin dealkylation (X = 0,N,S) 
(X=0) \3+ 
H 
1 
(FeOr  + RCHXRn — 
H* abstraction 
'abstraction^ ( * = N>i>) 
H 
(FeOH)3+ + RC*HXRn 
(FeO)2+ + RCHX*+Rn 
'proton release 
OH 
— Fe3+ + RCHXRn 
RCHO + HXR„ 
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Heteroatom oxygenation (X = N,S,I,P) 
\3+ (FeOy  + CR,XRn — abstraction (FeO)
2+
 + CR3X*tRn •*- Fe
3+
 + CR^XR 
O 
* . 
3Xivn 
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\3+ (FeO)J  + RoC=CRo •*- (FeO-CRj-C'Rzr 
O 
Fe3+ + R2C-CR2 
Aromatic ring hvdroxylation 
(FeO)-' R - ( F e O — ( à— R] 
( F e
°
) 3 + + < C } _ x H n 
,3+ 
Fe3+ + 
Fe3+ + 0 = < ù— R 
H 
" I 
Fe3+ + HO-& Ù— R-> 
— (FeOH)3+ + 
(FeOH)J+ + ,3  
0~ x 'H ( n 
4 )=XH(n-l) 
(FeOH) 3+ + / " " V X H ^ D — ^ — H O - ^ ~ y - X H „ 
Figure Al.7:Possible mechanisms for cytochrome P450 (FeOP+ catalysed 
substrate conversions 
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Bl.l Introduction 
The properties of membrane-bound enzyme systems which are associated 
with the endoplasmatic reticulum membrane, like the cytochrome P450 
system, may be influenced by characteristics of the membrane. Among 
the membrane characteristics that have been shown to influence the 
cytochrome P450 enzyme system are membrane fluidity (determining the 
lateral and rotational mobilities of the various protein constituents of the 
cytochrome P450 system), membrane charge (influencing electrostatic 
protein-protein and lipid-protein interactions) and the hydrophobic 
character of the core of the membrane (contributing to substrate 
accumulation in the vicinity of the enzymes) [1-10] These physical 
properties of the membrane are largely determined by the membrane 
phospholipids, important constituents of the membrane. This chapter 
focusses on the structural features of phospholipids and of the 
endoplasmatic reticulum membrane and especially on the effects of 
phospholipids on the cytochrome P450 enzyme system. 
B1.2 General structure of membrane phospholipids 
The membrane phospholipids are amphipathic in nature, i.e. they contain 
a hydrophobic and a hydrophilic region. The basis of the structure of 
most phospholipids is formed by a glycerol molecule. At the C\ and C2 
position of the glycerol molecule two fatty acids are esterified. Many 
phospholipids, occuring in natural membranes, exist as heteroacid lipids, 
i.e. phospholipids with two different fatty acyl chains, usually a saturated 
fatty acid at C\ and an unsaturated fatty acid at C2. Some phospholipids 
contain only a fatty acid at the Ci position and are not esterified at C2. 
These are the socalled lysophospholipids. The fatty acyl chain(s) form the 
hydrophobic region of the molecule. 
The hydrophilic region is formed by the phosporylalcohol bound to 
the hydroxyl group at the C3 position of the glycerol molecule. The 
common moieties of the phosphoryl alcohols in the endoplasmatic 
reticulum are phosphorylcholine, phosphorylethanolamine, 
phosphoryl serine and phosphorylinositol. Table Bl.l presents their 
structural formula. In addition, there are phospholipids which occur less 
frequent in the endoplasmatic membrane. These phospholipids are 
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phosphatidylglycerol (PG), containing a phosphorylglycerol at the C3 
position and phosphatidic acid (PA), containing only a phosphate group 
(PA). In the mitochodria an additional phospholipid, cardiolipin (CL), 
occurs which is composed of two phosphatidic acid molecules linked 
together at the phosphate group by a glycerol molecule (Figure Bl.l). 
Sphingomyeline (SM) is the only phospholipid in the membrane that is 
not derived from glycerol. Instead, the backbone is sphingosine, an amino 
alcohol that contains a long unsaturated hydrocarbon chain that is part of 
the hydrophobic domain of the molecule. This phospholipid contains only 
one fatty acid which is linked to the sphingosine molecule by an amide 
bond. In addition, the primary hydroxyl group is esterified to 
phosphocholine and consequently the structure of sphingomyeline 
resembles that of phosphatidylcholine (Figure Bl.l). 
Table Bl.l: Chemical structure of glycerol based phospholipids 
O 
II 
C ] — C — O — C H 2 
C o — C — 0 — C H 
II 1 
O H2C— 0 -
NAME 
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Figure BIJ: Structure of cardiolipin and sphingomyelin 
Because of their amphipathic nature phospholipids tend to orientate in 
aqueous solutions in a way that keeps the hydrophobic region away from 
the waterphase. This is usually done by self-assembling into aggregates. 
The kind of aggregates they form upon solvation in aqueous solutions 
depends on the molecular shape of the phospholipids. This shape is 
determined by the relative size of the headgroup compared to the size of 
the fatty acyl chains and can be either a cone (large headgroup relative to 
fatty acyl chains such as in for example lysophospholipids), a cilinder 
(headgroup and fatty acyl chains "equal" in size such as in for example 
PS, PC and SM) or a wedge or "inverted" cone (small headgroup relative 
to fatty acyl chains such as in for example unsaturated PE) (Figure B1.2) 
[11,12]. Cone-shaped lipids show a tendency to organise themselves in 
micelles, cilinder-shaped lipids in bilayers and wedge-shaped lipids in 
hexagonal U\] phases or reversed micelles (Figure B1.2) [11,12]. 
Biological membranes are composed of a mixture of cone-, cilinder- and 
wedge-shaped phospholipids and the overall orientation is that of a 
bilayer (Figure B1.3). 
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Figure B1.2: Phospholipid shape and orientation in aqueous solutions 
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Figure BI.3: Orientation of a mixture of cone-, cilinder- and wedge shaped 
phospholipids in aqueous solutions 
B1.3 Characteristics of the endoplasmatic reticulum 
membrane 
The cytosolic surface of 60% of the endoplasmatic reticulum is dotted 
with ribosomes. These regions are called the rough endoplasmatic 
reticulum, in contrast to the regions that contain no attached ribosomes, 
which are called the smooth endoplamatic reticulum [13,14]. By 
electronic microscopy the membranes were estimated to be 50-80 Â thick 
[15,16]. The endoplasmatic reticulum membrane is very dynamic in 
nature allowing the individual membrane components to be mobile. The 
mobility is influenced to a substantial degree by the fluidity of the lipid 
matrix which in turn is mainly determined by the length and degree of 
unsaturation of the fatty acyl chains of phospholipids, the cholesterol / 
phospholipid ratio, the amount of PE and SM and the presence of 
intrinsic membrane proteins [12,17]. 
About 70% by weight of the endoplasmatic reticulum membrane 
consists of protein and 30% of lipids. Of these lipids 85% is phospholipid 
[18] and the remaining 15% is made up of non-phosphorous containing 
lipids like cholesterol and free fatty acids. The composition of the 
phospholipid part of the endoplasmic reticulum membrane as reported by 
Glaumann and Dallner [18] is presented in Table B1.2. The constitution 
of the phospholipid species of the endoplasmatic reticulum membrane 
implies that at physiological pH the membrane has an overall negative 
charge. 
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The phospholipids of the endoplasmatic reticulum membrane 
contain a variety of fatty acids. In the endoplasmatic reticulum membrane 
the fatty acid moiety of phospholipids consists mainly of palmitic acid 
(from now on referred to as 16:0, i.e. a fatty acid, 16 carbon atoms long 
containing 0 double (unsaturated) bonds), palmitoleic acid (16:1), stearic 
acid (18:0), oleic acid (18:1), linoleic acid (18:2), arachidonic acid (20:4) 
and docosahexaenoic acid (22:6) [19]. The amount of each fatty acid in 
hepatic microsomal lipids as reported by Borlakoglu et al. [20] is 
presented in Table Bl .2. 
Table B1.2: Phospholipid and fatty 
reticulum membrane 
acid composition of the endoplasmatic 
Phospholipid 
[18] 
phosphatidylcholine 
(PC) 
phosphatidyl-
ethanolamine (PE) 
phosphatidylserine 
(PS) 
phosphatidylinositol 
(PI) 
sphingomyelin (SM) 
relative 
amount 
(%) 
55 
20-25 
8-10 
5-10 
4-7 
Fatty acid 
[20] 
palmitic acid (16:0) 
palmitoleic acid (16:1) 
stearic acid (18:0) 
oleic acid (18:1) 
linoleic acid (18:2) 
arachidonic acid (20:4) 
docosahexaenoic acid 
(22:6) 
unidentified 
relative 
amount 
(%) 
28 
3 
23 
15 
13 
10 
5 
12 
A significant proliferation of the endoplasmatic membrane has been 
reported upon treatment of rats with cytochrome P450 inducers. The total 
phospholipid concentration, the phospholipid composition and the fatty 
acid composition have been shown to be affected by phénobarbital, 20-
methylcholanthrene and polychlorinated biphenyls [20-23]. 
Controversy exists with respect to the distribution of the 
phospholipids over the inner and outer layer of the endoplasmatic 
reticulum membrane. Some authors reported an asymmetrical distribution 
with PE and PS predominantly on the outside and PI and SM 
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predominantly on the inside of the endoplasmatic reticulum membrane 
[24-26]. Others reported an asymmetrical distribution with PC and SM 
mainly on the outside and PE and PI mainly on the inside [27-29] 
whereas Sundler et al. [30] reported a symmetrical distribution for all 
phospholipids. 
B1.4 In vitro models for the cytochrome P450 enzyme 
system 
The exact structural organisation of the cytochrome P450 enzyme system 
in the natural endoplasmatic reticulum membrane is presently not well 
characterised. To allow detailed investigation concerning the effect of 
phospholipids on the properties of the monooxygenase system, three 
different types of in vitro systems are reported up to now. Before 
summarizing the effects of phospholipids on the cytochrome P450 system 
in more detail, each of the three in vitro systems will be briefly discussed. 
Bl.4.1 The microsomal system 
Of all three in vitro systems, the microsomal system resembles the actual 
situation in the natural membrane most. Microsomes are small fragments 
of the endoplasmatic reticulum membrane obtained after extensive 
homogenisation and differential centrifugation of liver tissue. These 
fragments seal right side out [24,31-33] to form closed vesicles of 
approximately 150-300 nm [34]. Thus, the external surface of 
microsomes corresponds to the cytoplasmatic surface of the 
endoplasmatic reticulum. Microsomal vesicles mirror the properties of 
the endoplasmatic reticulum [24,32]. Depending on the part from the 
endoplasmatic reticulum from which the microsomes originate the 
vesicles have ribosomes on their outer surface [24]. The composition and 
distribution of phospholipids and proteins in the vesicle membrane are 
comparable to those in the endoplasmatic reticulum membrane [24]. 
Uncharged molecules of low molecular weight (<600-1000 Da) can 
penetrate microsomal vesicles whereas most charged molecules and high 
molecular weight proteins do not cross the membrane [35,36]. Compared 
to the other two in vitro systems, the microsomal system is prepared 
relatively easy and resembles the actual situation in the endoplasmatic 
reticulum membrane most. However, for mechanistic studies on the 
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cytochrome P450 system an in vitro system is required in which the 
individual components of the enzyme system can be systematically and 
easily altered and influenced. This means that the protein components of 
the enzyme system and phospholipids have to be isolated. 
Bl.4.2 Reconstituted systems with isolated, membrane incorporated 
proteins. 
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Figure Bl .4: F PLC elation pattern of a cholate dialysed preparation of cytochrome 
P450, NADPH- cytochrome reductase and phospholipids and the 
alkoxyresorufin-O-dealkylating activity of the fractions (taken from 
Chapter 2) 
This in vitro system uses isolated cytochrome P450 and NADPH-
cytochrome reductase (and cytochrome b$ and NADH-cytochrome 
reductase) which are incorporated into an artificial phospholipid 
membrane. Unilamellar liposomes with diameters of 50-100 nm are 
formed upon the removal of cholate from a phospholipid and protein 
mixture either by dialysis [37] or gel filtration [38]. FPLC experiments 
demonstrate that the cholate dialysis technique results in the formation of 
large vesicles of high molecular weight (> 1000 kDa) as can be seen in 
Figure B1.4. The proteins are inserted in an unidirectional manner with 
the enzymes orientated toward the outside of the vesicles [39-42]. When 
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incorporated at a 1:1 stoichiometry cytochrome P450 and NADPH-
cytochrome reductase were demonstrated to form heterodimeric 
complexes of one reductase and one P450 molecule in these vesicles 
[43,44]. The difference with the microsomal system is that in this in vitro 
system both the protein and the phospholipid composition are well 
defined and can be changed according to the wishes of the investigator. 
However, because this in vitro system requires isolated proteins it is more 
difficult to prepare and more artificial than the microsomal system. 
Bl.4.3. Reconstituted systems with isolated, solubilised proteins 
This in vitro system also uses the isolated protein components of the 
cytochrome P450 enzyme system. However, in contrast to the previous 
(B 1.4.2) system, in which the isolated proteins are reincorporated into an 
artificial membrane, in the present type of in vitro system the individual 
proteins remain water soluble and are mixed with a solution containing 
phospholipid vesicles. This reconstituted system is obtained by 
incubating the proteins and phospholipids for a short period (5-10 
minutes) in a small volume [45,52]. Generally, this reconstituted system 
is prepared by incubation of only one form of isolated cytochrome P450, 
NADPH-cytochrome reductase and phospholipids, although in some 
cases isolated cytochrome bs may also be added. FPLC analysis of the 
system has shown that the isolated cytochrome P450 and NADPH-
cytochrome reductase component both exist as multimeric protein 
aggregates. Rather than forming heterogenic multimeric protein 
complexes, cytochrome P450 and NADPH-cytochrome reductase were 
demonstrated to exist as homomeric protein aggregates of respectively 
six P450 molecules (IIB1 and IA1) (Figure 2.5) [49,50,52-55] and 
approximately 31 reductase monomers [50]. For cytochrome P450 LM2 
(IIB1) and LM4 (IA2) the six monomeric molecules are suggested to be 
arranged in two layers of three monomers in a 6-pointed star manner 
[56]. Both protein multimers have a few individual phospholipids 
attached to each protein multimer [49-51,57]. 
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Figure BI .5: F PLC elution pattern of isolated cytochrome P450 IAl and IIB1 and 
the calibration curve to determine their aggregation number (taken 
from Chapter 2) 
Early reconstitution experiments in this so-called "solubilised 
reconstituted in vitro system" [45-47] have demonstrated that cytochrome 
P450 and NADPH-cytochrome reductase alone are however not 
sufficient to reconstitute optimal cytochrome P450 dependent 
conversions. The addition of phospholipids is necessary to obtain optimal 
cytochrome P450 dependent conversions (see also B1.5). Similar to the 
reconstituted system in which the proteins were incorporated into a 
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membrane, in the solubilised reconstituted system the protein and 
phospholipid compositions can also be changed but because the proteins 
are not membrane incorporated, this in vitro system is the most artificial 
of all three systems. 
B1.5 Phospholipids and cytochrome P450 
Since the first succesful reconstitution of cytochrome P450 dependent 
activities in 1968 [58], the enzyme system has been shown to require at 
least three endogenous components for optimal reconstitution of 
cytochrome P450 dependent activities, namely cytochrome P450, 
NADPH-cytochrome reductase and a microsomal component, stable to 
heat treatment. This heat stable factor, later identified as phospholipid 
[45-47] and more specifically phosphatidylcholine [48], was shown to 
affect the activity of cytochrome P450 dependent reactions, with the 
reaction rate not only being dependent on the phospholipid concentration 
but also on the composition of the fatty acyl moiety and the headgroup of 
the phospholipids [59]. Of several different phosphatidylcholine species 
tested, the addition of the phosphatidylcholine derivative with two 
saturated fatty acyl chains of 12 carbon atoms (dilauroyl 
phosphatidylcholine (PC dil2:0)) appeared to result in the highest 
reconstituted cytochrome P450 dependent activities [59]. Although the 
stimulating effect of phospholipids on cytochrome P450 dependent 
activities has been well documented the molecular mechanism underlying 
this phenomenon is still a matter of considerable debate. A number of 
hypotheses for the stimulating effect of phospholipids on the cytochrome 
P450 enzyme system have been proposed which are discussed in more 
detail hereafter. 
B 1.5.1 Hypotheses for the stimulating effect of phospholipids on the 
cytochrome P450 enzyme system 
(1) The membrane provides a lipophilic environment in which the 
hydrophobic substrates for cytochrome P450 can dissolve 
A low affinity of substrates for cytochrome P450 might in some cases be 
compensated by partitioning of the substrate into the membrane resulting 
in a higher effective concentration in the neighbourhood of the active site 
[2,3]. This assumption was supported by the observation that 
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incorporation of cytochrome P450 LM2 (IIB 1 ) from phénobarbital 
pretreated rabbit liver microsomes into an artificial membrane resulted in 
a 10-fold decrease in the apparent Michaelis constant (Km) for 
benzphetamine [10]. In close relation with this theory it was proposed 
that the substrate binding site (or the access channel of the substrate 
binding site) of cytochrome P450 LM2 from phénobarbital pretreated 
rabbit liver microsomes was in close contact with the membrane interior 
[8,9]. Although this hypothesis may very well be of importance for 
systems in which the proteins of the enzyme system are incorporated into 
a membrane, it does not explain the stimulating effect of phospholipids in 
reconstituted systems in which the proteins remain solubilised in an 
aqueous solution with only a few phospholipid molecules attached to 
each protein homo-multimer. 
(2) Phospholipids induce a change in the conformation of cytochrome 
P450 
An effect of phospholipids on the conformation of cytochrome P450 was 
demonstrated by various investigators using the solubilised reconstituted 
cytochrome P450 system. Chiang and Coon [60] observed that the 
presence of phospholipids results in an increase in the helical content of 
isolated cytochrome P450 LM2. Furthermore, studies using second 
derivative spectroscopy demonstrated an increase in the amplitude of the 
tyrosine band upon interaction of isolated cytochrome P450 LM2 with 
phospholipids (and detergents) [61]. The latter observation might best be 
explained by an increase in the apolar character of the immediate 
environment of (a) tyrosine residue(s) responsible for the phenomenon. 
Such an environmental change can be achieved by a conformational 
change of the protein influencing the tyrosine residue(s) at the surface of 
the protein. Recently, Rietjens et al. [50] observed a decrease in the 
tryptophan fluorescence polarization of cytochrome P450 IIB1 upon 
addition of PC dil2:0 indicating an increased mobility of this residue in 
the presence of PC dil2:0. This decrease in fluorescence polarization of 
the single tryptophan residue [62] of P450 IIB1 was suggested to result 
from a PC dil2:0 dependent change in the protein conformation. It should 
however be mentioned that the addition of PC dil8:0 to P450 IIB1 did 
not result in a significant decrease in the tryptophan fluorescence 
polarization but this might be related to the much lower ability of this 
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phospholipid to stimulate cytochrome P450 dependent activities 
compared to PC dil2:0 [501. 
(3) Phospholipids induce a change in the spin-equilibrium of cytochrome 
P450 
In close relation with the hypothesis described above phospholipids have 
been reported to cause a shift in the spin equilibrium of cytochrome P450 
LM2 (IIB 1 ) towards the high-spin conformer. Such a shift in the spin 
equilibrium of cytochrome P450 LM2 (IIB1) in the presence of PC dil2:0 
was first observed by Chiang and Coon [60]. In other studies this high-
spin shift appeared to be especially favoured by negatively charged 
phospholipids [63]. A phospholipid induced shift in the spin equilibrium 
was demonstrated to result in a significant decrease in the apparent 
binding constant of cytochrome P450 LM2 for the substrate 
benzphetamine [64]. Other investigators, however did not observe an 
altered substrate / enzyme interaction upon the addition of PC dil2:0 to 
cytochrome P450 IIB 1 [65-67]. 
(4) Phospholipids affect the aggregation state of (artificial) protein 
multimers 
This model is based on the fact that both isolated cytochrome P450 and 
NADPH-cytochrome reductase in solution selfaggregate to form 
homomultimers. Due to its high critical micellar concentration (CMC) of 
45 JIM [64], PC dil2:0 was suggested to act as a detergent and dispers 
these protein multimers, thereby increasing the effective protein 
concentration [8,66,67]. However, more recent data demonstrate that it is 
highly unlikely that the phospholipid induced stimulation of cytochrome 
P450 dependent activities proceeds according to this mechanism. First, 
the CMC value of PC dil2:0 was demonstrated by Rietjens et al. [50] to 
be two orders of magnitude lower than the one reported by Coon et al. 
[64]. Besides, although high concentrations of Triton X-100, n-
octylglucoside or Lubrol PX caused the dissociation of the aggregates 
[68,69], phospholipids themselves were not able to alter the aggregation 
state of cytochrome P450 IIB1 significantly [50,70]. Furthermore, the 
Lubrol PX induced dissociation of the cytochrome P450 IIB1 and 
NADPH-cytochrome reductase aggregates resulted in a decrease in the 
pentoxyresorufin-O-dealkylating activity instead of an increase (Figure 
B1.6) [50]. A new hypothesis by Causey et al. [51] suggested that 
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phospholipids might relax the tight multimeric complexes, thus 
facilitating functional interactions between P450 and reductase. Results 
from Figure B1.6, demonstrating an increase in activity at Lubrol 
concentrations just below concentrations that cause dissociation of the 
aggregates, seems to support this hypothesis. 
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Figure B1.6: The effect of Lubrol PX (concentrations in mM) on cytochrome P450 
IIB1 dependent activity and the aggregation state of cytochrome P450 
11B1 and NADPH-cytochrome reductase as determined by FPLC (see 
fig Bl .5). This figure was taken from Rietjens et al. [50] 
(5) Phospholipids facilitate the formation of the catalytically active 
complex 
The formation of the catalytically active cytochrome P450:NADPH-
cytochrome reductase complex can be facilitated by improving the 
recognition and alignment of the interacting proteins [48]. This can be 
achieved through hydrophobic interactions between proteins and the 
membrane phospholipids or through neutralization of repelling charges 
on the surface of cytochrome P450 and NADPH-cytochrome reductase 
by electrostatic interactions between charged amino acid residues on the 
protein surfaces and phospholipid headgroup. The dilauroyl derivative of 
phosphatidylcholine (PC dil2:0) has been demonstrated to facilitate 
complex formation by decreasing the apparent dissociation constants of 
the cytochrome P450 / reductase complex [64,67,71]. Especially the 
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negatively charged phospholipids appeared to favour the formation of the 
cytochrome P450 / reductase electron exchange complex [7]. 
Bl.5.2 Specific cytochrome P450 - phospholipid interactions 
Because of the importance of phospholipids for the cytochrome P450 
enzyme system the existence of specific lipid-protein interactions in the 
cytochrome P450 system has been a topic for investigation in several 
studies. For the mitochondrial cytochrome P-450scc a specific 
requirement has been reported for cardiolipin [72]. It was demonstrated 
that this mitochondrial cytochrome P450 form contained a specific 
effector site for cardiolipin [73]. For microsomal cytochrome P450 the 
existence of specific lipid-protein interactions is still a subject of 
controversy. Early reports suggested that the in rabbit liver microsomes 
the cytochrome P450 / NADPH-cytochrome reductase complex is 
enclosed by a halo of phospholipids which differs from the bulk 
phospholipid matrix [74]. More recently, specific interactions have been 
suggested between cytochrome P450 LM2 (IIB1) and a number of 
phospholipid species such as phosphatidic acid (PA) [4] and 
phosphatidylethanolamine (PE) [75,76]. The interactions with the 
negatively charged PA have been suggested to be based on the charge-
charge coupling of the negative charge on the phospholipid headgroup 
and positive charges on the protein surface. The interactions with PE on 
the other hand, have been suggested to originate from the wedge-shaped 
PE structure which might adapt cytochrome P450 specifically to the 
membrane [77]. Specific interactions with PS, which is well known for 
its ability to interact with positive charges on protein surfaces, have not 
yet been reported for cytochromes P450 although the stimulating effect of 
PS on the catalytic activity of reconstituted cytochrome P450 [5,78] 
points to a possible relationship between cytochromes P450 and PS. 
B1.6 Scope of this thesis 
In the paragraph above a number of hypotheses for the stimulating effect 
of phospholipids on the cytochrome P450 enzyme system have been 
described. However, despite the amount of work done on this topic over 
the last 25 years the exact molecular mechanism of phospholipid 
stimulation of vertebrate cytochrome P450 dependent activities is still not 
understood. This is at least to some extent due to the complexity of the 
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enzyme system and the diversity in effects induced by phospholipids. 
Important questions like: 
(i) what structural aspects of membrane phospholipids affect 
cytochrome P450 dependent substrate conversions, 
(ii) how do phospholipids affect different forms of cytochrome 
P450, 
(iii) do phospholipids affect the other protein constituents of the 
enzyme system as well and 
(iv) do the cytochrome P450 forms exhibit specific affinities for 
certain phospholipids 
still remain to be answered. 
The scope of this thesis was to gain further insight into the role(s) 
of the membrane and (membrane)phospholipids in the cytochrome P450 
enzyme system. This thesis is however, not solely focussed on the 
cytochrome P450 protein but also pays attention to NADPH-cytochrome 
reductase. 
Chapters 2 to 7 describe the results of the experiments as they were 
executed. The first chapters (Chapters 2, 3 and 4) deal with the relation 
between cytochrome P450 and phospholipids. Chapter 5 discusses the 
relation between NADPH-cytochrome reductase and phospholipids and 
Chapters 6 and 7 describe a side reaction that can occur during 
cytochrome P450 dependent substrate conversion; NADPH-cytochrome 
reductase catalysed redox cycling. Finally, in Chapter 8 of this thesis the 
results are summarized and evaluated and conclusions are presented. 
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Chapter 2 
Differential cumene hydroperoxide 
sensitivity of cytochrome P450 enzymes 
IA1 and IIB1 determined by their way of 
membrane incorporation 
published in 
(1992) Biochim.Biophvs.Acta 1117. 179-187 
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2.1 Summary 
The cytochrome P450-dependent O-dealkylation of alkoxyresorufins was 
used to study the effect of cumene hydroperoxide on cytochrome P450 
IIB1 and IA1 in microsomal and reconstituted systems. 
In liver microsomal systems from respectively phénobarbital and 
3-methylcholanthrene pretreated male Wistar rats, cytochrome P450 
IIB 1-dependent pentoxyresorufin O-dealkylation appeared to be more 
sensitive to cumene hydroperoxide treatment than cytochrome P450 IA1-
dependent ethoxyresorufin O-dealkylation. This phenomenon was also 
observed when the cumene hydroperoxide sensitivity of P450 IIB1 and 
IA1 was studied in an isosafrole pretreated rat liver microsomal system. 
The decrease in alkoxyresorufin O-dealkylating activities appeared to 
proceed by destruction of the cytochrome P450 component of the enzyme 
system. 
Purification and reconstitution of the enzyme system components 
in a system in which the isolated proteins were not incorporated into a 
membrane resulted in the disappearance of the difference in sensitivity 
between the two P450 enzymes . However, in a reconstituted system with 
membrane incorporated proteins, again cytochrome P450 IIB1 expressed 
a higher sensitivity towards cumene hydroperoxide than cytochrome 
P450IA1. 
From this it was concluded that the differential cumene 
hydroperoxide sensitivity of cytochrome P450IIB1 and IA1 is not caused 
by an intrinsic difference in their sensitivity but by a differential effect of 
membrane incorporation on their cumene hydroperoxide sensitivity. 
2.2 Introduction 
The membrane bound cytochrome P450 system, located in the 
endoplasmatic reticulum of mainly the liver, is involved in the 
monooxygenation of a broad range of endogenous substrates and 
xenobiotics. It is made up of several components, namely cytochrome 
P450, NADPH-cytochrome reductase, NADH-cytochrome reductase, 
cytochrome b^ and phospholipids. During biotransformation reactions, 
the cytochrome P450 system can produce reactive oxygen species, that 
may inactivate the cytochromes P450 and are considered to be initiators 
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of lipidperoxidation 11,2]. The lipid hydroperoxides, resulting from this 
process have also been reported to inactivate cytochrome P450 dependent 
substrate conversions by oxidizing the heme group of the protein [3-7]. 
Furthermore, inactivation of microsomal cytochromes P450 has been 
observed under other conditions of "oxidative stress" like exposure to 
ozone [8], hydrogen peroxide [9] and organic hydroperoxides like 
cumene and tert.butyl hydroperoxide [10]. With these organic 
hydroperoxides the oxidative stress may result from radicals formed 
during the homolytic cleavage of the peroxides at the active site of the 
cytochromes P450 [11-14]. 
Studies demonstrating the cytochrome P450 sensitivity to 
conditions of oxidative stress generally do not focus on a possible 
different sensitivity of the various cytochrome P450 enzymes. Such a 
difference, however, can be important from a toxicological point of view. 
Especially when one considers the possible bioactivation of a compound 
by one P450 enzyme and its conversion to a non-toxic metabolite by 
another [15]. In the literature, only a few studies point to a possible 
differential sensitivity of cytochromes P450 towards conditions of 
oxidative stress. Gibson and Schenkman [16] and Jefferey et al. [17] 
mentioned the possible existence of two populations of cytochrome P450 
that differed in their susceptibility to destruction by linoleic acid 
hydroperoxide, but these populations were not further characterized. In a 
study using lung microsomes an increased sensitivity of the lung 
cytochrome P450(s) catalyzing pentoxyresorufin O-dealkylation as 
compared to the P450 enzyme(s) catalyzing the O-dealkylation of 
ethoxyresorufin was demonstrated [8]. Recently, Kitada et al. [18] 
provided evidence that Sprague-Dawley rat liver microsomal cytochrome 
P450 PB-1 is more susceptible to lipidperoxidation than cytochromes 
P450d (IA2) and P450h (HCl 1). Furthermore, in a study from Sesardic et 
al. [19] it was shown that in male Wistar rats, cytochrome P450d (IA2) 
was more sensitive to treatment with CCI4 than cytochrome P450c (IA1). 
The present study was undertaken to investigate possible 
differences in sensitivity between cytochromes P450 IIB1 and IA1 
towards cumene hydroperoxide. Cytochrome P450 enzymes IIB1 and 
IA1 were used because they could be studied in microsomal form as well 
as in isolated form in reconstituted systems. 
In this paper it is demonstrated that microsomal cytochrome P450 
IIB 1 is more sensitive towards cumene hydroperoxide than microsomal 
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cytochrome P450 IA1. Possible factors underlying this different cumene 
hydroperoxide sensitivity were investigated, using the isolated P450 
enzymes in two types of reconstituted systems. 
2.3 Materials and methods 
2.3.1 Preparation of microsomes 
Microsomes were prepared from the perfused livers of male Wistar rats 
(ca. 300 g), pretreated with phénobarbital (Brocacef b.v., Maarssen, The 
Netherlands) (0.1% in drinking water for 7 days), 3-methylcholanthrene 
(Sigma, St. Louis, MO, USA) (30 mg/kg bodyweight, using a stock 
solution of 6 mg/ml in olive oil, i.p., daily for 3 days) and isosafrole 
(Janssen, Beerse, Belgium)(150 mg/kg bodyweight, using a stock 
solution of 100 mg/ml in olive oil, i.p., daily for 3 days). Following 
homogenization of the livers in Tris/sucrose buffer (50 mM Tris, 0.25 M 
sucrose pH 7.4) and centrifugation at 10,000 x g (20 min), the 
supernatants were centrifuged for 75 minutes at 105,000 x g. The 
microsomal pellet was washed once with Tris/sucrose buffer and finally 
resuspended in 0.1 M potassium phosphate pH 7.25, containing 20% 
glycerol and 0.1 mM EDTA, immediately frozen into liquid nitrogen and 
stored at -90 °C until use. 
2.3.2 Biochemical assays 
The concentration of cytochrome P450 was determined as described by 
Omura and Sato [20]. Cytochrome b$ concentrations were measured 
using the method of Omura and Sato [21]. NADPH- and NADH-
cytochrome reductase activities were determined as described by Phillips 
and Langdon [22], using cytochrome c (Boehringer, Mannheim, FRG) as 
the electron acceptor. Protein concentrations were measured using the 
method of Lowry et al. [23] using bovine serum albumin (Sigma, St. 
Louis, MO, USA) as the standard. Lipidperoxidation was measured by 
the thiobarbituric acid assay, described by Buege and Aust [24]. Lipid 
extraction from liver microsomes from phénobarbital pretreated rats was 
carried out according to the method of Bligh and Dyer [25]. The 
extracted lipids were stored under argon at -20 °C until use. 
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2.3.3 Purification of microsomal enzymes 
NADPH-cytochrome P450 reductase was isolated from liver microsomes 
of phénobarbital pretreated female Wistar rats essentially as described by 
Yasukochi and Masters [26], using the same minor modifications as 
described by Rietjens et al. [27]. Excess detergent and phospholipid was 
removed by binding the protein to the 2'5'ADP-sepharose column 
equilibrated with 20 mM potassium phosphate, pH 7.7, containing 20 % 
glycerol, 0.1 mM EDTA, 0.1 mM dithiothreitol and 0.1 mM 
phenylmethanesulfonyl fluoride (Merck, Darmstadt, FRG) followed by 
washing with at least 10 column volumes of equilibration buffer and 
elution of the protein with the same buffer, containing 10 mM adenosine 
2'(3')-monophosphate (Sigma, St. Louis, MO, USA) and 0.2% sodium 
deoxycholate (Merck, Darmstadt, FRG). The reductase preparation was 
concentrated over an Amicon YM-30 filter and dialyzed against 3 times 
2 litres of 20 mM potassium phosphate pH 7.7, 20% glycerol, 0.1 mM 
EDTA and 0.1 mM dithiothreitol to remove the deoxycholate and 
adenosine 2(3^-monophosphate. The final detergent-free preparation had 
a specific activity of 36.7 units/mg protein and was homogeneous as 
judged by SDS-PAGE, carried out as described by Laemmli [28]. 
Cytochrome P450 IIB1 was isolated from liver microsomes of 
phénobarbital pretreated male Wistar rats essentially as described by 
West et al. [29] using Lubrol PX (Sigma, St. Louis, MO, USA) instead of 
Emulgen 911. Excess detergent was removed by additional washing of 
the hydroxylapatite column bound protein using the prescribed buffers 
without detergents. The final detergent-free preparations contained 8-12 
nmoles of P450 heme/mg protein. 
Cytochrome P450 IA1 was isolated from liver microsomes of 3-
methylcholanthrene pretreated male Wistar rats, essentially as described 
by Ryan et al. [30] using Lubrol PX instead of Emulgen 911. Excess 
detergent was removed as described above for cytochrome P450 IIB1. 
The final detergent-free preparations contained 8-12 nmoles of P450 
heme/mg protein. Both cytochrome P450 preparations were over 95% 
pure as judged by SDS-PAGE and were identified as cytochrome P450 
IA1 and IIB 1 in an immunoblotting experiment using the monoclonal 
antibodies described by Letawe-Goujon et al. [31] (not shown). 
The purified, detergent-free cytochrome P450 preparations were 
further characterized by FPLC gel filtration as described below. 
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2.3.4 FPLC gel filtration 
FPLC gel filtration was carried out using a Superose 6 column (18x1 
cm) (Pharmacia, Uppsala, Sweden) in 0.1 M potassium phosphate pH 
7.5, at a flow rate of 0.5 ml/min with detection at 280 nm. 
2.3.5 Microsomal and reconstituted cytochrome P450 for in vitro 
incubations 
Microsomes were diluted before use in 0.1 M potassium phosphate pH 
7.25 containing 20% glycerol and 0.1 raM EDTA. In the microsomal 
assay 50 \i\ of the diluted microsomes, containing 0.125 nmol 
cytochrome P450, was used. 
The reconstituted system with solubilized enzymes was prepared 
essentially as described before [27]. In short, 0.125 nmol cytochrome 
P450, 0.31 units NADPH-cytochrome reductase and 20 jug of distearoyl 
phosphatidylcholine were preincubated in a small volume (50 |J.l) for 10 
minutes at 37 °C before buffers, substrate and NADPH were added up to 
a volume of 1.0 ml. 
The reconstituted system with enzymes incorporated into an 
artificial membrane was prepared by cholate dialysis essentially as 
described by Taniguchi et al. [32]. In short, a solution, containing 2.5 
nmol/ml cytochrome P450, 6.3 units/ml NADPH-cytochrome reductase 
and 0.31 mg/ml microsomal phospholipid, prepared from liver 
microsomes of phénobarbital pretreated rats as described above, in 50 
mM potassium phosphate pH 7.25,0.1 mM EDTA, 0.1 mM dithiothreitol 
and 1% (w/v) sodium cholate was dialyzed for 2x24 hr against 2x2 liters 
of the same buffer without cholate. In the assay 50 |il of the dialyzed 
solution, containing 0.125 nmol P450, was used. 
2.3.6 Exposure of microsomal and reconstituted cytochrome P450 
systems to cumene hydroperoxide 
In the microsomal systems, 10 JLLI of a cumene hydroperoxide (Aldrich, 
Steinheim, FRG) solution were added to 50 ju.1 of diluted microsomal 
solution, to give the final hydroperoxide concentration, depicted in the 
figures and tables. Cumene hydroperoxide was diluted in methanol. After 
10 minutes of incubation at 37 °C, pentoxy- and ethoxyresorufin O-
dealkylating activities were measured using the method of Burke et al. 
[33]. In short, 0.1 M (final concentration) potassium phosphate pH 7.5, 5 
m M (final concentration) MgCl2 and 5 |iM (final concentration) of the 
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alkoxyresorufin (10 u.1 of a 0.5 mM stock solution in Me2SO/ml assay) 
were added. The reaction was started by addition of NADPH (0.4 mM 
final concentration). 
In the reconstituted system with solubilized enzymes, 10 u.1 of a 
cumene hydroperoxide solution were added to the 50 jxl preincubation 
mixture. After 10 minutes buffers and substrate were added and the 
reaction was started by addition of NADPH, all as described above. 
In the reconstituted system with membrane-incorporated enzymes, 
50 u.1 of the dialyzed solution were incubated for 10 minutes at 37 °C 
with 10 jxl of a hydroperoxide solution After this incubation the other 
reagents were added as described above. 
Pentoxy- and ethoxyresorufin O-dealkylating activities are 
expressed as % of control unless indicated otherwise. Control activities 
being the activity measured after 10 minutes preincubation with 10 ui 
methanol. 
2.3.7 Statistical analysis of data 
Data are presented as the mean ± standard error of the mean (SEM) and 
statistical analysis was carried out using Student's t-test, for unpaired 
samples. The null-hypothesis was rejected at P<0.05. 
2.4 Results 
2.4.1 Pentoxy- and ethoxyresorufin O-dealkylating activities in 
different microsomal systems 
In Figure 2.1 the pentoxy- and ethoxyresorufin O-dealkylating activities 
in liver microsmes from phénobarbital pretreated, 3-methylcholanthrene 
pretreated, isosafrole pretreated and untreated male Wistar rats (control) 
are presented. These data demonstrate that a respective 4- and 30-fold 
increase in the pentoxyresorufin O-dealkylating activity (PROD) was 
obtained after treatment with respectively isosafrole and phénobarbital 
compared to control 
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Figure 2.1: Pentoxy- and ethoxyresorufin O-dealkylating activity in liver 
microsomal systems from phénobarbital, 3-methylcholanthrene and 
isosafrole pretreated rats and untreated male Wistar rats. 
Pentoxy- and ethoxyresorufin O-dealkylating activities were 
determined as described in 'Materials and methods'. The results 
represent the mean ± SEM of two different microsomal preparations 
each tested in triplicate. 
CON = liver microsomes of untreated rats; PB = liver microsomes of 
phénobarbital pretreated rats; 3-MC = liver microsomes of 3-
methylcholanthrene pretreated rats ; ISF = liver microsomes of 
isosafrole pretreated rats. 
microsomes. Furthermore, a 11- and 20-fold increase in the 
ethoxyresorufin O-dealkylating activity (EROD) was obtained after 
treatment with respectively isosafrole and 3-methylcholanthrene. This 
effect of the inducers on the pentoxy- and ethoxyresorufin O-dealkylating 
activity in microsomal systems has been described before by several 
authors [33-35]. From these results, together with the fact that (i) 
phénobarbital and 3-methylcholanthrene greatly increase the level of 
respectively P450 IIB1 and IA1 in rat liver microsomes [36] and (ii) 
antibodies against P450 families IIB and IA have been shown to decrease 
the pentoxy- and ethoxyresorufin O-dealkylation in respectively 
phénobarbital and 3-methylcholanthrene pretreated rat liver microsomes 
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by respectively >90% and 79% [37,38] , it was concluded that in liver 
microsomes from phénobarbital and 3-methylcholanthrene pretreated rats 
80-90% of the respective O-dealkylating activities can be ascribed to 
IIB1 and IA1. Based on similar arguments it was concluded that in liver 
microsomes of isosafrole pretreated rats the major part (>50%) of the 
respective activities can be ascribed to IIB1 and IA1 activity. 
2.4.2 Conditions for cumene hydroperoxide-dependent oxidative 
stress 
Figure 2.2 shows the time dependent inactivation of pentoxy- and 
ethoxyresorufin O-dealkylation in liver microsomes from isosafrole 
pretreated rats exposed to 0.9 mM (final concentration) cumene 
hydroperoxide. 
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Figure 2.2 : Time dependent inactivation of pentoxy- and ethoxyresorufin O-
dealkylating activity in a liver microsomal system from isosafrole 
pretreated male Wistar rats. 
0.125 nmol of microsomal cytochrome P450 was incubated at 37 °C for increasing 
time intervals in a small volume (60 ul) with 0.9 mM CuOOH (final concentration). 
The pentoxy- and ethoxyresorufin O-dealkylation were determined as described in 
'Materials and methods', (o-o) = pentoxyresorufin O-dealkylation. (•-•) = 
ethoxyresorufin O-dealkylation. The results represent the mean ± SEM of four 
experiments. Based on this experiment an incubation time of 10 minutes was chosen 
for further experiments. 
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2.4.3 Cumene hydroperoxide sensitivity of cytochromes P450 IIB1 
and IA1 in microsomal systems 
120 
100 -
"3 80 -
c o 
o 
o 
£ 
60 
40 
20 
0 
-
- ^ * j 
-
-
-
i 
L
*"*»^ * 
i 
V * * 
1 
S. *# 
i 
. ** 
* * T ~ 
** 
.4.4 -4.0 -3.6 -3.2 -2.8 
log [CuOOH] 
-2.4 -2.0 
Figure 2.3: CuOOH-sensitivity of alkoxyresomfin O-dealkylating activities in a 
microsomal system from isosafrole pretreated male Wistar rats. 
0.125 nmol of microsomal cytochrome P450 was incubated for 10 minutes at 37 °C 
with varying concentrations of cumene hydroperoxide (in M) in a small volume (60 
|il) before activities were determined. Pentoxy- and ethoxyresorufin O-dealkylating 
activities were determined as described in 'Materials and methods', (o-o) = 
pentoxyresorufin O-dealkylation. (•-•) = ethoxyresorufin O-dealkylation. The results 
represent the mean ± SEM of two independent microsomal preparations each tested in 
quadruplicate. 
* significantly different from the value for the pentoxyresorufin O-dealkylation at 
P<0.02 
** significantly different from the value for the pentoxyresorufin O-dealkylation at 
P<0.001 
Figure 2.3 demonstrates the cumene hydroperoxide dependent 
inactivation of alkoxyresomfin O-dealkylations in liver microsomes from 
isosafrole pretreated rats. From these curves EC-50 values, defined as the 
cumene hydroperoxide concentrations causing 50% inactivation, can be 
determined. Table 2.1 summarizes EC-50 values obtained from 
experiments in which the cumene hydroperoxide sensitivity of pentoxy-
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and ethoxyresorufin O-dealkylation in three different microsomal 
systems was studied. 
Table 2.1 EC-50 values for the cumene hydroperoxide dependent inactivation of 
microsomal pentoxy- and ethoxyresorufin O-dealkylation. 
inducer EC-50 (mM) 
pentoxyresorufin 
O-dealkylation 
ethoxyresorufin 
O-dealkylation 
phénobarbital 
3-methylcholanthrene 
isosafrole 
0.11 ±0.01 
n.d. 
0.41 ±0.03 
n.d. 
0.27 ±0.01* 
0.67 ±0.03** 
Liver microsomes from rats pretreated with different inducers were used. n.d. = not 
determined. Values presented are the mean ± SEM of two independent preparations. 
* significantly different from the EC-50 value for the pentoxyresorufin O-
dealkylating activity in phénobarbital pretreated rat liver microsomes at P< 0.001. 
** significantly different from the EC-50 for the pentoxyresorufin O-dealkylating 
activity in this microsomal system at P<0.001. 
From the data, presented in Figure 2.3 and Table 2.1, it appears that 
microsomal cytochrome P450 IIB1 is significantly more sensitive 
towards inactivation by cumene hydroperoxide than cytochrome P450 
IA1. In theory, the difference in cumene hydroperoxide sensitivity 
between pentoxyresorufin O-dealkylation in phénobarbital pretreated rat 
liver microsomes and the ethoxyresorufin O-dealkylation in 3-
methylcholanthrene pretreated rat liver microsomes might be caused by 
differences in lipid composition, P450 enzyme composition or 
antioxidant content between the two microsomal systems. Results from 
the isosafrole pretreated microsomal system, however, excluded this 
possibility. 
Additional experiments demonstrated that inactivation of the 
cytochrome P450 dependent activities was accompanied by a 
simultaneous formation of thiobarbituric acid reactive materials (Figure 
2.4), indicating the occurence of lipidperoxidation in these microsomes. 
Furthermore, a decrease in the microsomal cytochrome P450 content was 
shown to be responsible for the decrease in the alkoxyresorufin O-
dealkylating activity (Figure 2.4). The other components of the enzyme 
system, cytochrome b$, NADPH- and NADH-cytochrome reductase, 
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were not inactivated at these cumene hydroperoxide concentrations (data 
not shown). 
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Figure 2.4: Influence of cumene hydroperoxide on the cytochrome P450 levels and 
the amount of TBA reactive material in microsomes from 
phénobarbital, 3-methylcholanthrene and isosafrole pretreated male 
Wistar rats. 
0.125 nmol of microsomal cytochrome P450 was incubated for 10 minutes at 37 °C 
with varying concentrations of cumene hydroperoxide before the cytochrome P450 
content and the amount of malondialdehyde was determined. The amount of MDA 
(•-•) at varying hydroperoxide concentrations was comparable in all three 
microsomal systems and the results depicted in this figure represent the average of the 
three microsomal systems. The P450 level is expressed as % of control. Control level 
being the amount of P450 measured after 10 minutes incubation with \0\il methanol. 
(o-o) cytochrome P450 content in PB microsomes, (A-A) cytochrome P450 content in 
3-MC microsomes, (0-0) cytochrome P450 content in ISF microsomes. 
2.4.4 Characteristics of isolated cytochromes P450IIB1 and IA1 
To test whether the differential cumene hydroperoxide sensitivity of the 
cytochromes P450 IIB1 and IA1, was due to intrinsic differences in their 
sensitivities, the effect of the hydroperoxide on isolated cytochromes 
P450 was investigated. 
First, the isolated P450 preparations were characterized with 
respect to their purity, aggregation state and the effects of detergents on 
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their cumene hydroperoxide sensitivity to determine whether they were 
qualitatively comparable. The cytochrome P450 preparations contained 
8-12 nmoles of P450 heme per mg protein and were over 95% pure as 
judged by SDS-PAGE. Figure 2.5a shows the FPLC elution pattern of the 
purified cytochrome P450 preparations on a Superose 6 column. From 
these elution patterns and the calibration curve of the Superose 6 column 
given in Figure 2.5b it can be calculated that, in solubilized form, both 
cytochromes form aggregates. Cytochrome P450 IIB1, identified by 
pentoxyresorufin O-dealkylating activity in a reconstituted system, 
appears to elute in one peak (elution volume 14.10 ± 0.06 ml) with a 
mean apparent molecular mass of 317 ± 32 kDa. Using the value of 52 
kDa for its monomeric form [29], the detergent free cytochrome P450 
IIB1 turns out to exist as an aggregate of six polypeptide chains. This is 
in agreement with results presented earlier [27,39,40]. 
The elution pattern of cytochrome P450 IA1 also shows one peak 
(elution volume 13.89 ± 0.06 ml), containing ethoxyresorufin O-
dealkylating activity in a reconstituted system and thus identified as 
cytochrome P450 IA1. The apparent molecular mass of this peak was 
determined to be 358 ± 28 kDa. Using 56 kDa for the monomeric form of 
cytochrome P450 IA1 [30], this indicates aggregates of also six 
polypeptide chains, which has not yet been reported before in the 
literature for cytochrome P450 IA1 from rat liver. 
In addition, the FPLC data demonstrate the protein preparations to 
have similar purities. The nature of the low molecular weight impurities 
(Mr = ± 3 kDa), present in both preparations, is not further characterized. 
As the presence of detergent after purification might, in theory, 
influence the sensitivity of the P450 enzymes to cumene hydroperoxide, 
the effect of artificially added detergents on the hydroperoxide sensitivity 
of the P450 enzymes was also studied. For both preparations it was 
shown that the presence of neither lubrol nor cholate in concentrations up 
to at least 10% of their concentration in the isolation buffers did influence 
the cumene hydroperoxide sensitivity of the cytochrome P450 enzymes 
(data not shown). This implies that residual detergent in the protein 
preparations, expected to be far less than 10% of the concentration in the 
buffers of the isolation procedure, will not affect the EC-50 values for the 
cumene hydroperoxide sensitivity. 
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Figure 2.5: Determination of the apparent molecular mass of cytochrome P450 
IIB1 and IA1 using FPLC gel filtration on Superose 6 in 0.1 M 
potassium phosphate pH 75 
(A) Elution pattern of cytochrome P450 IIB 1(100 ul of a solution containing 2 nmol 
cytochrome P450 / ml) and cytochrome P450 IA1 (100 (il of a solution containing 2 
nmol cytochrome P450 / ml). The peaks containing O-dealkylating activity in a 
reconstituted system are indicated by arows. (B) Calibration cutve of the Superose 6 
column using proteins of known molecular mass and the determination of the 
molecular mass of isolated cytochrome P450 IIB1 and IA1. K ^ y is a distribution 
coefficient and defined as: K^y = (ve " v 0) / (v t " VQ) with Ve = elution volume, 
VQ = void volume (6.13 ml) and Vt = total column volume (22.58 ml). 
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Altogether the data, described above, demonstrate that both 
cytochrome P450 preparations are comparable with respect to their 
purity, specific heme content, aggregation state and the absence of an 
effect of residual detergents on their cumene hydroperoxide sensitivity. 
2.4.5 Cumene hydroperoxide sensitivity of cytochrome P450IIB1 and 
IA1 in reconstituted systems 
Table 2.2: EC 50 values for cumene hydroperoxide dependent inactivation of 
isolated cytochromes P450 IIB1 and IA1 in reconstituted systems in 
which the proteins are not membrane bound ("solubilized") and in 
reconstituted systems in which the proteins are incorporated into an 
artificial membrane by cholate dialysis ("membrane incorporated"). 
solubilized 
reconstituted system 
membrane bound 
reconstituted system 
EC-50 (mM) 
pentoxyresorufin 
O-dealkylation 
(P450IIB1) 
0.20 ± 0.03 
0.09 ± 0.01 
* 
ethoxyresorufin 
O-dealkylation 
(P450IA1) 
0.19 ± 0.02 "-s-
0.30 ±0.01 *** 
** 
Values given are the mean ± SEM of 2 independent preparations each measured in 
quadruplicate. n s - = not significant 
* significantly different from the value for the solubilized reconstituted system 
at P<0.005. 
** significantly different from the value for the solubilized reconstituted system 
atP<0.001. 
*** significantly different from the value for the pentoxyresorufin O-dealkylation 
at P<0.001 
Table 2.2 lists EC 50 values for cumene hydroperoxide dependent 
inactivation of the cytochrome P450 dependent activities in the two 
reconstituted systems. From the data presented it can be concluded that in 
a reconstituted system in which the isolated enzymes are not incorporated 
into a membrane, there is no difference in their cumene hydroperoxide 
sensitivity. The absence of a difference in cumene hydroperoxide 
sensitivity in this reconstituted system did not result from the use of 
68 
distearoyl phosphatidylcholine in the reconstitution; similar results were 
obtained when phospholipids, extracted from microsomes were used 
(data not shown). In this reconstituted system, as in the microsomal 
system, destruction of cytochrome P450 was responsible for the decrease 
in the alkoxyresorufin O-dealkylating activity; NADPH-cytochrome 
reductase activity being not affected (data not shown). The reconstituted 
system, used in the present study, contains reductasexytochrome P450 
ratio's that are about 15 times higher (1:1) than the ratio reported for 
microsomes (about 1:15) [41]. The 1:1 ratio for cytochrome P450 and 
NADPH-cytochrome reductase in reconstituted systems has been used 
before [40,42). Further experiments demonstrated that decreasing this 
reductase / P450 ratio from 1:1 to 1:10, in order to make it more 
comparable to the ratio in the microsomal system, did not affect the EC 
50 values (data not shown). 
In the second reconstituted system, the cholate dialysis technique 
was used to incorporate the proteins into an artificial membrane, made up 
of phospholipids, extracted from liver microsomes from phénobarbital 
pretreated rats. Figure 2.6 presents the FPLC elution pattern of one of 
these preparations. Cytochrome P450 dependent activity eluted as one, 
large peak in the void volume of the column, indicating an apparent 
molecular mass higher than 10,000 kDa. In addition, the elution pattern in 
figure 2.6 demonstrated a small peak, containing no O-dealkylating 
activity, with an apparent molecular mass of about 4 kDa, probably 
resulting from protein free lipid clusters. From the FPLC elution pattern 
of figure 2.6 it can be concluded that both the cytochrome P450 and the 
NADPH-cytochrome reductase are incorporated into the large 
phospholipid vesicle. Furthermore, the membrane incorporated enzyme 
preparations were free from cytochrome P-420, the inactive form of 
cytochrome P450. 
From the EC-50 values presented in Table 2.2 it can be derived 
that as a result of membrane incorporation of cytochrome P450 IIB1 and 
IA1 the difference in their cumene hydroperoxide sensitivity reappears 
(P<0.001). Upon membrane incorporation, cytochrome P450 IIB1 
becomes 2.1 times more sensitive (P<0.001) towards cumene 
hydroperoxide than in the solubilized reconstituted system. On the other 
hand, cytochrome P450 IA1 becomes 1.6 times less sensitive (P<0.005) 
than in the solubilized reconstituted system. Finally, from Table 2.2 it 
appears that the EC-50 values for the ethoxy- and pentoxyresorufin O-
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dealkylation by membrane incorporated, isolated cytochrome P450 IA1 
and IIB1 are almost identical to the EC-50 values for the respective 
activities in the 3-methylcholanthrene and phénobarbital microsomal 
system from which they were isolated (Table 2.1). 
10 15 20 
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Figure 2.6: F PLC gel filtration pattern of membrane incorporated, reconstituted 
cytochrome P450. 
Elution pattern of isolated cytochrome P450IIB1 and NADPH-cytochrome reductase, 
reconstituted in an artificial membrane of extracted endoplasmatic reticulum 
phospholipids (50 u.1 of a solution containing 0.9 nmol cytochrome P450/ml and 2.25 
units reductase/ml) on Superose 6 in 0.1 M potassium phosphate pH 7.5 
2.5 Discussion 
In the present study microsomal cytochrome P450 IIB 1-dependent 
pentoxyresorufin O-dealkylation and cytochrome P450 IA1-dependent 
ethoxyresorufin O-dealkylation were used to study the possible 
differential sensitivity of cytochromes P450 towards cumene 
hydroperoxide. The difference in sensitivity between the two P450 
enzymes towards this hydroperoxide was demonstrated in microsomal 
systems. For these systems it is important to stress that pentoxy- and 
ethoxyresorufin are not completely specific substrates for these P450 
enzymes. Nevertheless, based on literature data [33-38] it was concluded 
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that in liver microsomes from phénobarbital and 3-methylcholanthrene 
pretreated rats over 80-90% of the respective activities can be ascribed to 
IIB1 and IA1, whereas in liver microsomes of isosafrole pretreated rats 
the major part (>50%) of the respective activities can be ascribed to IIB1 
and IA1 activity. 
The results from the experiments on the difference in sensitivity 
between P450 IIB1 and IA1 in microsomal systems demonstrated 
cytochrome P450 IIB1 to be more sensitive towards cumene 
hydroperoxide treatment than cytochrome P450 IA1. Comparing the EC-
50 values in the microsomal systems it appears that in the isosafrole 
microsomal system the difference in hydroperoxide sensitivity is smaller 
than the difference observed, when comparing the phénobarbital and 3-
methylcholanthrene microsomal systems. This phenomenon is most 
likely related to the lower induction of cytochrome P450 IIB1 and IA1 in 
isosafrole microsomes [36]. Due to this lower induction larger parts of 
the O-dealkylating activities have to be ascribed to P450 enzymes other 
than P450 IIB1 and IA1. This could partly mask their difference in 
hydroperoxide sensitivity. 
In theory, the different sensitivities of cytochromes P450 IIB1 and 
IA1 can be caused by differences in intrinsic characteristics between the 
P450 enzymes, such as for example their affinity for cumene 
hydroperoxide, their capacity for homolytic cleavage of this peroxide, or 
their sensitivity to the reactive intermediates. On the other hand the 
difference in sensitivity can also be caused by external factors such as 
their way of membrane incorporation, membrane surroundings and 
antioxidant surroundings, determining the exposure and accessibility of 
their active sites. 
. To investigate these possibilities to a further extent the present 
study describes results from experiments in which the peroxide 
sensitivity of isolated cytochromes P450 IIB1 and IA1 was determined in 
two different reconstituted systems. Determination of the cumene 
hydroperoxide sensitivities of cytochromes P450 IIB1 and IA1 in 
reconstituted systems in which the proteins were not incorporated into an 
artificial membrane, demonstrated that the cytochrome P450 enzymes 
were equally sensitive, thereby excluding an intrinsic difference in 
peroxide sensitivity between the two P450 enzymes as a possible 
explanation for the observed difference in microsomal systems. 
Incorporation of the isolated P450 enzymes into an artificial membrane 
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resulted in a considerable effect on their sensitivity towards cumene 
hydroperoxide. Cytochrome P450 IIB1 became significantly (P<0.001) 
more sensitive compared to solubilized reconstituted P450 IIB1, whereas 
cytochrome P450 IA1 became significantly (P<0.005) less sensitive than 
solubilized reconstituted P450 IA1. It is interesting to note that the EC-50 
values for the O-dealkylating activities in this reconstituted system are 
nearly identical to those obtained for the phénobarbital and 3-
methylcholanthrene microsomal systems, from which the respective P450 
enzymes were isolated. This indicates that the isolation procedure did not 
affect the cumene hydroperoxide sensitivities of the P450 enzymes. 
From these results it was concluded that the mechanism underlying 
the difference in cumene hydroperoxide sensitivity between P450 IIB1 
and IA1, as observed in the microsomal and membrane incorporated 
reconstituted system was a differential effect of membrane incorporation 
on their structure and/or the accessibility of their active sites. A 
difference in the way of membrane association between rabbit liver 
microsomal cytochrome P450 LM3 (IIIA6) and LM4 (IA2) has been 
reported by Ingelman-Sundberg and Glaumann [43]. Their conclusion 
was based on the observation that reconstituted cytochrome P450 LM3 
formed vesicles with larger diameters than P450 LM4 Furthermore, both 
solubilized and membrane bound P450 LM4 could be denatured by the 
non-penetrating reagent diazobenzene sulphonate, whereas membrane 
bound P450 LM3 was not susceptible to the diazo-reagent. 
Over the last years the membrane topology of cytochromes P450 
has been a topic for many researchers. Contrary to earlier predictions, in 
which the active site and the majority of the polypeptide chain was 
believed to be deeply embedded in the microsomal membrane [44-46], 
recent data favor an orientation with only one or two membrane spanning 
helices at the N-terminus and the main part of the protein located in the 
cytoplasm [47-50]. Substrates would gain access to the active site directly 
from the membrane in which they are believed to be concentrated, as a 
result of their hydrophobic nature. A different effect of membrane 
incorporation on the cumene hydroperoxide sensitivity of cytochrome 
P450 IIB1 and IA1, as demonstrated in this study, could result from a 
different orientation and thus accessibility of their active sites with 
respect to the membrane. One could imagine cumene hydroperoxide 
gaining access to the active site of cytochrome P450 IIB1 through the 
membrane whereas it gains access to the active site of cytochrome P450 
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IA1 through the water phase. Cumene hydroperoxide, being hydrophobic, 
tends to partition into the apolar core of the membrane thereby increasing 
the effective concentration in the vicinity of the active site of cytochrome 
P450 IIB1, resulting in the higher sensitivity of this P450 enzyme, when 
incorporated into a membrane. Taking the proteins out of the membrane 
would result in equal accessibilities and therefore equal sensitivities of 
P450IIB1 andlAl. 
However, since there is no experimental evidence to support the 
model described above, other explanations for the observed difference in 
hydroperoxide sensitivity between membrane bound cytochromes P450 
IIB1 and IA1 have to be considered. The effects observed might also be 
explained by a different effect of membrane incorporation on the protein 
structures, thereby changing their intrinsic sensitivities in a different way, 
or by a different lipid environment for the two P450 enzymes. Further 
studies will be necessary to discriminate between these explanations. 
Nevertheless, the results presented clearly demonstrate that membrane 
incorporation can influence two cytochrome P450 enzymes in a different 
way. 
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Chapter 3 
Kinetics of cytochromes P450 IA1 and 
IIB 1 in reconstituted systems with 
dilauroyl- and distearoyl-
glycerophosphocholine 
published in 
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3.1 Summary 
In the present study the effect of changing the fatty acyl moiety of 
phosphatidylcholine from dilauroyl to distearoyl on the kinetic 
parameters of O-dealkylation of alkoxyresorufins and ethoxycoumarin 
dependent on reconstituted cytochrome P450 IA1 and IIB1 has been 
investigated. The results demonstrate that i) the maximum rate of O-
dealkylation (Vmax) for both P450 enzymes was about two times 
higher in the L-a-dilauroyl-5«-glycero-3-phosphocholine (PC dil 2:0) 
system compared with the L-a-distearoyl-srt-glycero-3-
phosphocholine (PC dil8:0) system and ii) changes in the fatty acyl 
moiety of phosphatidylcholine (PC) from dilauroyl to distearoyl 
affected the apparent Km for the substrate (Kms) of P450 IA1 and IIB1 
in a different way. In addition, (iii) the kinetic parameters appeared to 
be dependent on the PC : P450 ratio and a change in this ratio affected 
the kinetic parameters of P450 IA1 and IIB1 in a different manner. 
From these last two observations it was concluded that the mechanism 
by which phospholipids influence P450IA1 dependent O-dealkylation 
of ethoxycoumarin is different from that by which they influence 
P450 IIB1 dependent O-dealkylation of this substrate. Furthermore, 
the results of the present study demonstrate that the increase in the rate 
of O-dealkylation of ethoxycoumarin, reported in the literature for 
reconstituted systems in the presence of PC dil2:0, results from an 
effect of PC dil 2:0 on both the Kms and the Vmax. 
In a number of additional experiments possible mechanisms 
underlying the observed differential effect of PC dil 2:0 and PC dil 8:0 
on the Kms and Vmax of P450 IA1 and IIB1 were investigated. This 
was done by studying the effect of the two PC species on the kinetic 
parameters of some of the different steps of the P450 cycle, namely 
substrate binding, oxygen binding and the rate of electron transfer. 
The results demonstrate an influence of PC dil2:0 and PC dil8:0 on 
1) substrate binding to cytochrome P450, 2) the affinity of 
cytochromes P450 for NADPH-cytochrome reductase and thus on 3) 
the electron flow through the reconstituted system. Based on the 
results from these experiments it was concluded that the increased 
vmax of P450 IA1 and IIB1 in the presence of PC dil2:0 compared to 
the systems with PC dil8:0 was at least in part due to an increased 
affinity of both P450 enzymes for NADPH-cytochrome reductase in 
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the presence of PC dil 2:0 compared to PC dil8:0. With respect to the 
differential effect of PC dil2:0 and PC dil8:0 on the Kms of P450 IA1 
and IIB1 the results demonstrate that this phenomenon does not result 
from a differential effect of the two PC species on either the substrate 
binding, the oxygen binding or the rate of electron transfer. Therefore, 
it was concluded that the differential effect of PC dil2:0 and PC 
dil8:0 on the Kms of P450 IA1 and IIB1 must result from an effect of 
the PC species on the kinetic parameters of other steps in the P450 
cycle such as reductive oxygen splitting, substrate conversion and / or 
product release. 
3.2 Introduction 
The cytochrome P450 enzyme system is involved in the 
monooxygenation of a broad range of endogenous substrates and 
xenobiotics. Associated to the membrane of the endoplasmatic 
reticulum, the properties of this enzyme system, such as the rates and 
specificities of the reactions it catalyzes, may be influenced by the 
nature of the membrane. Especially membrane fluidity (determining 
the lateral and rotational mobilities of the proteins), membrane charge 
(determining the interaction between ionic groups on the proteins) and 
the hydrophobic character of the core of the membrane (contributing 
to substrate accumulation in the vicinity of the enzymes) have been 
demonstrated to influence the cytochrome P450 enzyme system [1-9]. 
These physical properties of the membrane are determined by the 
membrane phospholipids; membrane charge is dependent on the 
headgroups of the phospholipids and fluidity and hydrophobicity are 
influenced by the fatty acid substituents. 
Already in the late 1960's, it was demonstrated that 
reconstitution of cytochrome P450 dependent activities required, 
besides cytochrome P450 and NADPH-cytochrome reductase, a so 
called 'heat stable factor' [10,11], later identified as 
phosphatidylcholine [12,13]. Subsequent to the identification of 
phosphatidylcholine as the active lipid factor, different types of 
phospholipid were investigated for their stimulatory properties on 
P450 dependent reactions. The phosphatidylcholine with acyl = 
dilauroyl was found to be most efficient [14,15] and thereafter it was 
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chosen by many investigators for studies with reconstituted P450 
systems. 
In theory, the differences observed in substrate conversion rates 
in the presence of various phosphatidylcholine species might be a 
reflection of both changes in Kms for the xenobiotic substrate as well 
as in Vm a x characteristics of the reconstituted cytochrome P450 
systems. For the cytochrome P450 IIB1 conversion of 
pentoxyresorufin, for instance, apparent Vmax and Kms values for the 
substrate were different in the presence of PC dil2:0 or PC dil8:0 
[16]. The stimulating effect of PC dil2:0 on the Vm a x for P450 
dependent substrate conversions was studied in a number of 
investigations and could be caused by an increased efficiency of 
electron transfer from NADPH-cytochrome reductase (E.C.I.6.2.4) to 
cytochrome P450. This increased electron transfer may result from i) 
changed protein conformations, ii) a decreased apparent binding 
constant for the catalytically active reductase : cytochrome P450 
complex (Kcir) and / or iii) changes in the spin state of cytochrome 
P450 in the presence of PC dil 2:0 [16-20]. 
In contrast, the effect of different phosphatidylcholine species 
on the apparent Km for the substrate (Kms) has not been studied in 
detail. This in spite of the fact that in theory an effect of 
phosphatidylcholine species on the affinity of the P450 for the 
substrate i.e. the binding constant for the P450 : substrate complex 
(K(js), resulting from a role of the phospholipids in the binding of 
substrates to the active site of the cytochrome P450 molecule, might 
be reflected in an influence on the Kms. In addition, an effect of 
phosphatidylcholine species on other kinetic parameters of the P450 
cycle might also result in an influence on the Kms. An effect of the 
phosphatidylcholine species on the Kms and / or K^s value could be of 
considerable importance, especially because in living organisms 
substrate concentrations will generally be low. In addition, in systems 
containing multiple P450 enzymes, a different effect of PC species on 
the substrate apparent Kms of different P450 enzymes, converting a 
substrate to different metabolites, may not only influence the rate of 
metabolism but also the metabolite pattern observed. 
The objective of the present study was to investigate the effect 
of a change in the fatty acyl moiety of phosphatidylcholine on the 
kinetic parameters (especially Kms and K^s) for substrate conversion 
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by two cytochrome P450 enzymes. For these studies isolated 
reconstituted cytochromes P450 IA1 and IIB1 were used as the model 
P450 enzymes, PC dil2:0 and PC dil8:0 as the model 
phosphatidylcholine species and ethoxyresorufin, pentoxyresorufin 
and ethoxycoumarin as the substrates. 
3.3 Materials and methods 
3.3.1 Preparation of microsomes 
Microsomes were prepared from the perfused livers of Wistar rats (ca. 
300 g) which were pretreated with phénobarbital (Brocacef b.v., 
Maarssen, The Netherlands) (0.1% in drinking water) or ß-
naphthoflavone (Sigma, St. Louis, MO, USA) (30 mg/kg body mass, 
using a stock solution of 12.5 mg/ml in olive oil, intraperitoneally, 
daily for 3 days). Following homogenization of the livers in 
Tris/sucrose buffer (50 mM Tris , 0.25 M sucrose pH 7.4) and 
centrifugation at 10,000 x g (20 min), the supernatants were 
centrifuged for 75 minutes at 105,000 x g. The microsomal pellet was 
suspended in 0.1 M potassium phosphate pH 7.25, containing 20% 
glycerol and 0.1 mM EDTA, immediately frozen into liquid nitrogen 
and stored at -90 °C until use for isolation of NADPH-cytochrome 
reductase, cytochromes P450 IA1 or IIB1. 
3.3.2 Purification and characterization of NADPH-cytochrome 
reductase and cytochromes P450IA1 and IIB1 
NADPH-cytochrome P450 reductase was isolated from liver 
microsomes of phénobarbital pretreated female Wistar rats essentially 
as described by Yasukochi and Masters [21], using the same minor 
modifications as described before [16], and using Emulgen 911 (KAO 
Chemicals, Tokyo, Japan) instead of Lubrol PX. Excess detergent and 
phospholipid was removed by binding the protein to a column of 
adenosine 2'5'-bisphosphate linked to sepharoses, equilibrated with 20 
mM potassium phosphate, pH 7.7, containing 20% glycerol, 0.1 mM 
EDTA, 0.1 mM dithiothreitol (Boehringer, Mannheim, FRG) and 0.1 
mM phenylmethanesulfonyl fluoride (Merck, Darmstadt, FRG) 
followed by washing with at least 10 column volumes of equilibration 
buffer and elution of the protein with the same buffer containing 10 
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mM adenosine 2'(3')-monophosphate (Sigma, St.Louis, MO, USA) 
and 0.2% sodium deoxycholate (Merck, Darmstadt, FRG). The 
reductase preparation was concentrated over an Amicon YM-30 filter 
and dialyzed three times against 2 1 of 20 mM potassium phosphate 
pH 7.7, 20% glycerol, 0.1 mM EDTA and 0.1 mM dithiothreitol to 
remove the deoxycholate and adenosine 2'(3')-monophosphate. The 
final detergent-free preparation had a specific activity of 37.8 U/mg 
protein and was homogeneous as judged by SDS/PAGE, carried out as 
described by Laemmli [22]. One unit (U) of NADPH-cytochrome 
reductase activity is the amount required to catalyze the reduction of 1 
u.mol cytochrome c / min. 
Cytochrome P450 IA1 was isolated from liver microsomes of b-
naphthoflavone pretreated male Wistar rats essentially as described 
by Ryan et aï. [23], using Lubrol PX (Sigma, St.Louis, MO, USA) 
instead of Emulgen 911. Excess detergent was removed by additional 
washing of the hydroxy apatite column bound protein, using the 
prescribed buffers without detergents. The final detergent-free 
preparation contained 9 nmol P450 heme/mg protein. 
Cytochrome P450 IIB 1 was isolated from liver microsomes of 
phénobarbital pretreated rats, essentially as described by West et al. 
[24] using Lubrol PX instead of Emulgen 911. Excess detergent was 
removed as described above for cytochrome P450 IA1. The final 
detergent-free preparation contained 14 nmol P450 heme/ mg protein. 
Both cytochrome P450 preparations were over 90% pure as judged by 
SDS/PAGE. The purified cytochrome P450 preparations were 
identified as cytochrome P450 IA1 and IIB1 in an immunoblotting 
experiment using the monoclonal antibodies described by Letawe-
Goujon et al. (25|. 
3.3.3 Biochemical assays 
The concentration of cytochrome P450 was determined from the CO-
difference spectrum of the dithionite-reduced protein, based on an 
absorption coefficient of 91 mM-i.cnr1 as described by Omura and 
Sato [26]. NADPH-cytochrome reductase activities were determined 
as described by Phillips and Langdon [27], using cytochrome c 
(Boehringer, Mannheim, FRG) as the final electron acceptor. Protein 
concentrations were measured using the method of Lowry et al. [28] 
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using bovine serum albumin (Sigma, St. Louis, MO, USA) as the 
standard. 
Pentoxy- and ethoxyresorufin O-dealkylating activities were 
measured using the method of Burke et al. [29] in 0.1 M potassium 
phosphate pH 7.5 at 37 °C using 0.1-5 u,M (as indicated) of the 
alkoxyresorufins (Boehringer, Mannheim, FRG) added in 
dimethylsulfoxide (Me2SO,10 u.1 /ml assay). The activities were 
quantified upon calibration of the fluorescence scale by the addition of 
resorufin (10 |il of a 104 |iM solution in Me2SO), the product of the 
cytochrome P450 dependent O-dealkylation of alkoxyresorufins. 
Ethoxycoumarin O-dealkylating activities were measured 
essentially as described by Ullrich and Weber [30] in 0.1 M Tris/HCl 
pH 7.6 at 37 °C using 10-100 U.M (as indicated) of ethoxycoumarin 
(Janssen Chimica, Beerse, Belgium) added in Me2SO (10 uJ/ml 
assay). The activities were quantified upon calibration of the 
fluorescence scale by the addition of hydroxycoumarin (10 u.1 of a 103 
u,M solution in Me2SO), the product of the cytochrome P450 
dependent O-dealkylation of ethoxycoumarin. 
The O-dealkylating activities were determined on an 
SLM/Aminco SPF-500c spectrofluorometer and are expressed as rate 
of resorufin or hydroxycoumarin formation / molar amount of 
cytochrome P450" '. 
3.3.4 Reconstituted incubations 
The reconstituted system for the ethoxy- and pentoxyresorufin-O-
dealkylation was prepared as described before [16]. In short, 0.01 
nmol cytochrome P450, 0.025 U NADPH-cytochrome reductase and 2 
|ig of either PC dil 2:0 or PC dil8:0 (both from Sigma, St. Louis, MO, 
USA) were preincubated in a small volume (50 ui) for 6 minutes at 37 
°C before buffer, substrate and NADPH (0.4 mM final concentration) 
were added up to a volume of 1 ml. The O-dealkylating activity was 
measured as described above. 
The reconstituted system for the ethoxycoumarin O-
dealkylation was essentially the same as the reconstituted system for 
the alkoxyresorufin O-dealkylation, only 10 times higher 
concentrations of the P450 system components were used. In short, 
0.1 nmol of cytochrome P450, 0.25 U of reductase and 20 jig of 
phosphatidylcholine (unless indicated otherwise) were preincubated in 
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a small volume (50 [il) for 6 minutes at 37 °C before buffer, substrate 
and NADPH (0.4 mM final concentration) were added up to a volume 
of 1 ml. The O-dealkylating activity was measured as described 
above. 
3.3.5 Determination of the influence of phospholipids on the 
apparent binding constant of cytochrome P450 IIB1 and IA1 for 
ethoxycoumarin (Kds) 
In order to obtain conditions similar to those in the kinetic 
experiments the apparent K^ values of cytochrome P450 IA1 and ITB1 
for ethoxycoumarin (K(js) were determined in the presence of 
NADPH-cytochrome reductase. The K^s values were obtained from 
the substrate induced shift in the spin equilibrium of the cytochrome 
P450. For determination of the Kds of cytochrome P450 for 
ethoxycoumarin, 1 \xM P450, 1 U.M reductase and 320 ixM PC dil2:0 
or 240 |iM PC dil8:0 were preincubated for 15 min. at 25 °C in a 
small volume (200 p.1). After preincubation 0.1 M potassium 
phosphate buffer (pH 7.5) containing 20 % glycerol was added to the 
incubation mixture up to a volume of 1 ml. The Kds was determined 
by the stepwise addition of a 10 uM solution of ethoxycoumarin in 0.1 
M Tris/HCl pH 7.5 upto 15 jxl. After each addition the absorption 
spectrum between 350 and 450 nm was recorded on an SLM/Aminco 
DW-2000 spectrophotometer at 25 °C against a blank cuvet filled with 
buffer to which similar stepwise additions of ethoxycoumarin were 
made. The spectra were corrected for the absorption spectrum of P450 
and reductase without added ethoxycoumarin. The substrate apparent 
binding constants were calculated from the double reciprocal plots of 
(ethoxycoumarin concentration)-1 against (AA39Q.420)"1-
3.3.6 Statistical analysis of data 
Data are presented as the mean ± standard error of the mean and 
statistical analysis was carried out using unpaired Students' t-test. The 
null-hypothesis was rejected at P < 0.05. 
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3.4 Results 
3.4.1 The influence of PC dil2:0 and PC dil8:0 on the kinetic 
parameters of cytochrome P450 dependent O-dealkylation of 
alkoxyresorufins and ethoxycoumarin 
In Table 3.1 the Kms and Vmax of the ethoxy- and pentoxyresorufin-
O-dealkylation by cytochrome P450 IA1 and IIB1 in the PC dil2:0 
and PC dil 8:0 reconstituted systems are presented. 
Table 3.1 : Apparent substrate Kms and Vmax °f ethoxy- andpentoxyresorufin 
O-dealkylation by cytochromes P450IA1 and IIB! in the presence 
of either PC dil2:0 or PC dil8:0. 
reconstituted 
cytochrome 
P450 
IA1 
I1B1 
assay 
EROD 
PROD 
phospholipid 
PC dil2:0 
PCdil8:0 
PC dil2:0 
PCdil8:0 
Km* 
(uM) 
0.36 + 0.03 
0.63 ± 0.05*** 
4.8 ±0.4 
2.3 ±0.2*** 
»max 
(nmol. min"!. 
nmol P450"1) 
13.8 ±1.6 
8.0 ± 0.8* 
0.38 ± 0.06 
0.23 ± 0.02** 
The O-dealkylation of pentoxyresorufin (PROD) and ethoxyresorufin (EROD) by 
reconstituted cytochromes P450 IIB1 and IA1 was determined as described in 
'Materials and methods'. The P450 / reductase / PC molar ratio in the 
reconstituted system was 1 :1 : 320 in the PC dil2:0 system and 1 : 1 : 240 PC 
di 18:0 system. The results presented are the mean ± standard error of the mean of 
six to nine experiments with two independent P450 preparations. 
* significantly different from the value with PC dil2:0 at P<0.005 
** significantly different from the value with PC dil2:0 at P<0.002 
*** significantly different from the value with PC dil2:0 at P<0.001 
From these data it can be seen that for both P450 enzymes the Vmax in 
the presence of PC dil2:0 is 1.7 times higher than in the presence of 
PC dil8:0. However, cytochrome P450 IA1 and IIB1 exhibit an 
opposite behaviour with respect to the effect of PC dil2:0 and PC 
di 18:0 on the Kms for the alkoxyresorufins. Reconstitution of 
cytochrome P450 IA1 with PC dil2:0 decreases the K m s for 
ethoxyresorufin by a factor of almost two compared to the PC dil8:0 
system. On the other hand, reconstitution of cytochrome P450 IIB1 
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with PC di 12:0 results in a twofold increase of the Kms for 
pentoxyresorufin compared to the value observed in the PC dil8:0 
system. 
Table 3.2: Kms and Vmax of ethoxycoumarin-O-dealkylation by cytochromes 
P450 IA1 and 1IB1 in the presence of either PC dil2:0 or PC 
dil8:0. 
reconstituted 
cytochrome 
P450 
IA1 
IIB1 
assay 
ECOD 
ECOD 
phospholipid 
PC di 12:0 
PC di 18:0 
PC dil2:0 
PCdil8:0 
Kms 
(uM) 
28 ± 3 
45 + 4* 
201 ± 22 
92+ 11*** 
''max 
(nmol. min'1. 
nmolP450-1) 
9.210.8 
5.610.2** 
3.310.3 
2.110.2* 
The O-dealkylation of ethoxycoumarin (ECOD) by reconstituted cytochrome 
P450 IIB1 and IA1 was determined as described in 'Materials and methods'. The 
P450 / reductase / PC molar ratio in the reconstituted system was 1:1:320 in the 
PC dil2:0 system and 1:1:240 PC dil8:0 system. The results presented are the 
mean 1 standard error of the mean of eight experiments with two independent 
P450 preparations. 
* significantly different from the value for PC dil2:0 at P<0.01 
** significantly different from the value for PC dil2:0 at P<0.005 
*** significantly different from the value for PC dil2:0 at P<0.001 
In theory this differential effect of the phospholipids on the Kms for 
ethoxy- and pentoxyresorufin of cytochrome P450 IA1 and IIB1 
might be caused by the different structures of the substrates. To 
determine whether this was the mechanism underlying the observed 
differential effect on the Kms, the experiments were repeated with 
ethoxycoumarin as a substrate for both P450 IA1 and IIB1. The 
kinetic parameters obtained from these experiments are summarized in 
Table 3.2. From these data it can be seen that the effects observed for 
the ethoxy- and pentoxyresorufin O-dealkylation are also observed for 
the ethoxycoumarin O-dealkylation. Both P450 enzymes exhibit a 1.6 
times higher Vmax in the presence of PC dil2:0 compared to the PC 
dil8:0 system. In addition, for cytochrome P450 IA1 PC dil2:0 
causes a decrease in the substrate Kms compared to PC dil8:0 whereas 
87 
for cytochrome P450 IIB1 PC dil2:0 increases the Kms compared to 
PC dil8:0. The values for the Kms of P450 IA1 and IIB1 for 
ethoxycoumarin in the PC dil2:0 system are almost identical to those 
obtained by Miwa and Lu 131] for the ethoxycoumarin-O-dealkylation 
by these P450 enzyme systems, incorporated in an artificial membrane 
of egg yolk phosphatidylcholine. 
3.4.2 Influence of the phosphatidylcholine / cytochrome P450 ratio 
on the kinetics of the O-dealkylation of ethoxycoumarin 
So far, the results presented describe kinetic experiments using 
cytochrome P450, NADPH-cytochrome reductase and phospholipid in 
a molar ratio of 1:1:240 for the PC dil8:0 system and 1:1:320 for the 
PC dil2:0 system. The effects of varying the phospholipid : P450 ratio 
on the Kms and Vm a x of the P450 dependent O-dealkylation of 
ethoxycoumarin were also determined. The kinetic data obtained from 
these experiments are presented in figures 3.1 and 3.2. 
Figure 3.1a clearly demonstrates that for cytochrome P450 IA1 
an increase in the PC : P450 ratio from 0 to about 25 for both 
phospholipids is accompanied by a significant decrease in the Kms for 
ethoxycoumarin. Further increasing the PC : P450 ratio did not further 
affect the Kms. From Figure 3.1b it can be seen that increasing the 
ratio also decreases Vm a x although in the case of PC dil2:0 the 
decrease is relatively small. 
The effect of an increasing PC : P450 ratio on the Kms and 
Vmax of the P450 IIB 1 dependent O-dealkylation of ethoxycoumarin 
appeared to be significantly different. 
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molar PC : P-450 IM ratio 
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molar PC : P-450 IA1 ratio 
Figure 3.1: The effect of changes in the PC I P450 ratio on the Kms (a) and 
V/nax (b) °f cytochrome P450 IA1 for ethoxycoumarin in the PC 
dil2:0 (•-•) and PC dil8:0 (o-o) systems. 
Ethoxycoumarin-O-dealkylating activities were measured as described in 
'Materials and Methods'. The results represent the mean ± standard error of the 
mean of two experiments. 
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Figure 3.2: The effect of changes in the PC I P450 ratio on the Kms (A) and 
V/nax (B) of cytochrome P450IIB1 for ethoxycoumarin in the PC 
dil2:0 (0-0) and PC dil8:0 (0-0) systems. 
Ethoxycoumarin-O-dealkylating activities were measured as described in 
'Materials and methods'. The results represent the mean ± standard error of the 
mean of two experiments. 
In contrast to P450 IA1, an increase in the PC dil2:0 : P450 ratio is 
accompanied by an increase in the Kms (Figure 3.2a). A similar 
pattern is observed when the influence of the PC dil2:0 : P450 ratio 
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on the Vm a x of the P450 IIB1 dependent O-dealkylation of 
ethoxycoumarin was studied (Figure 3.2b). However, an increase in 
the PC dil8:0 : P450 ratio did not affect the Km« and Vm a x to a 
significant extent (Fig. 3.2). 
The results above demonstrate that the effects of an increasing 
phospholipid : P450 ratio on the kinetic parameters of cytochrome 
P450 IA1 are different from the effects on the kinetic parameters of 
cytochrome P450 IIB1. Obviously, the mechanism by which 
phospholipids influence P450 IA1 dependent O-dealkylation of 
ethoxycoumarin is different from the mechanism by which 
phospholipids affect the P450IIB1 dependent reaction. 
In a number of additional experiments the mechanism underlying the 
observed differential effect of PC dil2:0 and PC dil8:0 on the Kms 
was investigated. The differential effect of PC dil2:0 and PC dil8:0 
on the Kms could result from a differential effect of the two PC's on 
one of the kinetic parameters of the reaction steps of the cytochrome 
P450 cycle [32]. Kinetic parameters of reaction steps involved in (a) 
substrate binding, (b) donation of the first electron, (c) oxygen 
binding, (d) donation of the second electron, (e) reductive oxygen 
splitting, (f) substrate conversion and / or (g) product release may all 
influence the Kms observed. 
3.4.3 Influence of PC dil2:0 and PC dil8:0 on the Kds of 
cytochrome P450 IA1 and IIB1 for ethoxycoumarin 
An effect of the phospholipids on the substrate binding, i.e. on the 
apparent binding constant of the P450 - substrate complex (K(js) 
(reaction step 1) might be reflected in an influence on the substrate 
apparent Kms. Therefore, the effect of PC dil2:0 and PC dil8:0 on the 
K(js of the cytochromes P450 for ethoxycoumarin was determined. 
Cytochrome P450, NADPH-cytochrome reductase and phospholipids 
were preincubated at the molar ratios used in the kinetic experiments 
to make the results from the kinetic and binding experiments 
comparable. For cytochrome P450 IA1 no spectral changes were 
detected upon the addition of ethoxycoumarin. Therefore, the Kds of 
P450 IA1 for ethoxycoumarin could not be determined. 
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Figure 3.3: Difference spectrum of a purified reconstituted cytochrome P450 
IIB1 system upon addition of ethoxycoumarin in the presence of 
PC dil2:0 (A) and PC dil8:0 (B). 
A solution, containing 1 |iM cytochrome P450, 1 .^M NADPH-cytochrome 
reductase and either 320 |iM PC dil2:0 or 240 \iM PC dil8:0 was titrated with 
small amounts of a 10 .^M solution of ethoxycoumarin. After each addition the 
absorption spectrum was recorded between 350 - 450 nm. Further details are 
described in 'Materials and methods'. 
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The addition of ethoxycoumarin to a solution containing 1 [iM 
cytochrome P450 IIB1 and 1 |J.M NADPH-cytochrome reductase in 
the absence of added PC resulted in a type I difference spectrum. 
From these difference spectra an ethoxycoumarin apparent binding 
constant of 57 ± 5 nM was calculated. Preincubation of cytochrome 
P450 IIB1 and reductase with PC dil2:0 and PC dil8:0 at PC / P450 
ratios of 320 and 240, respectively, resulted in an increase in the high 
spin content of cytochrome P450 (data to be published elsewhere). 
Subsequent addition of ethoxycoumarin further increased the high 
spin content (Fig. 3.3, a and b). From these results K^s values of 39 ± 
2 nM and 25 ± 1 nM were calculated for a reconstituted P450 IIB1 
system in the presence of PC dil2:0 and PC dil8:0 respectively. 
Comparison of these results to the data presented in Table 3.2 
demonstrates that the Kms value is at least 1000-fold higher than the 
values obtained for the K<js. From this result it can be concluded that, 
although the K^s value of P450 IIB1 for ethoxycoumarin is different 
in the presence of PC dil2:0 from that in the presence of PC dil8:0, 
this parameter is not the main factor influencing Kms. Therefore the 
different effects of PC dil2:0 and PC dil8:0 on the Kms must 
originate from effects on other kinetic parameters of the P450 reaction 
cycle. 
3.4.4 Influence of the oxygen concentration on the kinetics of O-
dealkylation of ethoxycoumarin by P450IA1 and IIB1 
The differences in Kms in the presence of PC dil2:0 and PC dil8:0 of 
P450 IA1 or IIB1 for ethoxycoumarin could result from a difference 
in the effect of PC dil2:0 and PC dil8:0 on the availability of oxygen 
for the two cytochrome P450 enzymes (reaction step 3). To determine 
whether the oxygen concentration was rate limiting at the conditions 
in the experiments described above, the effect of PC dil2:0 and PC 
dil8:0 on the kinetic parameters of P450 dependent O-dealkylation of 
ethoxycoumarin was also investigated at increased oxygen 
concentrations. To obtain increased oxygen concentrations, the 
reaction mixture was flushed for 1 min. with oxygen, prior to the 
addition of NADPH. The results from these experiments demonstrated 
that an increase in the oxygen concentration has no effect on the 
kinetic parameters of the O-dealkylation of ethoxycoumarin (data not 
shown). 
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3.4.5 Influence of electron donation on the kinetics of O-
dealkylation of ethoxycoumarin by P450IA1 and IIB1 
The differential effect of PC dil2:0 and PC dil8:0 on the Kms of P450 
IA1 and IIB 1 for alkoxyresorufins and ethoxycoumarin may also 
originate from a different effect of the phospholipids on the interaction 
of NADPH-cytochrome reductase to cytochrome P450 influencing the 
rate of electron transfer (reaction step 2 and 4). To investigate this 
possibility the kinetic experiments were repeated at a reductase / P450 
ratio of 5 instead of 1 used in the experiments described above. The 
results, summarized in Table 3.3, demonstrate that an increase in the 
reductase concentration causes a considerable increase in all Vm a x 
values of ethoxycoumarin-O-dealkylation. The relative increase in 
Vmax w a s higher in the PC dil8:0 than in the PC dil2:0 systems, 
resulting in elimination of the differences in Vmax in the PC dil2:0 
and PC dil8:0 system at a reductase / P450 ratio of 5 for both P450 
enzymes (Table III). However, the different effects of PC dil2:0 and 
PC dil8:0 on the Kms of cytochromes P450 IA1 and IIB1 for 
ethoxycoumarin is maintained upon increasing the reductase 
concentration. Our results are in agreement with those obtained by 
Miwa and Lu [31J for cytochrome P450 IA1 and IIB1. They observed 
that upon increasing the reductase / cytochrome P450 ratio from 0.25 
to 1 to 4 the Kms for ethoxycoumarin was unaffected and only the 
Vmax increased. These results demonstrate that the differing effects of 
the two PC species on the Kms for ethoxycoumarin of P450 IA1 and 
IIB1 cannot be ascribed to their different effects on the kinetic 
constants of the electron transfer steps in the two reconstituted P450 
systems 
The identical Vmax values for the PC dil2:0 and PC dil8:0 
system at high reductase concentration suggest that the about twofold 
higher Vm a x in the PC dil2:0 system, observed in reconstituted 
systems with a reductase : P450 molar ratio of 1, may result from an 
improved formation of the P450 / reductase complex compared to the 
PC dil8:0 system. This was confirmed in an additional experiment, 
demonstrating an about two times lower apparent Km of cytochrome 
P450 IIB1 and IA1 for NADPH-cytochrome reductase (Kmr) in the 
presence of PC dil 2:0 compared to PC dil8:0 (Table 3.4). 
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Table 3.3: The influence of the P450 I reductase ratio on the Kms and Vmax 
of the ethoxycoumarin-O-dealkylation by cytochromes P450 IA1 
and IIB1 in the presence of PC dil2:0 and PC dil8:0. 
reconstituted 
cytochrome 
P450 
IA1 
IIB1 
phospholipid 
PC di 12:0 
PCdil8:0 
PCdil2:0 
PCdil8:0 
Values at P450 / reductase molar ratio of 
1:1 
Kms 
(uM) 
28±3 
45+4** 
201±22 
92+11**** 
»max 
(nmol.min"! 
nmolP450"1) 
9.2±0.8 
5.6±0.2*** 
3.3±0.3 
2.110.2** 
1:5 
" • m 
(uM) 
27±9 
57±6* 
160±27 
65±6* 
'max 
(nmol.min"! 
nmolP450"1) 
16.510.8 
14.210.7 
9.811.9 
8.411.4 
Experiments were essentially carried out as described in 'Materials and methods'. 
In the case of the high reductase concentration, 0.1 nmol cytochrome P450 and 20 
(j.g phospholipid were incubated for 6 min. with 1.25 U reductase at 37 °C. The 
results from the kinetic experiments at a reductase / P450 ratio of 5 are the mean 1 
standard error of the mean of three experiments with two independent P450 and 
reductase preparations. The results presented for the 1:1 ratio are similar to those 
in Table 3.1, but are presented again for comparison. 
* significantly different from the value for PC dil2:0 at P<0.05 
** significantly different from the value for PC dil2:0 at P<0.01 
*** significantly different from the value for PC dil2:0 at P<0.005 
**** significantly different from the value for PC dil2:0 at P<0.001 
From the results described above, the apparent binding 
constants of the catalytically active P450 / reductase complex in the 
PC dil2:0 and PC dil8:0 system can also be determined using the 
mass action model described by Miwa et al. [33]. The calculated K,/ 
values are also presented in Table 3.4 and demonstrate that the lower 
apparent Kmr value of P450 for reductase in the PC dil2:0 system 
compared to the PC dil 8:0 system, originates from a lower K^T value 
in the PC dil2:0 system. Furthermore, the results show a higher 
affinity of cytochrome P450 IA1 for NADPH-cytochrome reductase 
compared to cytochrome P450 IIB1. 
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Table 3.4: Kmr. Vmax and K^r of cytochrome P450 IA1 and IIB1 for 
NADPH-cytochrome reductase in the presence of either PC dil2:0 
or PC dil8:0. 
reconstituted 
cytochrome 
P450 
IA1 
IIB1 
phospholipid 
PC di 12:0 
PC di 18:0 
PC di 12:0 
PCdil8:0 
Kmr 
(nM) 
10±2 
21 ±3* 
34 ±3 
70 + 5** 
»max 
(nmol. min"l. 
nmol P450-1) 
24 + 2 
22 ±2 
6 ± 1 
7 ± 1 
Kdr 
(nM) 
6±1 
14+ i** 
28 ±2 
63 ± 3** 
Ethoxycoumarin-O-dealkylating activities were determined essentially as 
described in 'Materials and methods'. 0.01 nmol P450 and 2 ug phospholipid was 
incubated with 0.025-0.25 U NADPH-cytochrome reductase for 6 min. at 37 °C 
before the ethoxycoumarin-O-dealkylating activity was determined. The apparent 
K(jr values were calculated using the mass action model of Miwa et al. [33]. The 
results represent the mean ± standard error of the mean of three experiments. 
* significantly different from the value for PC dil2:0 at P<0.05 
** significantly different from the value for PC dil2:0 at P<0.001 
3.5 Discussion 
The present study describes the effect of a change in the fatty acid 
substituents of phosphatidylcholine from dilauroyl to distearoyl on the 
kinetics of reactions in reconstituted systems dependent on 
cytochrome P450 IIB1 and IA1. In the reconstituted system used in 
the present study cytochrome P450 and NADPH-cytochrome 
reductase were incubated in the presence of phospholipids for 6 min. 
before activities were determined. This method does not result in 
incorporation of the proteins into the phospholipid vesicles. Instead, 
the proteins remain soluble and exist as multimeric protein aggregates 
with a few individual phospholipids attached to each protein multimer 
[16,34-36]. The aggregation states of the isolated cytochrome P450 
IA1 and IIB 1 used in the present study were demonstrated to be 
comparable [37]. Nevertheless, a different orientation of the two P450 
enzymes in their respective multimers might be a factor adding to the 
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differential effect of phospholipids on the kinetic characteristics of 
cytochrome P450 IA1 and IIB1 reported here. 
The results of the present study demonstrate that PC dil2:0 and 
PC dil8:0 differentially affect the kinetic parameters of the reactions 
dependent on cytochrome P450 IA1 and IIB1. At high phospholipid 
concentrations (phospholipid / cytochrome P450 ratios of 240 in the 
PC dil8:0 and 320 in the PC dil2:0 system) both P450 enzymes 
exhibited a higher Vmax in the PC dil2:0 system. This higher Vmax 
was demonstrated to result from an about two times lower Kmr and 
K,jr of cytochrome P450 for NADPH-cytochrome reductase in the PC 
dil2:0 system. Cytochrome P450 IA1 and IIB1 however, showed an 
opposite effect of the change from PC dil2:0 to PC dil8:0 on their 
Kms values. Cytochrome P450 IA1 appeared to have a significantly 
lower Kms in the PC dil2:0 system compared with the PC dil8:0 
system, whereas for P450 IIB1 a significantly higher Kms was found 
in the PC dil2:0 system compared to the PC dil8:0 system. This was 
observed not only for the O-dealkylation of pentoxy- and 
ethoxyresorufin, but also for the O-dealkylation of ethoxycoumarin. 
The Kms and Vmax for the P450 IA1 and IIB1 dependent O-
dealkylation appeared not only to be dependent on the fatty acyl 
moiety of the phospholipids but also on the PC / P450 ratio. For 
cytochrome P450 IA1 an increase in the PC : P450 ratio from 0 to 
about 300 resulted for both PC species in an exponential decrease in 
the Kms and Vmax . The Kms and Vm a x of P450 IIB1 exhibited a 
significantly different behaviour. In contrast to P450 IA1, increasing 
the PC dil2:0 / P450 ratio from 0 to about 320 resulted in increases in 
both the Km s and V m a x , whereas increasing the PC dil8:0 
concentration did not significantly alter the Kms and Vmax. Especially 
the decrease in the Vmax of the reaction catalyzed by cytochrome 
P450 IA1 upon addition of PC species is surprising compared to the 
literature data reporting increased substrate conversion rates by 
reconstituted cytochrome P450 systems upon addition of PC dil2:0 
[14,19,20,38]. However, in the latter studies conversion rates were 
generally determined at non-saturating substrate concentrations 
resulting in conversion rates influenced by Vmax and Kms. Thus, if the 
decreased V m a x of P450 IA1 in the presence of PC dil2:0 is 
accompanied by a decreased Kms (a situation proved to be the case in 
the present study) the conversion rate at non-saturating substrate 
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concentrations might be increased in the presence of PC dil2:0 in 
spite of a decreased Vm a x . From the present results it can be 
concluded that the stimulating effect of phospholipids on the O-
dealkylation of ethoxycoumarin by rat liver P450 IA1 and IIB1 results 
from an effect on both the Kms and Vmax. Miwa and Lu [19] reported 
that an increase in the PC dil2:0 / P450 ratio from 0 to 480 resulted in 
an about 8-fold increase in the Vmax of P450 IIB1 dependent N-
demethylation of benzphetamine whereas the Kms for benzphetamine 
was unchanged upon increasing the PC dil2:0 / P450 IIB1 ratio. The 
different observation with respect to the effect of PC dil2:0 on the 
Kms of P450 IIB 1 reported in the present study is most probably due 
to the fact that in the study of Miwa and Lu [19] a different substrate 
was used. Furthermore, from the fact that increasing the PC : P450 
ratio from 0 to about 300 results in different effects on the kinetic 
parameters of O-dealkylation of ethoxycoumarin dependent on 
cytochrome P450 IA1 and IIB1 (Figs 3.1 and 3.2) it can be concluded 
that the mechanism by which phospholipids influence P450 IA1 
dependent O-dealkylation is different from that by which they 
influence P450 IIB1 dependent O-dealkylation. 
Additional experiments described in the present study were 
performed to investigate some of the possible reasons for the 
differential effects of the two PC species on the kinetic parameters of 
either P450 IA1 or P450 IIB1. The differential effect on Kms and 
Vmax could result from a different effect of the two PC species on one 
or more of the many kinetic parameters of the cytochrome P450 cycle 
. Kinetic parameters of influence could be parameters for (a) substrate 
binding, (b) transfer of the first electron, (c) oxygen binding, (d) 
transfer of the second electron, (e) reductive oxygen splitting, (f) 
substrate conversion and / or (g) product release. In the present study 
some of these factors were studied in more detail. 
The results from cytochrome P450 binding studies demonstrate 
that the presence of PC dil2:0 or PC dil8:0 causes a significant 
decrease in the K,js of cytochrome P450 IIB1 for ethoxycoumarin. 
Nevertheless, it is concluded that the effects of the phospholipids on 
the Kms and Vmax of P450 IIB1 do not result from an effect on the 
binding of the substrate (reaction step 1) but from an effect on another 
rate limiting step of the P450 cycle. This conclusion is derived from 
the facts that (a) the Kds is 1000-fold smaller than the Kms and (b) an 
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increase of the PC / P450 ratio affects the Kms and Vmax in a similar 
way (Figs 3.1 and 3.2). 
In addition, a differential effect of the PC species on the oxygen 
binding (reaction step 2) cannot be the mechanism underlying the 
changes observed in Vm a x and Kms as an increase in the oxygen 
concentration did not result in a significant change of the various 
parameters, demonstrating the oxygen concentration to be optimal at 
normal saturation. 
As a third factor of influence the effect of an increase in the 
electron flow through the system (steps 2 and 4) was investigated by 
increasing the reductase / P450 ratio. An increase in the ratio 
reductase / P450 indeed increased the electron flow through the 
system resulting in increased Vmax values for both P450IA1 and IIB1 
(Table 3.3). Additional experiments demonstrated the effect on the 
V m a x to be at least in part due to an increased affinity of both 
cytochromes P450 for the NADPH-cytochrome reductase in the 
presence of PC dil2:0 compared to PC dil8:0. This observation is in 
accord with the increased affinity of P450pß-B (ÜB1) and P450bNF-B 
(IA1) for reductase in the presence of PC dil2:0 compared to these 
systems in the absence of PC [19,20]. Furthermore, although the 
absolute values for Kmr and K^T for the reductase reported in the 
present study in the presence of PC dil2:0 differ somewhat from the 
ones reported by Miiller-Enoch et al. [20] (also using enzymes from 
rat liver), the present observation of a higher reductase affinity of 
P450IA1 than of P450IIB1 was consistent in both studies. The higher 
affinity of both P450 enzymes for reductase is however, not in 
agreement with results published before, demonstrating a similar 
effect of PC dil2:0 and PC dil8:0 on the reductase Kmr and Kdr of 
cytochrome P450 IIB1 for the conversion of pentoxyresorufin [16]. 
Because substrates are known to affect the formation of the 
catalytically active P450 / reductase complex [35], this different 
observation by Rietjens et al. [16] may be ascribed to the fact that the 
apparent Kmr and K^r of cytochrome P450 for reductase were 
determined in the presence of pentoxyresorufin instead of 
ethoxycoumarin as was done in the present study. 
The results of the experiments of the present study with 
increasing reductase : P450 ratio also demonstrated that the 
disappearence of the difference in Vmax in the presence of PC dil2:0 
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or PC dil8:0 was not accompanied by the disappearance of the 
differences in the effect of both PC species on the Km s for 
ethoxycoumarin. At increased electron flow through the system the 
Kms of P450 IA1 for ethoxycoumarin is still lower in the presence of 
PC dil2:0 than in the presence of PC dil 8:0 whereas the Kms of P450 
IIB1 for ethoxycoumarin is still higher in the presence of PC dil2:0 
than in the presence of PC dil8:0. From this observation it is 
concluded that although PC species influence the electron flow 
through the system, this is not the factor causing the differential effect 
of PC dil2:0 and PC dil8:0 on the Kms of P450 IIB1 and IA1 for 
ethoxycoumarin. Altogether this implies that the best hypothesis for 
future research is that the different effect of the phospholipids on the 
Kms of P450 IA1 and IIB1 results from an influence on the kinetic 
parameters of reductive oxygen splitting, substrate conversion and / 
or product release. 
Because the effects of increasing the PC : P450 ratio on the Kms 
and Vmax for ethoxycoumarin were similar (Figures 3.1 and 3.2) but 
differ for P450 IA1 and IIB1, it is concluded that this additional 
kinetic parameter influencing Kms also influences Vmax. The factor 
causes a decrease in Kms and Vmax with added PC for P450 IA1, 
especially with PC dil8:0, and an increase in Kms and Vmax with 
addition of PC dil2:0 to P450 IIB1, PC dil8:0 having no effect. 
In conclusion, results of the present study using reconstituted 
systems with cytochrome P450 IA1 and IIB1, NADPH-cytochrome 
reductase and PC dil2:0 or PC dil8:0 demonstrate an influence of the 
two model phospholipids on (a) substrate binding to cytochrome 
P450, (b) affinities of cytochromes P450 for NADPH-cytochrome 
reductase and thus on (c) the electron flow through the reconstituted 
system and on (d) the apparent Kms of the two cytochromes P450 for 
a similar substrate. The latter effect must be related to an effect of PC 
species on kinetic parameters of either the reductive oxygen splitting , 
substrate conversion and / or product release. 
The results also demonstrate that the apparent K m s , K^s and 
Vmax values of cytochromes P450 for the substrate and Kmr and K<jr 
of cytochromes P450 for NADPH-cytochrome reductase are 
dependent on (a) the fatty acyl moiety of the PC, (b) the ratio PC / 
P450 used and (c) the ratio reductase / P450. In contrast to what has 
been generally accepted, based on results from conversion rate 
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measurements under non-saturating substrate conditions 
[14,19,20,38], the present study demonstrates that the addition of PC 
species might even result in lower conversion rates (Vmax) of a 
reconstituted system. However, this is not reflected in lower but in 
higher conversion rates at non-saturating substrate concentrations due 
to a simultaneously lowered Kms. Furthermore, the effects on the 
kinetic parameters, observed upon changing the type of PC and / or 
the PC : P450 ratio appear to be dependent on the P450 enzyme used 
in the reconstitution. This has not been as well recognized in studies 
reported up to now. 
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Chapter 4 
The effect of variation in the headgroup 
and fatty acyl chains of phospholipids on 
their binding to cytochrome P450 IIB 1 
105 
4.1 Summary 
In the present study the interaction of cytochrome P450 IIB1 with 
phospholipids with varying headgroups or fatty acyl chains was 
investigated. The apparent dissociation constant (K^) of the 
cytochrome P450 IIB1 - phospholipid complex was determined for 
various phospholipids. 
All phospholipids studied induced a Type I difference spectrum 
upon addition to purified cytochrome P450 ÓB1. The apparent K^ for 
the cytochrome P450 IIB1 - phospholipid complex, determined from 
these binding spectra, appeared to be independent of the length of the 
fatty acid chains of the phospholipid molecule. In contrast, the 
apparent K^ of cytochrome P450 IIB1 for the different PC's studied 
shows a tendency to decrease with increasing degree of desaturation 
of the fatty acyl moiety of this type of phospholipid. Furthermore, the 
apparent Kd of cytochrome P450 IIB1 for phospholipids was 
dependent on the headgroup of the phospholipid, demonstrating a 
significantly higher apparent K^ of cytochrome P450 IIB1 for PE 
dil6:0 compared to the apparent Kj values observed with PS dil6:0, 
PC dil6:0 and PI 16:0/18:1. 
Together the data demonstrate that the affinity of cytochrome 
P450 IIB1 for different phospholipids can be influenced by the 
headgroup and the degree of desaturation of the fatty acyl chains of a 
phospholipid. The length of the acyl chains is of minor or no 
importance. 
4.2 Introduction 
The hepatic cytochrome P450 is the terminal monooxygenase of an 
electron transport chain which is capable of catalyzing a wide variety 
of different reactions. This enzyme system plays a key role in the 
metabolism of drugs, steroids and other xenobiotics. It is well known 
that besides cytochromes P450 and NADPH-cytochrome reductase a 
third component, namely phospholipid is needed for optimal activity 
[1-4]. Furthermore, it was demonstrated that the dilauroyl derivative 
of phosphatidylcholine (PC dil2:0) was very effective in stimulating 
cytochrome P450 dependent reactions in reconstituted systems [1-4]. 
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Since then the role of phospholipids in the cytochrome P450 enzyme 
system has been a topic for many investigations. For the 
mitochondrial cytochrome P-450scc it was demonstrated that the 
specific requirement of this P450 enzyme for cardiolipin [5] resulted 
from a specific effector site on this mitochondrial cytochrome P450 
for cardiolipin [6|. For microsomal cytochromes P450 the existence of 
specific lipid-protein interactions has also been investigated. Already 
in 1973 Stier and Sackmann [7] suggested that in rabbit liver 
microsomes the cytochrome P450 / NADPH-cytochrome reductase 
complex is enclosed by a halo of phospholpids which differs from the 
bulk phospholipid matrix. More recently, Bayerl et al. [8] reported a 
preference of liver microsomal cytochrome P450 of phénobarbital 
pretreated rabbits for the binding of PE, demonstrated by use of 31P-
NMR, quasi-electric light scattering and freeze-fracture electron 
microscopy. Bösterling et al. [9] studying cytochrome P450 LM2 -
phospholipid interactions in reconstituted vesicles reported a 
preference for the negatively charged phospholipid phosphatidic acid 
(PA). A special role for negatively charged phospholipids was also 
observed by Ingelman-Sundberg et al. [10] who demonstrated that a 
phospholipid mixture of phosphatidyl ethanolamine (PE) and the 
negatively charged phosphatidylserine (PS) could stimulate 
cytochrome P450 dependent substrate conversions even further than 
PC dil2:0. Despite these observations, the existence of boundary 
phospholipids for the microsomal cytochrome P450 system is still 
poorly established. 
The objective of the present study was to investigate the 
interaction of a cytochrome P450 enzyme with phospholipids with 
varying headgroup or side-chain. Cytochrome P450 IIB1 from the 
liver of phénobarbital pretreated rats was used as the P450 protein. 
The phospholipids used in the present study were PC dil0:0, PC 
dil2:0, PC dil4:0, PC dil6:0, PC dil8:0 (increasing length of the side 
chain), PC dil8:l, PC dil8:2, PC di20:4 (increasing degree of 
desaturation), PE dil6:0, PS dil6:0 and PI dil6:0/18:l (varying 
headgroup). Possible influences of a variation in the headgroup or the 
side-chains of a phospholipid on its interaction with a cytochrome 
P450 form have not been systematically studied before. The apparent 
dissociation constant (K^) of the cytochrome P450 IIB1 -
phospholipid complex was determined on the basis of the type I 
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binding spectrum of purified cytochrome P450 IIB1 induced by the 
various phospholipids. 
4.3 Materials and methods 
4.3.1 Preparation of microsomes 
Microsomes were prepared from the perfused livers of male Wistar 
rats which were pretreated with phénobarbital (Brocacef b.v., 
Maarssen, The Netherlands) (0.1% in drinking water). Following 
homogenization of the livers in Tris/sucrose buffer (50 mM Tris , 0.25 
M sucrose pH 7.4) and centrifugation at 10,000 x g (20 min), the 
supernatants were centrifuged for 75 minutes at 105,000 x g. The 
microsomal pellet was suspended in 0.1 M potassium phosphate pH 
7.25, containing 20% glycerol and 0.1 mM EDTA, immediately 
frozen into liquid nitrogen and stored at -90 "C until use for 
purification of cytochrome P450IIB1. 
4.3.2 Purification of cytochrome P450 IIB1 
Cytochrome P450 IIB1 was isolated from liver microsomes from male 
Wistar rats, pretreated with phénobarbital, essentially as described by 
West et al. [11]. Excess detergent was removed by additional washing 
of the hydroxylapatite column bound protein, using the prescribed 
buffers without detergents, after which the protein was eluted with 0.3 
M potassium phosphate, pH 7.25 containing 20% glycerol. The final 
detergent-free preparation contained 14 nmoles of P450 heme/mg 
protein. The cytochrome P450 preparation was over 90% pure as 
judged by SDS-PAGE [12] and identified as cytochrome P450 IIB1 in 
an immunoblotting experiment using the monoclonal antibodies 
described by Letawe-Goujon et al. [13]. The concentration of 
cytochrome P450 was determined from the CO-difference spectrum of 
the dithionite-reduced protein, based on an extinction coefficient of 91 
m M - i . c m 1 as described by Omura and Sato [14]. Protein 
concentrations were measured using the method of Lowry et al. [15] 
using bovine serum albumin (Sigma, St. Louis, MO, USA) as the 
standard. 
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4.3.3 Determination of the apparent dissociation constant (Kd) of 
cytochrome P450 IIB1 for various phospholipids 
The apparent K<j values were obtained from the phospholipid induced 
spectral shift in the spin equilibrium of cytochrome P450. All 
phospholipids were purchased from Sigma (St.Louis, MO, USA). The 
apparent Kj values were determined by the stepwise addition of a 
phospholipid suspension (0.01 mg/ml in water) to 1 U.M of 
cytochrome P450 in 0.1 M potassium phosphate buffer (pH 7.5) 
containing 20 % glycerol. After each addition the absorption spectrum 
between 350 and 450 nm was recorded against a blank cuvet filled 
with buffer to which similar stepwise additions of phospholipid were 
made. The spectra were corrected for the absorption spectrum of 
cytochrome P450 IIB1 without added phospholipid measured against 
the buffer. The absorption spectra were recorded on an SLM/Aminco 
DW-2000 spectrofotometer at 25 °C. The apparent K<j values were 
calculated by fittin» the data to the function: 
AA = AAnax * [S] 
Kd+ [S] 
where AAmax = maximum AA(3g6_420) 
[S] = phospholipid concentration 
AA = AA(3g6_420) at a certain phospholipid 
concentration 
K,j = apparent dissociation constant for the P450 
IIB 1 -phospholipid complex. 
4.3.4 Statistical analysis of data 
The results presented are the mean ± standard error of the mean. 
Statistical analysis was carried out using Student's t-test, for unpaired 
samples. The null-hypothesis was rejected at P<0.05. 
4.4 Results 
4.4.1 The effect of the length and the degree of desaturation of the 
fatty acyl chains on the apparent dissociation constant of the 
cytochrome P450 IIB1 - phosphatidylcholine complex 
10 
0.0050 
0.0025 
0.0000 -
^ -0.0025 
-0.0050 
-0.0075 
-0.0100 
0.0140 
0.0120 
1 = 0.000 jiM PC 
2 = 0.068 nM PC 
3 = 0.136 \M PC 
4 = 0.268 |iM PC 
5 = 0.468 nM PC 
6 = 0.664 \iM PC 
340 360 380 400 420 440 
Wavelength (nm) 
460 
0.0100 -
3 0.0080 
00 
<"" 0.0060 
<] 
0.0040 
0.0020 
0.0000 
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 
[PCdil2:0](nM) 
Figure 4.1: Difference spectra of purified cytochrome P450IIB1 upon addition 
of PC dil2:0 (A) and calculation of the apparent K^ value from the 
difference spectra (B). 
A solution, containing 1 (J.M cytochrome P450 IIB1 in 0.1 M potassium phosphate 
(pH 7.5) containing 20% glycerol was titrated with small amounts of a 16 .^M 
solution of PC dil2:0. After each addition the absorption spectrum was recorded 
between 350 and 450 nm. Further details are described in 'Materials and 
methods'. The apparent Kj value was calculated by plotting AA(3g6-421) 
obtained from Figure l a as a function of the phospholipid concentration. The 
plotted line presents the best fit of the data to the function AA = 
correlation coefficient was 0.994. 
AAn, a x * [ S ] . T h e 
Kd+[S] 
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In Figure la the difference spectra of purified cytochrome P450 IIB1 
obtained upon the stepwise addition of PC dil2:0 are presented. These 
results demonstrate that the addition of PC dil2:0 to cytochrome P450 
IIB1 induces a type I difference spectrum with a peak at 386 nm and a 
through at 421 nm, typical of a shift in the spin equilibrium of the 
cytochrome P450 from low spin to high spin. Type I binding spectra 
were also observed upon the addition of the other phospholipids (data 
not shown). Figure lb presents the plot of the PC dil2:0 concentration 
versus the AA(3g6-420) derived from the a difference spectrum. For all 
phospholipids the AAmax was comparable (average AAmax = 0.0214 ± 
0.0008).From this plot an apparent K,j value of 0.164 \iM was 
calculated. The apparent K<j values of cytochrome P450 IIB1 for the 
other phosphatidylcholine species were obtained in a similar way. The 
apparent K^ of cytochrome P450 IIB1 was determined for PC species 
with varying length and degree of desaturation of the fatty acyl chains. 
Table 4.1: Determination of the effect of the fatty acyl chain length on the 
apparent K^ values of cytochrome P450IIB1 for PC. 
phospholipid 
PC di 10:0 
PC di 12:0 
PC di 14:0 
PC di 16:0 
PC di 18:0 
apparent K^ 
(UM) 
0.142 ±0.009 
0.155 ±0.020 
0.148 ±0.010 
0.144 ±0.022 
0.152 ±0.020 
The apparent dissociation constants were determined as described in 'Materials 
and methods'. The results represent the mean ± standard error of the mean of 3 
experiments. 
The results, presented in Tables 4.1 and 4.2, demonstrate that the 
apparent Kj value of cytochrome P450 IIB1 for PC is independent of 
the length of the fatty acyl moieties (Table 4.1). However, upon 
increasing the degree of desaturation of the fatty acid chains the 
apparent K^ shows a tendency to decrease. The apparent K^ of P450 
IIB1 for PC di20:4 is even significantly (P<0.05) smaller that the 
apparent K^ for PC dil 8:0 (Table 4.2). Expression of the apparent Kj 
values as a function of the number of unsaturated bonds per fatty acyl 
chain results in a linear relationship with a correlation coefficient of 
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0.996 and a decrease of about 0.007 uM in the apparent K^ value for 
an additional bond in the fatty acid moiety of the phospholipid 
molecule. 
Table 4.2 : Determination of the effect of degree of desaturation of the fatty 
acyl chain on the apparent K^ values of cytochrome P450IIB1 for 
PC. 
phospholipid 
PC di 18:0 
PCdil8:l 
PCdil8:2 
PC di20:4 
apparent K<j 
(UM) 
0.152 ±0.020 
0.134 ±0.001 
0.125 ±0.008 
0.094 ±0.011* 
The apparent dissociation constants were determined as described in 'Materials 
and methods'. The results represent the mean ± standard error of the mean of 3 
experiments. The value for PC dil 8:0 is similar to the one given in Table I but 
presented again for comparison. 
* significantly different from the value presented for PC dil8:0 at P<0.05 
4.4.2 The effect of the phospholipid headgroup on the apparent 
K(j of the cytochrome P450 IIB1 - phospholipid complex 
In addition to the fatty acyl chain, the binding of phospholipids to 
cytochrome P450 might also be dependent on the headgroup of the 
phospholipids. Therefore, the apparent Kj of cytochrome P450 IIB1 
for three other major phospholipid constituents of the endoplasmic 
membrane besides PC, namely PE, PI and PS were also determined. 
The model phospholipids chosen contained two palmitoyl side chains 
(16:0) if possible. Because PI dil6:0 is not commercially available PI 
16:0/18:1 was chosen for studying the effect of a inositol headgroup. 
Based on the results presented above, replacement one 16:0 acyl chain 
by a 18:1 acyl chain is expected to influence the K^ only to a very 
limited extend, i.e. an estimated decrease by about 0.007 u.M. Again, 
all phospholipids studied induced type I difference spectra . The 
apparent K^ values, calculated from these cytochrome P450 difference 
spectra, are presented in Table 4.3. The data demonstrate that the 
headgroup of the phospholipids can affect the apparent K^ of the 
cytochrome P450 IIB1 - phospholipid complex. The apparent K^ for 
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PE is significantly higher than the apparent Kj value for PC, PS and 
PI. The values for PC, PI and PS do not differ significantly. 
Table 4.3: Determination of the effect of the phospholipid headgroup on the 
apparent K^ values of cytochrome P450IIB1 for phospholipids. 
phospholipid 
PC di 16:0 
PEdil6:0 
PSdil6:0 
PI 16:0/18:1 
apparent Kj 
(uM) 
0.144 ±0.022 
0.238 ±0.016* 
0.131 ±0.015 
0.141 ±0.013 
The apparent dissociation constants were determined as described in 'Materials 
and Methods'. The results represent the mean ± standard error of the mean of 6 
experiments. The value for PC dil6:0 is similar to the one given in Table I but 
presented again for comparison. 
* significantly different from the value for PC (P<0.02), Pino (P<0.002) and 
PSer(P<0.001). 
4.5 Discussion 
In the present study the effect of the headgroup and fatty acyl moiety 
of phospholipids on their binding affinity to cytochrome P450 IIB1 is 
investigated. The apparent K^ values were obtained from the 
phospholipid induced type I shift in the spin equilibrium of 
cytochrome P450 IIB1. Using PC's with varying length and degree of 
de saturation of the fatty acyl chains it could be demonstrated that the 
apparent K^ of the cytochrome P450 IIB1 - phospholipid complex is 
not dependent on the length of the fatty acid chains. However, a 
tendency was observed for the apparent K<j to decrease with an 
increase in the number of double bonds in the fatty acyl side chains of 
phosphatidylcholine. Furthermore, the apparent K<j appeared to be 
dependent on the headgroup of the phospholipid. PS dil6:0, PC dil6:0 
and PI 16:0/18:1 were demonstrated to have similar apparent K^ 
values. PE dil6:0 however, appeared to have a significantly higher 
apparent K^ value. 
The apparent Kj values obtained in the present study are three 
orders of magnitude smaller than the apparent K^ value of 0.45 mM 
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reported by Chiang and Coon [16] for the rabbit cytochrome P450 
LM2 - PC dil 2:0 complex. French et al. [17] observed a biphasic 
behaviour for the binding of PC dil2:0 to cytochrome P450 LM2 
representing binding with high and low affinity. The apparent 
dissociation constants were estimated to be 3-6 |j.M and 50-70 (J.M for 
respectively the high and low affinity site. Although smaller than the 
apparent K<j value reported by Chiang and Coon [16], the values 
reported by French et al. [17] are still 1 to 2 orders in magnitude 
higher than the apparent K^ of cytochrome P450 IIB1 for PC dil2:0 
observed in the present study. These different observations for the 
apparent K^ for the P450 IIB1 - PC dil2:0 complex may be ascribed 
to the facts that (i) in the studies of Chiang and Coon [16] and French 
et al. [17] rabbit cytochrome P450 IIB1 was used whereas in this 
study rat cytochrome P450 IIB1 was investigated and / or (ii) the 
different (more extensive) method for the removal of detergent from 
the isolated cytochrome P450 IIB1 preparation used in the present 
study resulting in the liberation of high affinity phospholipid binding 
sites. 
Up to now, the information on the existence of specific lipid-
protein interactions in the cytochrome P450 enzyme system is limited. 
Bosterling et al. [9] reported a preference of reconstituted cytochrome 
P450 LM2 for the negatively charged phospholipid PA. The basis for 
specific PA / P450 interactions would be the charge-charge coupling 
of positive charges on the protein surface and the negative charge on 
the phospholipid headgroup. In analogy to this observation the higher 
apparent K<j of the uncharged PE dil6:0 compared to the apparent K<j 
values of the negatively charged PI 16:0/18:1 and PS dil6:0 might be 
ascribed to the absence of electrostatic interactions between PE and 
cytochrome P450 IIB1 resulting in a lower affinity i.e. a higher 
apparent K .^ However, the significantly lower apparent K^ of the 
uncharged PC dil6:0 compared to PE dil6:0 must result from a 
different effect. 
Bayerl et al. [8] reported a preference of microsomal 
cytochrome P450 from phénobarbital pretreated rabbits for the 
binding of PE. This preference of cytochrome P450 for PE was 
suggested to result from the shape of this phospholipid [18]. The 
relatively small headgroup of PE compared to the fatty acyl moiety 
gives this phospholipid a wedge shape which was suggested to adapt 
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cytochrome P450 to the membrane [18]. The results of the present 
study demonstrate that the apparent K<j of cytochrome P450 IIB1 for 
the wedge shaped PE is significantly higher than the apparent K<j's for 
the cilindrically shaped (phospholipid headgroup and fatty acyl chain 
are about equal in size) phospholipids PC, PI and PS. On the other 
hand, the results also show that increasing the degree of desaturation 
of the fatty acyl chain, which increases the size of the fatty acyl 
moiety relative to the headgroup and thus can be expected to make the 
molecule more wedge shaped, results in a significant decrease in the 
phosphatidylcholine apparent Kj. From this it is concluded that the 
shape of the phospholipid molecule is not factor determining the 
affinity of cytochrome P450 IIB1 for phospholipids and that the 
interaction of phospholipids with cytochromes P450 is more likely to 
be dependent on a combination of electrostatic and hydrophobic 
interactions. 
In conclusion, the results of the present study demonstrate that 
the affinity of cytochrome P450 IIB1 for different phospholipids is 
dependent on both the headgroup as well as the degree of desaturation 
of the fatty acyl moiety of a phospholipid molecule. However, in the 
present study the dependency on fatty acid chain length and degree of 
desaturation was characterized for PC phospholipids. For a further 
understanding of the factors determining the interaction of 
phospholipids with cytochrome P450, the effect of chain length and 
degree of desaturation of phospholipids with other headgroups on the 
apparent Kj might have to be investigated. Because series of pure 
molecular species of PE, PS and PI with varying fatty acyl chain 
characteristics are not commercially available these studies have to 
await synthesis and / or purification of the model phospholipids. 
Furthermore it remains to be established whether the factors that were 
shown to influence cytochrome P450 IIB1 - phospholipid interactions 
in the solublized system also play a role in the microsomal membrane. 
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5.1 Summary 
In the present study the interaction of NADPH-cytochrome reductase 
with phospholipids was investigated using 31P-NMR, thin layer 
chromatography combined with chemical analysis, fluorescence 
spectroscopy and kinetic studies with purified rat liver cytochrome P450 
IIB1. 
31P-NMR analysis demonstrates that the composition of the 
phospholipids that remain associated to NADPH-cytochrome reductase 
upon its purification is significantly different from the phospholipid 
composition of the microsomal membrane, thin layer chromatography 
followed by chemical analysis of the phospholipid composition 
demonstrates that the isolated NADPH-cytochrome reductase was 
enriched in L-a-l,2-diacyl-^«-glycero-3-phosphoserine (PS) and L-oc-
l,2-diacyl-i«-glycero-3-phosphoinositol (PI) compared to the microsomal 
membrane. The observed preference of NADPH-cytochrome reductase 
for PS and PI appeared not to be a result of the procedure for 
solubilisation and / or purification of the protein. 
The specific interaction of NADPH-cytochrome reductase with PS 
and PI was further investigated by comparison of the effect of PS and PI 
with that of PC and PE on the 2-(3-(diphenylhexatrienyl)propanoyl)-l-
hexadecanoyl-.vtt-glycero-3-phosphocholine (DPH-PC) dependent 
quenching of the tryptophan fluorescence of purified NADPH-
cytochrome reductase. The results demonstrate that the addition of PS or 
PI affects the DPH-PC dependent quenching of the tryptophan 
fluorescence in a manner significantly different from the addition of PC 
or PE. The relatively larger DPH-PC induced quenching of the 
tryptophan fluorescence of NADPH-cytochrome reductase in the 
presence of PS and PI must result from a PS and PI induced change in the 
conformation of NADPH-cytochrome reductase. 
Finally, the possible consequences of this special interaction of PS 
and PI with NADPH-cytochrome reductase on the kinetic characteristics 
of the cytochrome P450 system were studied using cytochrome P450 
IIB1 dependent O-dealkylation of pentoxyresorufin as the model 
reaction. These studies demonstrate that a 1:1 mixture of PC and PS 
results in a significantly higher apparent maximum rate (Vmax) of O-
dealkylation than a 1:1 mixture of PC and PE or PC alone. This increase 
in the apparent Vmax can be ascribed to an PS dependent improvement of 
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the interaction of NADPH-cytochrome reductase with cytochrome P450. 
This improvement of the interaction of the proteins can however not be 
exclusively ascribed to the negative charge of PS, since the other 
negatively charged phospholipid investigated, namely PI, resulted in a 
significant decrease in the apparent Vmax. In both cases the substrate 
apparent Km was not affected. This opposite effect of PS and PI on the 
kinetics of the cytochrome P450 IIB1 system might provide a means for 
phospholipid mediated regulation of this cytochrome P450 enzyme. 
5.2 Introduction 
The cytochrome P450 enzyme system is involved in the 
biotransformation of a wide variety of substrates. The first succesful 
reconstitution of cytochrome P450 dependent activities already 
demonstrated the importance of lipid-protein interactions for this 
membrane bound multi-enzyme complex [1-4]. The interaction of the 
cytochrome P450 component with phospholipids has been a topic for 
investigation in several studies. For the mitochondrial cytochrome 
P450scc a specific requirement was reported for cardiolipin [5] which was 
later demonstrated to result from a specific effector site on the 
cytochrome P450 for this phospholipid [6]. For microsomal cytochromes 
P450 however, the importance of so-called "boundary phospholipids" for 
the activity of the cytochrome P450 system is still a matter of 
considerable debate. In 1973 Stier and Sackmann [7] suggested that in 
rabbit liver microsomes the cytochrome P450 / reductase complex is 
enclosed by a halo of the phospholipid matrix which differs from the bulk 
matrix. More recently, Bayerl et al. [8] reported a preference of liver 
microsomal cytochrome P450 of phénobarbital pretreated rabbits for the 
binding of L-a-l^-diacyl-^n-glycero-S-phosphoethanolamine (PE), 
demonstrated by use of 31P-NMR, quasi-electric light scattering and 
freeze fracture electron microscopy. The rationale for a specific PE / 
P450 interaction was suggested to be the wedgeshaped structure of PE 
which might adapt cytochrome P450 to the bilayer membrane by half-
micellar structures [9]. Bosterling et al. [10], studying the phospholipid-
P450 interactions in reconstituted vesicles, reported a preference of 
cytochrome P450 LM2 for the negatively charged phospholipid L-oc-1,2-
diacyl-.m-glycero-3-phosphate (PA). This interaction was suggested to be 
122 
based on the charge-charge coupling of the negative charge of the 
phospholipid headgroup and the positive charges on the surface of the 
protein. Specific interactions of cytochrome(s) P450 with naturally more 
abundant negatively charged phospholipids like L-a-l,2-diacyl-^«-
glycero-3-phosphoserine (PS) and L-a-l,2-diacyl-^«-glycero-3-
phosphoinositol (PI) might be of more interest. Ingelman-Sundberg et al. 
[11] for example reported an increase in the reconstituted cytochrome 
P450 LM2 catalysed O-dealkylation of p-nitroanisole or ethoxycoumarin 
upon increasing the negative charge of the membrane. Furthermore, an 
increased thermal denaturation temperature of rat liver microsomal 
cytochrome P450 was observed in the presence of PI [12]. These data 
from previous studies point to a special role of negatively charged, 
naturally-occuring phospholipids in the cytochrome P450 system. 
So far, studies on the interaction of the cytochrome P450 system 
with phospholipids were confined to investigations on the interactions 
between the cytochrome P450 component and the phospholipids. Very 
little is known about interactions between phospholipids and NADPH-
cytochrome reductase, the other important enzyme component of the 
cytochrome P450 system. Therefore, the objective of the present study 
was to investigate the possible specific lipid-protein interactions for 
NADPH-cytochrome reductase in more detail. This was done using 31P-
NMR, chemical analysis, fluorescence spectroscopy and kinetic studies 
with purified rat liver NADPH-cytochrome reductase and cytochrome 
P450IIB1. 
5.3 Materials and methods 
5.3.1 Preparation of microsomes 
Microsomes were prepared from the perfused livers of Wistar rats (±300 
g) which were pretreated with phénobarbital (Brocacef b.v., Maarssen, 
The Netherlands) (0.1% in drinking water, for 7 days). Following 
homogenisation of the livers in Tris/sucrose buffer (50 mM Tris , 0.25 M 
sucrose pH 7.4) and centrifugation at 10,000 x g (20 min), the 
supernatants were centrifuged for 75 minutes at 105,000 x g. The 
microsomal pellet was resuspended in 0.1 M potassium phosphate pH 
7.25, containing 20% glycerol and 0.1 mM EDTA, immediately frozen 
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into liquid nitrogen and stored at -90 °C until use for isolation of 
NADPH-cytochrome reductase or cytochrome P450 IIB1. 
5.3.2 Chemicals 
Phospholipid references, PC, PE, PS, PI, PG, LPC, LPE and LPS were all 
purchased from Sigma (St. Louis, MO, USA). Emulgen 911 and Lubrol 
PX used for the purification of NADPH-cytochrome reductase and 
cytochrome P450 IIB1 were obtained from respectively KAO Chemicals 
(Tokyo, Japan) and Sigma (St.Louis, MO, USA). 2-(3-
(Diphenylhexatrienyl)propanoyl)-1 -hexadecanoyl-*«-glycero-3-
phosphocholine (DPH-PC) was purchased from Molecular Probes Inc. 
(Eugene, OR, USA). 
5.3.3 Purification of proteins 
NADPH-cytochrome reductase was isolated from liver microsomes of 
phénobarbital pretreated Wistar rats essentially as described by 
Yasukochi and Masters [13]. Emulgen 911 (Kao Corporation, Tokyo, 
Japan) was used instead of Renex 690, and all buffers contained 100 |J.M 
phenylmethanesulfonyl fluoride (Merck, Darmstadt, FRG) to inhibit 
protease activities. Excess detergent and phospholipid was removed by 
binding the protein to the 2'5'ADP-sepharose column (15 ml), 
equilibrated with 20 mM potassium phosphate (pH 7.7) containing 20% 
glycerol, 0.1 mM EDTA, 0.1 mM dithiothreitol (Boehringer, Mannheim, 
FRG) and 0.1 mM phenylmethanesulfonyl fluoride. The effluent with 
proteins not bound to the 2'5'ADP-sepharose column was collected, 
concentrated over an Amicon YM-30 filter and prepared for 31P-NMR as 
described below. The 2'5'ADP-sepharose column was washed with at 
least 10 column volumes of equilibration buffer and the NADPH-
cytochrome reductase was eluted with the same buffer, containing 10 
mM adenosine 2'(3 ^ -monophosphate (Sigma, St.Louis, MO, USA) and 
0.2% sodium deoxycholate (Merck, Darmstadt, FRG). The NADPH-
cytochrome reductase preparation was concentrated over an Amicon YM-
30 filter and dialysed against 3 times 2 litres of 20 mM potassium 
phosphate (pH 7.7) containing 20% glycerol, 0.1 mM EDTA and 0.1 mM 
dithiothreitol to remove the deoxycholate and adenosine 2'(3')-
monophosphate. The final detergent-free preparation had a specific 
activity of about 35 units/mg protein and was homogeneous as judged by 
SDS-PAGE, carried out as described by Laemmli [14]. 
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Cytochrome P450 IIB 1 was isolated from liver microsomes of 
phénobarbital pretreated rats, essentially as described by West et al. [15] 
using Lubrol PX instead of Emulgen 911. Excess detergent was removed 
by additional washing of the hydroxylapatite column bound protein, 
using the prescribed buffers without detergents, after which the protein 
was eluted with 0.3 M potassium phosphate, pH 7.25 containing 20% 
glycerol. The final detergent-free preparation contained 13 nmoles of 
P450 heme/ mg protein. The cytochrome P450 IIB1 preparation was over 
90% pure as judged by SDS-PAGE and was identified as cytochrome 
P450 IIB1 in an immunoblotting experiment using the monoclonal 
antibodies described by Letawe-Goujon et al. [16]. 
5.3.4 Biochemical assays 
NADPH-cytochrome reductase activity was determined as described by 
Phillips and Langdon [17], using cytochrome c (Boehringer, Mannheim, 
FRG) as the final electron acceptor. One \imo\ cytochrome c reducing 
activity per minute was taken as the unit to quantify the NADPH-
cytochrome reductase activity. Protein concentrations were measured 
using the method of Lowry et al. [18] using bovine serum albumin 
(Sigma, St. Louis, MO,USA) as the standard. The concentration of 
cytochrome P450 was determined from the CO-difference spectrum of 
the dithionite-reduced protein, based on an extinction coefficient of 91 
mM^.cnr1 as described by Omura and Sato [19]. 
Lipid extraction from liver microsomes from phénobarbital 
pretreated rats and from isolated NADPH-cytochrome reductase was 
carried out according to the method of Bligh and Dyer [20]. The 
extracted lipids were stored under argon at -20 °C until use. Separation of 
the lipid mixtures was performed by 1-dimensional thin layer 
chromatography on prefabricated, 20x20 cm silicagel plates (Sigma, St. 
Louis, MO, USA) using the solvent chloroform-methanol-acetic acid-
water (90:40:12:2). Chromatography was performed at room temperature 
until the solvent reached the upper edge of the plate (150 minutes). The 
thin layer chromatography-plate was dried and the lipid spots were 
visualised by heating the plate after spraying with 20% sulphuric acid in 
water. The spots on the thin layer chromatography plate were identified 
using phospholipid references and were assayed for phosphorous content 
by the method of Rouser et ai.[21]. 
125 
Pentoxyresorufin O-dealkylating activities were measured using 
the method of Burke et al. [22] in 0.1 M potassium phosphate pH 7.5 at 
37 °C using 0.25-2 |0.M of pentoxyresorufin (Boehringer, Mannheim, 
FRG) added in Me2SO (10 u,l /ml assay). Calibration of the fluorescence 
measurement for quantification of the resorufin formation was carried out 
by addition of 10 jil of a 104 \iM stock solution of resorufin (Boehringer, 
Mannheim, FRG) in Me2SO to the cuvette containing the reaction 
mixture. 
5.3.5 31P-NMR experiments 
The protein preparations were dialysed four times against 1 liter of 50 
fflM Tris/HCl buffer (pH 7.9), containing 10% glycerol, 5 mM EDTA 
and 1% sodium cholate (Merck, Darmstadt, FRG) to remove free 
phosphate. After dialysis the NADPH-cytochrome reductase preparations 
were concentrated over an Amicon YM-30 filter to a final concentration 
of approximately 75 \\M. The microsomal lipid extract and the 
phospholipid reference samples were dissolved in 50 mM Tris/HCl buffer 
(pH 7.9) containing 10% glycerol, 5 mM EDTA and 1% sodium cholate 
to a final concentration of approximately 2 mM and the solutions were 
sonicated briefly. 
Norell (Landisville, NJ, USA) 10 mm NMR tubes were filled with 
1.5 ml sample to which 100 (0,1 2H2Û was added for locking the magnetic 
field. 3lp-NMR measurements were performed on a Bruker AMX 300 
NMR spectrometer using 30° pulses and a recycle time of 1.1 s. 
Decoupling of ] H was done with the inverse gated decoupling technique. 
Chemical shifts were determined relative to an external reference of 85% 
H3PO4 at 303K. 
All 3!P-NMR samples were measured at 303K except the isolated 
NADPH-cytochrome reductase, which was measured at 290K. This was 
done to prevent denaturation of the NADPH-cytochrome reductase 
during the 31P-NMR experiment. 
5.3.6 Solubilisation of liver microsomes of phénobarbital pretreated 
rats with different (mixtures of) detergents 
The liver microsomes of phénobarbital pretreated Wistar rats were 
diluted with water and glycerol (10% final concentration) to a final 
protein concentration of 14 mg/ml. Sodium cholate, sodium 
deoxycholate, Lubrol PX and / or Emulgen 911 were added to the 
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microsomal solution and the mixture was stirred for 1 hour at 4 °C. After 
centrifugation at 105,000 x g (75 minutes) the supernatants, containing 
the solubilised proteins, were concentrated over an Amicon YM-30 filter 
to approximately 3 ml and dialysed four times against 1 liter of 50 mM 
Tris/HCl buffer (pH 7.9), containing 10% glycerol, 5 mM EDTA and 1% 
sodium cholate (Merck, Darmstadt, FRG) to remove free phosphate. The 
protein preparations were prepared for 31p-NMR as described above. 
5.3.7 Quenching of the tryptophan fluorescence of NADPH-
cytochrome reductase 
The fluorescence quenching experiments were carried out essentially as 
described by East and Lee [23]. The lipids were dissolved in 0.1 M 
Tris/HCl buffer (pH 7.5) containing 3% sodium cholate and the solutions 
were sonicated briefly. The lipid solutions (final lipid concentration = 
0.75 |iM) contained different molar fractions of DPH-PC. 0.20 Units of 
isolated NADPH-cytochrome reductase (± 75 pmol) and 20 nmol of 
phospholipid in 0.1 M Tris/HCl buffer (pH 7.5) containing 3% sodium 
cholate were incubated for 30 minutes at 37 °C in a small volume (50 |il). 
After this preincubation 950 |il of 0.1 M Tris/HCl buffer (pH 7.5) were 
added and the mixture was allowed to equilibrate for 15 minutes before 
tryptophan fluorescence was determined. The fluorescence experiments 
were performed with a SLM/Aminco SPF-500C spectrofluorometer at 37 
°C. The excitation wavelength was 280 nm and tryptophan fluorescence 
was detected at an emission wavelength of 340 nm. The presence of 
sodium cholate (less than 0.1% in the final mixture) which was used to 
dissolve the phospholipids did not affect the tryptophan fluorescence. 
5.3.8 Reconstituted incubations 
To determine the effect of phospholipids with different headgroups on the 
kinetics of the cytochrome P450 IIB1 dependent O-dealkylation of 
pentoxyresorufin 0.04 nmol of cytochrome P450, 0.1 units of NADPH-
cytochrome reductase and 10 nmol of phospholipid (resulting in a molar 
P450 : reductase : phospholipid ratio of 1:1: 250) were preincubated in a 
small volume (50 (0.1) for 6 minutes at 37 °C before buffers, substrate and 
NADPH (0.4 |aM final concentration) were added up to a volume of 1 ml. 
This type of reconstitution does not result in incorporation of the proteins 
into the phospholipid vesicle. Instead, the proteins remain soluble and 
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exist as homomultimeric protein aggregates with a few individual 
phospholipids attached to each protein multimer [24-27]. 
The O-dealkylating activity was determined as described above 
with a SLM/Aminco SPF-500C spectrofluorometer at 37 °C and is 
expressed as nmol resorufin formed, min-1, nmol P450"1. 
5.3.9 Statistical analysis of data 
The results are presented as the mean ± standard error of the mean 
(SEM). Statistical analysis was carried out using Students' t-test, for 
unpaired samples. The null-hypothesis was rejected at P<0.05. 
5.4 Results 
5.4.1 31P-NMR analysis of purified NADPH-cytochrome reductase 
31P-NMR was used to investigate the composition of the phospholipids 
that remain associated to NADPH-cytochrome reductase upon its 
purification. Figure 5.1a presents the part of the 31P-NMR spectrum 
containing the 31P-NMR resonances of reductase-bound phospholipids 
[28-30]. Comparison of the 31P-NMR spectrum of isolated NADPH-
cytochrome reductase with that of the phospholipid extract of the 
microsomal membrane (Figure 5.1b) demonstrates that the phospholipid 
content of the purified NADPH-cytochrome reductase differs 
significantly from that of the microsomal extract. Comparison of 31P-
NMR data of three independent NADPH-cytochrome reductase 
preparations demonstrated that, compared to the microsomal lipids, the 
NADPH-cytochrome reductase preparations show relatively higher 
intensities of the peaks at 0.16, 0.48 and 1.00 ppm, whereas the 
intensities at 0.02 and 0.66 ppm are relatively lower. Unequivocal 
identification of the various phospholipid peaks in the 31P-NMR 
spectrum of the isolated NADPH-cytochrome reductase preparations was 
hampered by the small differences in chemical shift of PS (0.52 ppm) and 
LPC (0.50 ppm) as well as of LPE (1.01 ppm) and PG (1.05 ppm), in 
combination with the relatively broad line width of the peaks. 
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1 o 
Chemical shift (ppm) 
Figure 5.1: -^P-NMR spectra of isolated NADPH-cytochrome reductase and a 
phospholipid extract of microsomes of phénobarbital pretreated rats. 
Isolated NADPH-cytochrome reductase (a) and the phospholipid extract (b) were 
prepared for 3'P-NMR as described in 'Materials and methods'. 
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Nevertheless, comparison of the chemical shift values of the reference 
phospholipids (Table 5.1) to the 31P-NMR spectra presented in Figure 
5.1 indicates that the peaks at 0.02,0.16 and 0.61 ppm probably belong to 
respectively PC, PI and PE. The peak at 0.48 ppm could either be LPC or 
PS. Results from thin layer chromatography-experiments however, 
described hereafter, demonstrate that the peak at 0.48 ppm belongs to PS, 
since no LPC spot was observed on the thin layer chromatography plate. 
Thus, these results point to a relative enrichement of the isolated 
NADPH-cytochrome reductase in PI and PS. 
Table 5.1: -''P-NMR chemical shift of phospholipids in 50 mM TrislHCl buffer 
(pi I 7.9) containing 10% glycerol, 5 mM EDTA and 1% cholate at 303 
K. 
phospholipid 
PC 
PI 
LPC 
PS 
PE 
LPS 
LPE 
PG 
chemical shift 
(ppm) 
0.01 
0.16 
0.50 
0.52 
0.61 
0.82 
1.01 
1.05 
The phospholipid solutions were prepared for 31p-NMR as described in 'Materials 
and methods'. 
5.4.2 Characterisation and quantification of the phospholipid 
contents of the purified NADPH-cytochrome reductase by thin layer 
chromatography and chemical analysis 
Because the ?1 P-NMR data presented above only allowed qualitative 
analysis and comparison of the phospholipid content of isolated reductase 
to that of the microsomal membrane, the phospholipid compositions of 
the isolated NADPH-cytochrome reductase preparation and the 
microsomal membrane were also determined by thin layer 
chromatography in combination with chemical analysis. This method is 
much more sensitive than 31 P-NMR and allows a better resolution of 
LPC, PS, PE and SM, although separation of PS and PI cannot be 
achieved [31]. The individual lipid spots on the thin layer 
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chromatography plate were assayed for phosphorous content and the 
results from these chemical analyses are presented in Table 5.2. For 
comparison, Table 5.2 also presents data reported in the literature for the 
phospholipid composition of the microsomal membrane. Finally, Table 
5.2 presents a phospholipid composition of the microsomal membrane 
lipid extract as derived from its 31P-NMR spectrum already presented in 
Figure 5.1b. 
Table 5.2: The phospholipid composition of rat liver microsomes of 
phénobarbital pretreated rats and isolated NADPH-cytochrome 
reductase preparations. 
Preparation 
Method 
microsomes 
TLC + chemical analysis 
31P-NMR 
literature |32| 
isolated reductase 
TLC + chemical analysis 
PA 
l ±1 
n.o. 
n.o. 
n.o. 
Phospholipid composition 
(% of total) 
PC 
57 ±1 
59 
62 
57 ± 3 
PE 
26 ±2 
21 
23 
20 + 3 
SM 
2 ± 1 
n.o. 
2 
n.o. 
PS+PI 
% 
15±1 
7 ±10 
14 
23 + 2* 
PG 
n.o. 
3 
n.o. 
n.o. 
The phospholipid composition was determined as described in 'Materials and 
methods'. 31p-NMR data for the isolated NADPH-cytochrome reductase are not 
included because they could not be accurately quantified. The results represent the 
mean + standard error of the mean of seven experiments with different reductase and 
microsomal preparations. The literature values for the phospholipid composition of 
rat liver microsomes of untreated Wistar rats are taken from Davison and Wills [32]. 
n.o. = not observed 
X For thin layer chromatography analysis the amount of PS and PI is presented 
as the sum of both phospholipids as they gave rise to a single spot on the thin 
layer chromatography plates. 
* significantly different from the value in the microsomes at P<0.02 
Together, the data in Table 5.2 demonstrate that the phospholipid 
composition of the microsomal membrane as determined in the present 
study by chemical analysis and 3lp-NMR corresponds well to values 
previously reported in the literature [32]. Furthermore, the data show that, 
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compared to the microsomal membrane, the isolated NADPH-
cytochrome reductase is enriched in PS / PI, whereas the relative amounts 
of PC and PE are comparable. This result corresponds to the results from 
the 31P-NMR experiments (Figure 5.1) demonstrating a relative 
enrichement of PS (0.48 ppm) and PI (0.16 ppm) compared to PC (0.02 
ppm) and PE (0.61 ppm). 
Altogether it is concluded that NADPH-cytochrome reductase 
appears to bind preferentially the negatively charged phospholipids PS 
and PI. 
5.4.3 The effect of the purification procedure on the phospholipid 
composition of isolated NADPH-cytochrome reductase preparations 
In the experiments described above, the phospholipid composition of 
purified NADPH-cytochrome reductase was demonstrated to be 
relatively enriched in PS and PI. However, during the purification 
procedure, in theory, one (or more) of the isolation steps may remove 
selectively certain phospholipids from the protein resulting in a different 
phospholipid composition of the isolated protein compared with that of 
the microsomal membrane. Especially the method for membrane 
solubilisation might influence the phospholipid content of the purified 
membrane protein [33]. Therefore, it was investigated whether the 
solubilisation procedure affects the phospholipid composition of the 
solubilised NADPH-cytochrome reductase. 
Liver microsomes from phénobarbital pretreated rats were 
solubilised with different mixtures of various detergents after which the 
phospholipid compositions of the solubilised proteins were determined by 
31P-NMR. The detergents used were sodium cholate and sodium 
deoxycholate, both ionic detergents, and Emulgen 911 and Lubrol PX, 
both non-ionic detergents. Solubilisation of liver microsomes with 0.63% 
sodium cholate, 0.63% sodium deoxycholate, 0.63% Lubrol, 0.63% 
Emulgen, 0.31 % sodium cholate / 0.31% Lubrol, 0.31% sodium cholate / 
0.31% Emulgen, 0.31% sodium deoxycholate / 0.31% Lubrol, 0.31% 
sodium deoxycholate / 0.31% Emulgen or 0.37% sodium deoxycholate / 
0.71% Lubrol (used in the isolation procedure of NADPH-cytochrome 
reductase) resulted in 31P-NMR spectra similar to the one presented in 
Figure 5.2 for the solubilisation with 1.11% sodium cholate / 0.55% 
Lubrol (used in the isolation procedure of cytochrome P450). 
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Comparison of the 31P-NMR spectrum of the solubilised protein 
preparation (Figure 5.2) with the 31P-NMR spectra of the purified 
NADPH-cytochrome reductase and the microsomal membrane (Figure 
5.1a and b) demonstrates that the spectrum of the solubilised preparation 
resembles that of the isolated NADPH-cytochrome reductase and is 
different from the microsomal membrane. These results indicate that, 
irrespective of the concentration and type of detergent used for the 
solubilisation, the phospholipid composition of the solubilised 
microsomal protein preparation is different of that of the membrane. 
1 o 
Chemical shift (ppm) 
Figure 5.2: •' 'P-NMR spectrum of a solubilised microsomal protein preparation. 
Solubilisation was carried out as described in 'Materials and methods' with 1.11% 
sodium cholate and 0.55% Lubrol. The protein preparation was prepared for 31p. 
NMR as described in 'Materials and methods'. 
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To investigate whether differences in the phospholipid contents for the 
purified NADPH-cytochrome reductase and the microsomal membrane is 
mainly determined by the solubilisation procedure, the phospholipid 
contents of the protein preparations obtained during the affinity column 
chromatography of the NADPH-cytochrome reductase purification were 
compared. During the last step of the isolation NADPH-cytochrome 
reductase is separated from the remaining proteins by a 2'5'ADP-
sepharose column. The 3lp_NMR spectrum of a concentrated sample 
containing these collected protein impurities is presented in Figure 5.3 
and can be compared to the 31P-NMR spectrum of the purified NADPH-
cytochrome reductase originating from the same isolation procedure 
(Figure 5.1a). 
o 
Ö 
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2 1 0 - 1 
Chemical shift (ppm) 
Figure 5.3: J^P-NMR spectrum of the protein fraction which did not bind to the 
2'5'ADP-sepharose column used for the NADPH-cytochrome 
reductase purification. 
The protein preparation was prepared for 31p-NMR as described in 'Materials and 
methods'. 
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Comparison of the 31P-NMR spectra of NADPH-cytochrome reductase 
and the 2'5'ADP-sepharose effluent shows that the phospholipid 
composition of the protein preparation which does not bind to the 
2'5'ADP-sepharose column, is different from the phospholipid 
composition of the isolated NADPH-cytochrome reductase. In particular, 
the increase in the peak at 0.48 ppm (PS) was even more pronounced in 
the effluent protein fraction than already observed in the isolated 
NADPH-cytochrome reductase, whereas the relative increase in the peak 
at 0.16 ppm (PI) was only observed for the NADPH-cytochrome 
reductase samples. Together, these results demonstrate that the 
phospholipid composition of the isolated NADPH-cytochrome reductase 
preparation is not solely determined by its solubilisation from the 
membrane, but it also reflects a special affinity of the protein for the 
different phospholipids. 
5.4.4 The effect of the phospholipid headgroup on the DPH-PC 
dependent quenching of tryptophan fluorescence of NADPH-
cytochrome reductase 
The experiments described above point to a specific relationship between 
NADPH-cytochrome reductase and PS and PI. In additional experiments 
we further investigated a possible special interaction of NADPH-
cytochrome reductase with PS, PI and other phospholipids by studying 
the effect of PC, PE, PS and PI on the DPH-PC mediated quenching of 
the tryptophan fluorescence of NADPH-cytochrome reductase. Figures 
5.4 and 5.5 present the results obtained. From these data it follows that 
upon the addition of DPH-PC to a solution of NADPH-cytochrome 
reductase its tryptophan fluorescence at Xcm = 340 nm decreases. The 
decrease in the NADPH-cytochrome reductase tryptophan fluorescence is 
accompanied by an increase in the fluorescence emission spectrum of 
DPH-PC (400-500 nm). Furthermore, Figure 5.4 demonstrates that the 
apparent decrease in the fluorescence emission of tryptophan residues at 
340 nm does not result from an inner filter effect by DPH-PC as DPH-PC 
does not demonstrate its characteristic emission spectrum at A,ex = 280 
nm (inset a, Figure 5.4). More likely, the appearance of the fluorescence 
emission spectrum of DPH-PC is explained by the energy transfer from 
tryptophan residue(s) of NADPH-cytochrome reductase to DPH-PC 
molecules located in the direct vicinity of these tryptophans. Because 
energy transfer is effective over distances ranging to 50 Â [34], the DPH-
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PC molecules must be located within this distance from the tryptophan 
residues. The excitation of these DPH-PC molecules results in the typical 
DPH-PC fluorescence emission spectrum between 400 and 500 nm (inset 
b, Figure 5.4). 
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Figure 5.4: Fluorescence emission spectrum of 75 pmol NADPH-cytochrome 
reductase in the presence of 20 nmol PC (A) or 20 nmol PC I DPH-PC 
(1:1)(B). 
The DPH-PC mediated quenching of tryptophan fluorescence of NADPH-cytochrome 
reductase was determined as described in 'Materials and methods'. Inset: the 
fluorescence emission spectrum of 20 nmoles of DPH-PC in 0.1 M potassium 
phosphate buffer (pH = 7.5) at ^-excitation ~ 280 nm (a) and A.exci t a tjon = 355 nm 
(b). 
Figure 5.5 presents the results from experiments in which the tryptophan 
fluorescence was measured as a function of the molar fraction of DPH-
PC, mixed with other phospholipids (PC, PE, PS or PI). The results 
obtained demonstrate that - as expected - increasing the molar fraction of 
DPH-PC results in a gradual decrease in the tryptophan fluorescence. 
However, even a 150 times molar excess of DPH-PC over NADPH-
cytochrome reductase cannot completely quench the tryptophan 
fluorescence of the protein. This means that either some of the 
tryptophans are deeply burried in the reductase molecule and their 
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fluorescence cannnot be quenched by DPH-PC or a finite distance exists 
between DPH-PC and the tryptophan residues. 
Furthermore, Figure 5.5 shows that at a molar DPH-PC fraction of 
about 0.5 in the PS- and Pi-system the tryptophan fluorescence is lower 
than the tryptophan fluorescence at a molar DPH-PC fraction of 1. Since 
this phenomenon was only observed in the PS- and Pi-system it could be 
related to the negative charge of these phospholipids and may be 
connected with either a charge dependent conformational change in the 
reductase structure or a different kind of association of DPH-PC with 
reductase in the presence of PS and PI. 
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Figure 5.5: The effect of PC (o-o), PE (Â-Â), PS {•-•) and PI (A-A) on the DPH-
PC dependent quenching of the tryptophan fluorescence of NADPH-
cytochrome reductase. 
The DPH-PC mediated quenching of tryptophan fluorescence of 75 pmol NADPH-
cytochrome reductase mH was determined as described in 'Materials and methods'. 
The results present the mean ± standard error of the mean of three experiments. 
5.4.5 The effect of the phospholipid headgroup on the kinetics of the 
cytochrome P450 IIB1 dependent O-dealkylation of pentoxyresorufin 
In addition to the effect of phospholipids with different headgroups on 
the DPH-PC dependent quenching of the tryptophan fluorescence of 
NADPH-cytochrome reductase, their effect on the kinetics of cytochrome 
P450 IIB 1-dependent O-dealkylation of pentoxyresorufin was 
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investigated. This was done to characterise a possible special role for PS 
and PI in the NADPH-cytochrome reductase / cytochrome P450 system. 
The results from these experiments are presented in Table 5.3.The results 
demonstrate that compared to a system without added phospholipids, the 
addition of phospholipids to the reconstituted system results in a 
significant increase in Vmax whereas the substrate apparent Km is not 
affected. However, when the kinetic parameters of the pentoxyresorufin 
O-dealkylation in the presence of phospholipid (mixtures) are compared 
to one another, the data demonstrate that the presence of PC and a 1:1 
(w/w) mixture of PC with PE affect the substrate's apparent Km and 
Vm a x in a similar way. On the other hand, the use of a phospholipid 
mixture of PC and the negatively charged PI results in a significantly 
smaller increase in the apparent Vmax. An opposite effect on Vmax was 
observed when cytochrome P450 and NADPH-cytochrome reductase 
were preincubated with a mixture of PC and PS. Addition of the 
negatively charged PS resulted in a significant larger increase in the 
apparent Vmax compared to PC and PC / PE. These results imply that the 
Vmax of pentoxyresorufin-O-dealkylation in the presence of PC / PS is 
significantly higher than the V in the presence of PC / PI. 
Table 5.3: The effect of (mixtures of) phospholipids with different headgroups on 
the kinetics of the pentoxyresorufin-O-dealkylation by reconstituted 
cytochrome P450IIB1. 
phospholipid(s) 
none 
PC 
PC/PE(l:lw/w) 
PC/PS(1:1*VW) 
PC/PI(l: lw/w) 
Km 
(uM) 
0.65 ± 0.07 
0.77 ± 0.02 
0.72 ± 0.02 
0.72 ±'0.01 
0.72 ± 0.01 
Vmax 
(nmol.min" 1 .nmol P450" 1 ) 
0.12 ±0.01** 
0.30 ±0.01 
0.31 ±0.02 
0.37 ±0.01* 
0.22 ±0.02* 
The O-dealkylation of pentoxyresorufin by cytochrome P450IIB1 was determined as 
described in 'Materials and methods'. The results represent the mean ± standard error 
of the mean of three experiments with two different protein preparations. Substrate 
apparent Km and V m a x values were determined by fitting the experimental data to 
the Michaelis-Menten equation. 
* significantly different from the value for PC at P<0.05. 
** significantly different from the values with phospholipids at P<0.005. 
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5.5 Discussion 
In the present study the interaction of NADPH-cytochrome reductase 
with phospholipids was investigated using 31P-NMR, thin layer 
chromatography combined with chemical analysis, fluorescence 
spectroscopy and kinetic experiments in a reconstituted cytochrome P450 
IIB1 system. The results from the 31P-NMR experiments demonstrate a 
significant difference between the phospholipid composition of the 
microsomal membrane and the composition of the phospholipids that 
remain associated to NADPH-cytochrome reductase upon purification of 
the protein. The 31P-NMR data suggest a relative enrichment of the 
purified NADPH-cytochrome reductase in PS or LPC (0.48 ppm) and PI 
(0.16 ppm). Unequivocal identification and quantification of the 
phospholipid contents of the various samples came from thin layer 
chromatography analysis combined with chemical analysis of extracted 
spots. The results from these experiments were in agreement with those 
from the NMR study and demonstrated that the peak at 0.48 ppm results 
from PS and thus, the isolated NADPH-cytochrome reductase 
preparations were enriched in PS and PI compared to the microsomal 
membrane. 
The enrichement of NADPH-cytochrome reductase in PS and PI, 
observed in the present study, is not in line with the results reported by 
Narayanasami et al. [30] who observed that in E.coli -expressed forms of 
NADPH-cytochrome reductase the major form of phospholipid that 
remains bound to reductase upon its purification, is PE. However, the fact 
that in their study the protein was expressed in E.coli. might also be the 
reason for this differential observation because in E. coli PE is the most 
abundant form of phospholipid [35]. 
Additional data demonstrate that the PI / PS enrichment which 
occurs upon solubilisation of the proteins from the membrane is 
independent of the type or concentration of the detergent used for 
solubilisation of the microsomal proteins and to be to some extent 
dependent on the nature of the solubilised protein. 
Additional results show that (i) PS and PI affect the DPH-PC 
dependent quenching of the tryptophan fluorescence of NADPH-
cytochrome reductase in a different way than PC and PE and (ii) 
preincubation of cytochrome P450 IIB1 and NADPH-cytochrome 
reductase with a mixture of PC with either PS or PI results in a 
139 
significantly different effect on the apparent Vmax of the 
pentoxyresorufin-O-dealkylation with respect to preincubation of the 
proteins with either a mixture of PC and PE or PC alone. These 
observations show an PS and PI dependent change in the NADPH-
cytochrome reductase conformation, resulting on the one hand in an 
improved interaction with DPH-PC and a concomitant increase in the 
quenching of the reductase's tryptophan fluorescence, due to enhanced 
energy transfer to DPH-PC, and on the other hand in a possible change in 
its interaction with cytochrome P450 resulting in an effect on Vmax. The 
increase in Vmax by PS might, for example, be achieved by improving 
the alignment of the proteins through charge-charge interactions of 
protein(s) and phospholipid or through neutralisation of repelling positive 
charges on the surface of NADPH-cytochrome reductase and cytochrome 
P450 IIB1. This improved interaction between the proteins may result in 
an increased rate of electron transfer and thus an increased apparent 
Vmax- 0 ° the other hand, the different effects of PI and PS on the 
apparent Vmax might also result from a different effect of the two 
phospholipids on other, not yet characterized properties of the proteins of 
the reconstituted system. The fact that the also negatively charged PI 
affects the kinetic parameters in a different manner than PS - PI causing a 
decrease in the apparent Vmax - indicates that the stimulating effect of PS 
on the pentoxyresorufin-O-dealkylating activity of the reconstituted 
system must at least in part be due to other factors than its negative 
charge. 
At this stage it should be stressed that the results of the kinetic 
experiments were obtained with an in vitro system which differs 
significantly from the in vivo , membrane bound situation. In the 
reconstituted system of the present study the proteins are not incorporated 
in a membrane and the molar cytochrome P450 : reductase ratio is much 
lower than the one known to exist in the endoplasmatic reticulum 
membrane (1:1 versus 30-15:1). This makes extrapolation of the results 
from the in vitro system to the situation in the endoplasmatic reticulum 
membrane to some extent speculative although the results do provide a 
basis for formulation of new working hypotheses. 
The importance of the negatively charged phospholipids in the 
cytochrome P450 enzyme system has also been reported by some other 
investigators. Ingelman-Sundberg etal. [11] reported an apparent linear 
relationship between the negative charge of reconstituted vesicles and the 
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rate of cytochrome P450 LM2 (= IIB 1 from rabbit liver) catalysed O-
dealkylation of p-nitroanisole and 7-ethoxycoumarin. When incorporated 
into vesicles composed of PE and PS the ethoxycoumarin-O-dealkylating 
activity of cytochrome P450 LM2 was about double that of systems in 
which the proteins are incorporated into vesicles composed of PE or PC 
alone. This result is in line with the increased Vmax for P450 IIB1 
catalysed pentoxyresorufin-O-dealkylation reported in the present study. 
In the previous study however, only PS was used to increase the negative 
charge of the phospholipid vesicle; studies on the effect of PI on the 
ethoxycoumarin-O-dealkylating activity were not reported. In another 
study, Blanck et al. [36] reported that the dissociation constant for the 
catalytically active P450 LM2 / reductase complex in the presence of a 
3:1 mixture of PE and PS is comparable to the dissociation constant in 
the presence of a microsomal lipid extract and 10 times smaller than in 
the presence of PC. This observation is also in line with the higher Vmax 
for the cytochrome P450 IIB1 catalysed pentoxyresorufin-O-dealkylating 
activity in the presence of PS reported in this study. However, in the 
presence of the other naturally abundant negatively charged 
phospholipid, namely PI, Vmax of the pentoxyresorufin-O-dealkylation 
by the reconstituted cytochrome P450 IIB1 system was decreased. Thus, 
the results of the present study not only demonstrate a preference of 
NADPH-cytochrome reductase for the negatively charged PS and PI, but 
also point at possibilities for regulation of the kinetics of a reconstituted 
cytochrome P450 IIB1 system by PS (increasing Vmax) and PI 
(decreasing Vmax). Furthermore, the results clearly demonstrate that in 
addition to the cytochrome P450 component, the NADPH-cytochrome 
reductase component of the system might add to the phospholipid 
preference of the enzyme system for negatively charged phospholipids. 
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Chapter 6 
Experimental and theoretical study on the 
redoxcycling of resorufin by solubilized 
and membrane-bound NADPH-
cytochrome reductase 
published in 
(1992) Chem.Res.Toxicol 5, 268-273 
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6.1 Summary 
The present study describes both experimental and theoretical data on the 
redox cycling of resorufins catalyzed by NADPH-cytochrome reductase. 
At 1-5 |J.M concentrations at physiological pH, the redox cycling of 
ethoxy- and pentoxyresorufin was shown to be far more efficient than the 
redox cycling of their product from the cytochrome-P450 dependent O-
dealkylation, resorufin (7-hydroxyphenoxazone). This was shown to 
result from the fact that i) the protonated form of the resorufin is a much 
better substrate for redox cycling than the deprotonated resorufin O-anion 
and that ii) at physiological pH the redox cycling active protonated form 
is present at only 1-4 % of the total amount of resorufin. 
In addition to experimental data, AMI molecular orbital computer 
calculations provided evidence for the difference in redox cycling 
capacity between the resorufin O-anion and its protonated form. The 
energy of the lowest unoccupied molecular orbital ( E H J M O ) °f t n e 
resorufin O-anion is higher than the EHJMO va^ue f° r m e protonated 
form. This low ELUMO value of the protonated form can be taken as a 
parameter for its easier reduction. Furthermore, computer calculations 
demonstrated one electron reduction of the protonated form to be 
energetically favourable by 363.5 kJ/mol, compared to one electron 
reduction of the deprotonated O-anionic form. 
Additional AMI molecular orbital computer calculations indicated 
that the one-electron reduced resorufin will become protonated at the O-
atom of the intramolecular semiquinoneimine moiety before reduction by 
a second electron becomes likely. Finally, redox cycling of resorufin by 
solubilized and membrane incorporated NADPH-cytochrome reductase 
provided evidence that membrane surroundings increase the 
concentration of the protonated form of resorufin. This effect is achieved 
either by favored partitioning of the protonated resorufin into the 
membrane and / or by an effect of the membrane on the protonation 
equilibrium of resorufin in favour of the protonated form. 
6.2 Introduction 
The 7-alkoxyresorufins are frequently used in biochemical toxicology to 
study the activity of cytochromes P450 in liver microsomal preparations. 
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Cytochromes P450 catalyze the O-dealkylation of these substrates to the 
highly fluorescent resorufin (7-hydroxyphenoxazone) [1-3]. Recently, it 
was reported that this series of alkoxyresorufins and resorufin, containing 
an intramolecular quinoneimine function, are substrates for redox 
cycling, catalyzed by NADPH-cytochrome reductase (E.C.I.6.2.4.) [4]. 
During redox cycling electrons from the NADPH-cytochrome reductase 
are not passed to cytochrome P450 for substrate monooxygenation, but 
are passed to the quinone(imine), resulting in semiquinone(imine)s and/or 
dihydroquinone(imine)s. As these one or two electron reduced forms pass 
their electrons on to molecular oxygen they give rise to the formation of 
toxic, reactive oxygen species like superoxide anions and hydrogen 
peroxide, from which, in a Fenton-type reaction, hydroxyl radicals can be 
formed [5]. This reoxidation of the semi- or dihydroquinone(imine)s by 
oxygen results in their conversion to the original quinone(imine)s which 
can participate in a new redox cycle. 
In the present paper the redox cycling of the resorufin derivatives 
is investigated in more detail. At physiological pH and 1-5 U.M 
concentration, the alkoxyresorufins appear to be better substrates for 
NADPH-cytochrome reductase dependent redox cycling than their O-
dealkylation product resorufin. Furthermore, membrane incorporated 
NADPH-cytochrome reductase is shown to catalize higher redox cycling 
rates than solubilized NADPH-cytochrome reductase at a given 
concentration of resorufin. 
Experiments and computer AMI molecular orbital calculations 
presented in this paper demonstrate the reason underlying these effects. 
6.3 Materials and methods 
6.3.1 Purification of NADPH-cytochrome reductase 
NADPH-cytochrome reductase was isolated from liver microsomes of 
phenobarbital-treated female Wistar rats essentially as described by 
Yasukochi and Masters [6]. Lubrol PX (Sigma, St. Louis, MO, USA) was 
used instead of Renex 690 and all buffers contained 100 mM 
phenylmethanesulfonyl fluoride (Merck, Darmstadt, FRG) to inhibit 
protease activics. Excess detergent and phospholipid was removed by 
additional washing of the 2'5'-ADP-Sepharose column bound protein 
using the prescribed buffers without the detergents lubrol and 
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deoxycholate (Merck, Darmstadt, FRG). The enzyme was eluted using 20 
mM potassium phosphate buffer (pH 7.7) containing 10 raM adenosine 
2'(3')-monophosphate (Sigma, St. Louis, MO, USA), 20 % (v/v) glycerol, 
0.1 mM EDTA, 0.1 mM dithiotreitol (Boehringer, Mannheim, FRG), 0.1 
mM phenylmethanesulfonyl fluoride and 0.2 % (w/v) sodium 
deoxycholate. The final preparation was concentrated over an Amicon 
YM-30 filter and dialysed 4 times against 1 liter 20 mM potassium 
phosphate buffer (pH 7.7) containing 20 % (v/v) glycerol and 0.1 mM 
EDTA to remove the deoxycholate and adenosine 2'(3')-monophosphate. 
NADPH-cytochrome reductase activity was measured as described 
by Philips and Langdon [7] using cytochrome c as the final electron 
acceptor. One \imol cytochrome c reducing activity was taken as the unit 
to quantify the NADPH-cytochrome reductase activity. Protein was 
measured according to Lowry et al. [8] using bovine serum albumin 
(Sigma, St. Louis, MO, USA) as the standard. 
The final detergent-free preparation had a specific activity of at 
least 35 units/mg protein, was homogeneous as judged by SDS/PAGE, 
carried out as described by Laemmli [9] and stored in small portions at 
-20 °C until use. 
6.3.2 Reconstituted NADPH-cytochrome reductase systems 
Two types of systems with isolated NADPH-cytochrome reductase were 
used. The first one is referred to as solubilized NADPH-cytochrome 
reductase. For this system the isolated reductase preparation is used as 
such, if necessary diluted in 0.1 M potassium phosphate buffer (pH 7.5) 
containing 20% (v/v) glycerol just before use. 
In addition, membrane incorporated NADPH-cytochrome 
reductase was used. Membrane incorporation of the isolated enzyme was 
achieved by the so called cholate dialysis method, carried out essentially 
as described by Taniguchi et al. [10]. In short 6.25 units of the isolated 
NADPH-cytochrome reductase were mixed with 0.15 mg L-oc-dilauroyl-
.m-glycero-3-phosphocholine (PC di-12:0) (Sigma, St. Louis, MO, USA) 
and diluted with at least two volumes of 50 mM potassium phosphate 
buffer (pH 7.25) containing 0.1 mM EDTA, 0.1 mM dithiothreitol and 1 
% (w/v) sodium cholate (Merck, Darmstadt, FRG). Two ml of this 
mixture were dialysed for 48 hours against 2 times 2 liters of 50 mM 
potassium phosphate buffer (pH 7.25) containing 0.1 mM EDTA and 0.1 
mM dithiotreitol. 
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6.3.3 Redoxcycling of resorufins 
The redox cycling of resorufins was measured in 0.1 M potassium 
phosphate buffer (pH 7.5) at room temperature. Both the solubilized and 
the membrane incorporated NADPH-cytochrome reductase preparation 
were used in such dilutions that 10 JJ.1 reductase preparation added per ml 
reaction mixture resulted in a final concentration of 0.025 units 
reductase/ml. The desired concentrations of resorufin (Janssen Chimica, 
Beerse, Belgium), ethoxy- or pentoxyresorufin (both from Boehringer, 
Mannheim, FRG) were added as 1 % (v/v) of a 100 times concentrated 
solution in dimethylsulfoxide. Reactions were started by addition of 
NADPH (0.15 mM final concentration) and followed by the decrease in 
the NADPH absorption at 340 nm. Reactions were corrected for resorufin 
independent NADPH oxidation which was routinely less than 5% of the 
resorufin dependent one. 
The amount of H2O2 was determined indirectly by production of 
formaldehyde during oxidation of methanol essentially as described by 
Werringloer [11] using the method of Nash [12]. Oxygen consumption 
was measured using the Clark oxygen electrode at 25 °C. 
6.3.4 Molecular orbital computer calculations 
Computer calculations were performed on a Silicon Graphics Iris 4D/85 
with Quanta/Charmm (Polygen Ltd., Reading, U.K.) using the semi-
empirical molecular orbital AMI method from the AMP AC program 
obtained from the Quantum Chemistry Program Exchange (QCPE 
program no. 506(2.1)) (Indiana University, Bloomington, IN, USA). 
Geometries were optimized for all bond lengths, bond angles and torsion 
angles. Geometry was optimized using the Fletcher-Powell criteria. For 
all calculations Herberts test was satisfied in Fletcher-Powell and the self-
consistent field was achieved. 
The results from these computer calculations represent the data for 
the compounds in vacuo, a situation different from the one in biological 
systems, where solvation and a different polarity of the direct 
environment (dielectric constant) might influence Coulomb and Frontier 
orbital characteristics of the substrates to the in-vacuo situation. In the 
present study, however, a series of related resorufins is compared and it is 
assumed that deviations from the in-vacuo situation will be similar for all 
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Substrates, and will not influence relative differences between the various 
resorufins. 
6.3.5 Statistical analysis of data 
Data are presented as the mean ± standard error of the mean (SEM) and 
statistical analysis was carried out using Student's t-test, for unpaired 
samples. The null-hypothesis was rejected at P<0.05. 
6.4 Results 
6.4.1 Redox cycling of resorufin and its 7-alkoxy derivatives 
The redox cycling of resorufin and two of its 7-alkoxy derivatives by 
isolated, solubilized NADPH-cytochrome reductase was investigated. 
From Table 6.1 it can be seen that the observed reaction for the resorufin 
derivatives can indeed be ascribed to redox cycling. For the different 
substrates the NADPH oxidation is accompanied by proportional oxygen 
Table 6.1: NADPH oxidation, H2O2 production and O2 consumption during 
redox cycling of resorufin and pentoxyresorufin by solubilized and 
membrane incorporated NADPH-cytochrome reductase. 
reconstituted system 
solubilized reductase 
+ resorufin 
solubilized reductase 
+ pentoxyresorufin 
membrane incoiporated 
reductase + resorufin 
Time 
(min.) 
5 min. 
10 min. 
15 min. 
5 min. 
10 min. 
15 min. 
5 min. 
10 min. 
15 min. 
NADPH 
oxidation 
(nmoLml'l) 
16 
30 
43 
20 
39 
58 
30 
58 
82 
H 2 0 2 
production 
(nmol.ml"!) 
13 
26 
38 
17 
33 
46 
24 
48 
69 
O2 
consumption 
(nmol.mH) 
14 
29 
42 
15 
30 
44 
35 
58 
71 
NADPH oxidation, H2O2 production and 0 2 consumption were measured in 0.1 M 
potassium phosphate buffer (pH 7.5) containing 0.1 units/ml reductase and 50 uM 
resorufin or 5 uM pentoxyresorufin essentially as described in 'Materials and 
methods'. 
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Table 6.2: Kinetic data from Lineweaver-Burk plots for the NADPH-cytochrome 
reductase dependent redox cycling of resorufin and its 7-alkoxy 
derivatives atpH 75. 
substrate 
resorufin 
ethoxyresorufin 
pentoxyresorufin 
apparent Km 
OiM) 
125 ±11 
4 + 1 
4+1 
*max 
(nmol NADPH oxidized, 
min'l. unit reductase" 1) 
308 ± 29 
336 ± 26 
282 ± 77 
Solubilized NADPH-cytochrome reductase was used. The values represent the mean 
± SEM of four experiments. 
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Figure 6.1: Redox cycling of resorufin (•-•), ethoxyresorufin (i-+) and 
pentoxyresorufin (A-A) by solubilized NADPH cytochrome reductase 
atpH 7.5. 
Redoxcycling was measured as described in 'Materials and methods', by NADPH 
oxidation at 340 mn. The values represent the mean ± SEM of three experiments. 
consumption and H2O2 formation. When the redox cycling of the three 
substrates was investigated as a function of their concentration, ethoxy-
and pentoxyresorufin appeared to be far more efficient than resorufin 
(Figure 6.1). Data from kinetic studies, presented in Table 6.2, show that 
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this is mainly caused by the about thirty times larger apparent Km for 
resorufin. This results in a low rate of redox cycling of resorufin at the 1-
5 (J.M concentrations used in the experiment of Figure 6.1. Increasing the 
concentration results in a Vmax that is comparable to those observed for 
ethoxy- and pentoxyresorufin (Table 6.2). 
6.4.2 Effect of pH on resorufin redox cycling 
It is demonstrated in Figure 6.2 that the redox cycling of resorufin is 
increased upon lowering the pH in spite of an inactivation of the 
NADPH-cytochrome reductase (measured by cytochrome c reduction). In 
contrast the redox cycling of the two alkoxyresorufins decreases to the 
same extent as the cytochrome c reducing activity of the enzyme. Results 
from kinetic studies on the redox cycling of resorufin at pH values below 
7.5, namely 7.0 and 6.5, showed that a decrease in the pH is accompanied 
by a decrease in the Km of NADPH-cytochrome reductase for resorufin 
(Table 6.3). The Vmax appeared to be not significantly affected by 
changes in the pH. 
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Figure 6.2: Redox cycling of resorufin (•-•), ethoxyresorufin (t-t) and 
pentoxyresorufin (A-A), and cytochrome c reduction (M-M) by 
solubilized NADPH-cytochrome reductase as a function of decreasing 
pH. 
Assays were carried out as described in 'Materials and methods'. The pH was varied 
by varying the pH of the potassium phosphate buffer. 
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Table 6.3: Kinetic data from Lineweaver-Burk plots for the NADPH-cytochrome 
reductase dependent redox cycling of resorufin at different pH. 
PH 
7.5 
7.0 
6.5 
apparent Km 
(uM) 
125 ±11 
53 ± 4** 
33 + g*,*** 
"max 
(nmol NADPH oxidized 
.min'l .unit reductase" *) 
308 ± 29 
281 ±25 
264 ±9 
Solubilized NADPH-cytochrome reductase was used. The values represent the mean 
+ SEM of three experiments. Redox cycling was measured as described in 'Materials 
and methods'. 
* = significantly different from the value at pH 7.0 for P<0.05 
** = significantly different from the value at pH 7.5 for P<0.005 
*** = significantly different from the value at pH 7.5 for P<0.001 
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Figure 6.3 : Determination of the pKa of resorufin by fluorescence spectroscopy. 
At Xcx = 530 nm, the intensity of the fluorescence emission at A.em = 585 nm was 
determined for resorufin dissolved in 0.1 M potassium phosphate buffer of varying 
pH. For reasons indicated in the text, the fluorescence is ascribed to the deprotonated 
resorufin O-anion. 
Altogether, these data suggest that a protonated and deprotonated form 
of resorufin show different capacities for redox cycling, the protonated 
one being more active. 
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From the results presented in Figure 6.3 the pKa for resorufin was 
calculated to be 5.7. This means that an increase in the ratio protonated / 
deprotonated resorufin will occur with decreasing pH in the range where 
the redox cycling of resorufin is increased. 
Based on the highly coloured and fluorescent character of resorufin 
at pH values higher than its pKa, and on the observation that at pH values 
below the pKa the colour of the resorufin changes from pink to orange, 
thereby becoming similar to that of its alkylated derivatives ethoxy- and 
pentoxyresorufin, it is concluded that the acid-base equilibrium between 
the protonated resorufin and its deprotonated O-anion is involved, as 
indicated in Figure 6.3. 
From the pKa value of 5.7 it can be calculated that going from pH 
7.5 to 6.5, the relative amount of the protonated resorufin increases from 
1.6 % to 13.7 % of the total amount of resorufin added. If the protonated 
form is indeed the only form participating in the redox cycling this 
explains the increase in resorufin dependent redox cycling activity with 
decreasing pH (Figure 6.2), and the decrease in the apparent Km with 
decreasing pH (Table 6.3). 
6.4.3 AMI molecular orbital calculations. 
As the results presented above suggested that protonated resorufin would 
be a much better substrate for redox cycling than its deprotonated, O-
anionic form, computer calculations were carried out to see whether the 
phenomenon can be ascribed to molecular characteristics of this anionic 
form. Table 6.4 shows the results of AMI computer calculations. From 
these data it can be derived that the energy of the lowest unoccupied 
molecular orbital (EJJJMO). t n e molecular orbital into which the electron 
will be placed upon the one electron reduction, might indeed provide a 
parameter to predict whether compounds are likely candidates for redox 
cycling or not. The E H J M O °f m e resorufin O-anion is significantly 
higher than the ELUMO ^or m e P r o t o n a t ed resorufin and the ELUMO f° r 
the alkoxyresorufins. This indicates that one electron reduction of the 
resorufin anion will require more energy than one electron reduction of 
either the protonated resorufin or the resorufin ethers. This is confirmed 
by the difference in the final heats of formation between the one electron 
reduced form and the oxidized form (AHF) calculated for the different 
resorufins (Table 6.4). From these data it can be derived that one electron 
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reduction of the protonated resorufin form is 363.5 kJ/mol energetically 
favourable over one electron reduction of the resorufin O-anion. 
Table 6.4: Calculated ELUMO values of the resorufin derivatives and difference 
in final heats of formation for the one electron reduced forms. 
resorufin 
derivative 
txcr 
resorufin 
resorufin anion 
ethoxyresorufin 
pentoxyresorufin 
R= 
-OH 
-o-
-OC2H5 
-OC 5 H n 
ELUMO 
(eV) 
-1.71 
+2.06 
-1.65 
-1.63 
AHF 
(kJ/mol) 
-219.2 
+144.3 
-215.1 
-214.2 
Calculations were carried out as described in 'Materials and methods'. The heat of 
formation difference between the one electron reduced form and the oxidized form of 
the resorufins (AHF) is calculated as HFi
 e-recj - HFo x 
Table 6.5: Calculated energies of the single occupied molecular orbital (SOMO) 
in which the electron has to be placed upon one electron reduction of 
the resorufin semiquinoneimine radical, and final heats of formation 
(HF)for the O- or N-protonated one electron reduced resorufin forms. 
molecular structure 
H
°^°^°' 
KAN<U HOY^ró-rr°'H KXnkJ 
»Y^o^x, 
KXnkJ i 
H 
ESOMO 
(eV) 
-0.28 
-4.58 
-4.91 
HF 
(kJ/mol) 
-106.7 
-91.6 
Calculations were carried out as described in 'Materials and methods'. In the 
molecular structures depicted, the charge and the unpaired electron were situated on 
the atom with, respectively, the highest negative charge and the highest spin density. 
The actual, calculated charge and spin distributions are depicted in Figure 6.4. 
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Figure 6.4: Calculated charge distribution f or the one electron reduced resorufin 
(a) and calculated spin distribution for the O-protonated (b) and N-
protonated (c)form of one electron reduced resorufin. 
Values given represent the net atomic charges (a) or the total spin density (b+c) on the 
atoms. For the spin distribution calculation only the spin densities larger than 0.03 are 
presented. Calculations were carried out as described in 'Materials and methods'. 
In Table 6.5 similar AMI calculation results for non-protonated and O- or 
N-protonated one electron reduced resorufin are presented. In analogy to 
the arguments refered to above, it can be concluded from these results 
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that the semiquinoneimine form has to be protonated before it might 
become reduced in a second redox cycling step. It is proposed by Dutton 
and Parkinson [4] that this protonation takes place at the nitrogen atom of 
the intramolecular semiquinoneimine moiety. However, the charge 
distribution calculated for the one electron reduced resorufin (Figure 
6.4a) suggests that protonation of the oxygen of the semiquinoneimine 
moiety is more likely than protonation of the nitrogen atom. This follows 
from the observation that the negative charge, located on the O-atom of 
the intramolecular semiquinoneimine moiety, is much larger than the one 
located on the N-atom. Furthermore, calculation of the spin distribution 
on the O- or N-protonated one electron reduced resorufins (Figure 6.4b 
and c) show a larger derealization of the radical electron in the O-
protonated form, suggesting it to be more stable than the N-protonated 
form. This is confirmed by calculation of the final heat of formation of 
the O- and N-protonated resorufin radicals respectively (Table 6.5), 
showing O-protonation to be 15.1 kJ/mol energetically favourable over 
N-protonation. Similar calculations for the one electron reduced 7-
alkoxyresorufins provided the same results (data not shown), 
demonstrating the charge and spin distribution and thus the protonation to 
be independent of the ether side chain. 
6.4.4 Redox cycling catalyzed by membrane incorporated NADPH-
cytochrome reductase 
In an additional experiment the redox cycling of resorufin by membrane 
incorporated reductase was studied. Upon membrane incorporation of the 
reductase by cholate dialysis, recovery of the cytochrome c reducing 
activity was over 95 %. Expressed per unit of cytochrome c reducing 
activity, membrane incorporation of the reductase showed no effect on 
ethoxyresorufin dependent redox cycling (Table 6.6). The resorufin 
dependent redox cycling, however, appeared to be significantly 
(P<0.001) higher when catalyzed by membrane incorporated NADPH-
cytochrome reductase. 
The explanation underlying the observed difference in resorufin 
redox cycling activity between solubilized and membrane incorporated 
NADPH-cytochrome reductase was investigated in a kinetic study. The 
data from this experiment are summarized in Table 6.7. The results 
clearly demonstrate that the higher resorufin redox cycling activity by 
membrane incoiporated reconstituted reductase is caused by a significant 
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Table 6.6: Redox cycling of resorufin (50 ßM final concentration) and 
ethoxyresorufin (4.5 [M final concentration) by solubilized and 
membrane incorporated NADPH cytochrome reductase. 
substrate 
resorufin 
ethoxyresorufin 
reductase 
solubilized 
membrane 
incorporated 
solubilized 
membrane 
incorporated 
redoxcycling 
(nmol NADPH 
oxidized. min'l. 
unit reductase" 1) 
105 ±1 
174 ± 4 * 
183 ±6 
188 ±6 
% of solubilized 
activity 
100 
168 ± 4 * 
100 
103 ±7 
Activity is expressed per unit of cytochrome c reducing activity of the two 
preparations. The values represent the mean ± SEM of five experiments. 
* = significantly different from the solubilized reductase activity at P<0.001. 
Table 6.7: Kinetic data from Lineweaver-Burk plots for the redox cycling of 
resorufin by solubilized and and membrane incorporated NADPH 
cytochrome reductase. 
reconstituted system 
solubilized reductase 
+ PC di-12:0 vesicles 
membrane incorporated 
reductase 
apparent Km 
(uM) 
153 ±13 
107 ± 8* 
'max 
(nmoles NADPH oxidized 
.min"l .unit reductase-!) 
512±39 
571 ± 30 
Redoxcycling was essentially measured as described in 'Materials and methods'. 
Redoxcycling by solubilized NADPH-cytochrome reductase was measured in the 
presence of PC di-12:0 vesicles. Lipid vesicles were added upto the 
reductase/phospholipid ratio used in the membrane incorporated system. The values 
represent the mean ± SEM of six experiments. 
* = significantly different from the value for solubilized reductase at P<0.02 
159 
decrease in the apparent Km for the resorufin (P<0.02), whereas the Vmax 
is unaffected. With the assumption that only the protonated form of the 
resorufin contributes significantly to the resorufin redox cycling, it 
follows from the observed difference in apparent Km that the 
concentration of the protonated resorufin in the membrane environment is 
1.4 times its concentration in the bulk waterphase. 
6.5 Discussion 
The present study describes both experimental and theoretical data on the 
redox cycling of resorufins by NADPH-cytochrome reductase. Based on 
the outcomes of these studies a scheme for the redox cycling of resorufin 
at physiological pH can be presented (Figure 6.5) that differs from the 
one recently published in the literature by Dutton and Parkinson [4]. 
Redoxcycling of resorufin was shown to be pH dependent. Due to 
its pKa determined to be 5.7, at physiological pH (pH 7.1-7.7) the 
compound is mainly (96-99%) present in its deprotonated O-anionic 
form. Based on further experimental data and the results from AMI 
molecular orbital calculations presented in this study, it can be concluded 
that the protonated resorufin and not this O-anionic form is the one active 
in redox cycling. This conclusion emerges from the facts that i) redox 
cycling of resorufin increases with decreasing pH in spite of a lower 
activity of the NADPH-cytochrome reductase at these lower pH values, 
ii) the ELUMO *or t n e O-anionic form was positive and thus significantly 
higher than the negative ELUMO f° r m e protonated resorufin and iii) one 
electron reduction of the protonated form was calculated to be 
energetically favoured by 363.5 kJ/mol compared to one electron 
reduction of the resorufin O-anion. 
In addition, AMI molecular orbital calculations confirmed that 
protonation of the intramolecular semiquinoneimine moiety has to occur 
before a second one electron reduction is likely to take place. This is in 
agreement with an assumption made by Dutton and Parkinson [4]. Up to 
now, the literature data on the protonation of benzosemiquinoneimines 
show controversy as to whether the semiquinoneimines become 
protonated on their N- or O-atom [4,13,14]. Charge and spin distributions 
for N-acetyl-p-benzoquinoneimine were suggested, that located the 
charge and the unpaired electron on the O- and N-atom respectively, 
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suggesting protonation to take place at the O-atom [13]. On the other 
hand Fischer et al. [14] proposed the N-acetyl-p-benzosemiquinoneimine 
to become protonated at the N-atom. Dutton and Parkinson [4] proposed 
protonation of the intramolecular semiquinoneimine moiety of the 
resorufin radical anion to take place at the N-atom. In the present study 
however, the charge distributions, calculated for the one electron reduced 
resorufin, together with the spin distributions and the final heats of 
formation calculated for the O- or N-protonated form of the one electron 
reduced resorufin, indicate that the O-atom is the one most likely to 
become protonated. 
The results of the present study demonstrate that calculation of the 
energy of the molecular orbital into which an electron will be placed 
upon redox cycling (ELUMO f°r non-radicals), might be used as a tool to 
predict the capacity of a compound to take part in redox cycling 
reactions. However, affinity of the NADPH-cytochrome reductase for the 
compound, as well as the capacity of the one or two electron reduced 
xenobioticum to pass the electron(s) on to molecular oxygen, will also 
represent factors controlling redox cycling activities [13,15]. Obviously, 
possible correlations between calculated parameters (ETJJMO o r ^HF) 
and redox cycling of other xenobiotics than the resorufins, remains an 
interesting topic for future research. 
It is also demonstrated in the present study that for resorufin at a 
given concentration the redox cycling by solubilized NADPH-
cytochrome reductase was significantly lower than the activity by 
membrane incorporated NADPH-cytochrome reductase. The results of 
kinetic studies, using membrane incorporated reductase and solubilized 
reductase in the presence of PC di-12:0 vesicles, demonstrated this to be 
caused by a reduced apparent Km for resorufin for the membrane 
incorporated enzyme. The Vmax values for both systems appeared to be 
the same, but they were higher than for solubilized reductase without 
added phospholipid vesicles (Table 6.7). This higher Vm a x in the 
presence of phospholipids might be caused by an improved electron 
transfer from NADPH-cytochrome reductase to resorufin. For the 
cytochrome P450 enzyme system, which includes NADPH-cytochrome 
reductase, phospholipids have also been reported to affect electron 
transfer from NADPH-cytochrome reductase to cytochrome P450 [16-
19]. 
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The observed difference in apparent Km for resorufin for 
membrane incorporated and solubilized reductase might originate from 
the fact that in the apolar membrane environment the amount of the 
protonated, redox cycling active form of resorufin is increased compared 
to its concentration in the bulk water phase. This could be the result of 
either partitioning of resorufin into the membrane or an effect of the 
membrane on the protonation equilibrium of resorufin in favour of the 
more apolar protonated form or a combination of both phenomena. The 
effect can not be ascribed to a change in proteinconformation of 
NADPH-cytochrome reductase upon membrane incorporation because 
the redox cycling of ethoxyresorufin was not affected by membrane 
incorporation. Furthermore, the fact that ethoxyresorufin redox cycling is 
not affected by membrane incorporation of the reductase also implies that 
the positive effect of membrane incorporation on the redox cycling of 
resorufin can not be solely ascribed to the partitioning of the substrate 
into the membrane, but must at least in part be caused by a shift in the 
protonation equilibrium of resorufin. In other literature reports it has 
often been assumed that membrane surroundings may influence substrate 
availabilities of apolar xenobiotics for biotransformation enzymes. 
Especially with respect to the cytochrome P450 enzyme system the 
membrane has often been regarded as the place where apolar substrates 
might accumulate [18,20-23]. Experimental evidence for this assumption 
was first provided in a study by Taniguchi and Pyerin [24]. They 
demonstrated that the apparent dissociation constant of benzphetamine 
for purified, solubilized cytochrome P450 was one order of magnitude 
larger than for purified, membrane incorporated cytochrome P450 and 
microsomal cytochrome P450. The results of the present study provide 
further evidence for the concept, mentioned above. In addition they 
demonstrate that membrane surroundings might even cause a shift in the 
protonation equilibrium of a xenobiotic compound, in favour of its most 
apolar form. 
Such membrane induced shifts in protonation equilibria, as 
demonstarted for resorufin in the present study, might also influence the 
conversion of other xenobiotics by membrane bound biotransformation 
enzymes, such as cytochromes P450, UDP-glucuronyltransferases and 
microsomal glutathion S-transferase. Clearly this will especially be of 
importance when there is a difference in the rate of conversion of 
protonated and deprotonated forms of the xenobiotic. 
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pKa = 5.7 
H+ 
XOCT 4= w C 
XCcr 
Figure 6.5: Reaction scheme for the NADPH-cytochrome reductase catalyzed 
redox cycling of resorufin based on the results of the present study. 
The unpaired electron is situated on the atom with the highest spin density. The actual 
spin distribution is depicted in Figure 6.3. 
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Chapter 7 
NADPH-cytochrome reductase catalysed 
redox cycling of 1,4-benzoquinone; 
hampered at physiological conditions, 
initiated at increased pH values. 
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7.1 Summary 
In the present study the inability of 1,4-benzoquinone to support 
NADPH-cytochrome reductase catalyzed redox cycling was investigated. 
The results obtained demonstrate that NADPH-cytochrome reductase is 
able to initiate a rapid two electron reduction of 1,4-benzoquinone 
resulting in formation of the hydroquinone. The intermediate one electron 
reduced semiquinone form does not pass its electron on to molecular 
oxygen, i.e. giving rise to redox cycling, but is reduced by a second 
electron, either by NADPH-cytochrome reductase upon protonation of 
the semiquinone or through disproportionation, both giving rise to the 
two electron reduced hydroquinone. At pH values below the pKa of the 
hydroquinone, the electrons of the hydroquinone are also not passed on to 
molecular oxygen due to efficient protonation. However, at pH values 
around or above the pKa (9.85) of the two electron reduced hydroquinone 
form, significant redox cycling activity is observed in a 1,4-benzoquinone 
containing incubation. Further experiments demonstrate a similarity in 
both the concentration and pH dependence of 1,4-benzoquinone or 1,4-
hydroquinone supported NADPH-cytochrome reductase catalyzed redox 
cycling. From these observations it is concluded that 1,4-benzoquinone is 
able to redox cycle from its deprotonated two electron reduced 
hydroquinone form, but only at relatively high pH values. 
Together the data provide insight into why the NADPH-
cytochrome reductase catalyzed redoxcycling of 1,4-benzoquinone is 
inhibited at physiological conditions, but initiated at increased pH values. 
7.2 Introduction 
The toxicity of quinones is generally ascribed to their capacity to bind 
covalently to cellular nucleophilic macromolecules, and/or to their 
capacity to support a process called redox cycling [1-3]. The redox 
cycling of quinones is initiated by their one electron reduction catalyzed 
by flavin containing enzymes like NADPH-cytochrome reductase (EC 
1.6.2.4), NADH-cytochrome reductase (EC 1.6.2.2) or xanthine oxidase 
(EC 1.2.3.2) [4], resulting in formation of a reactive semiquinone radical. 
The semiquinone radical may pass its unpaired electron on to molecular 
oxygen, giving rise to the formation of reactive oxygen species and 
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regeneration of the quinone which can participate in a new redox cycle. 
In addition, upon protonation and a second single electron reduction of 
the semiquinone radical the two electron reduced deprotonated 
hydroquinone form arises. This form might also react with molecular 
oxygen passing on one or both of its electrons, resulting in formation of 
respectively superoxide anion radicals or hydrogen peroxide. The extent 
to which redox cycling may add to the toxicity of the benzoquinones 
varies with the substituent pattern of the quinone [3,5]. 1,4-Benzoquinone 
as well as mono-substituted 1,4-benzoquinone derivatives have been 
reported to redox cycle very poorly, or not at all [6]. The poor redox 
cycling of 1,4-benzoquinone has been ascribed to its very positive one-
electron reduction potential in aqueous solutions, although the reason for 
poor redox cycling due to a relatively positive single electron reduction 
potential remained unclear [2,6,7]. Other investigators ascribed the lack 
of redox cycling ability of 1,4-benzoquinone to the slow reaction of its 
semiquinone radical with molecular oxygen (k= 0.5-4.5 x 104 M_1.s_1) 
[3,8,9,10]. 
Generally, factors not taken into consideration when studying the 
redox cycling capacities of the quinones in biological systems, are the 
protonation-deprotonation equilibria of their semiquinone and of their 
two electron reduced hydroquinone form, which are, however, well 
documented in the literature [11,12]. This, in spite of the fact that 
protonation can be expected to stabilize the negative charge resulting 
from the one or two electron reduction, thereby decreasing the possibility 
of a reaction of the one or two electron reduced form with molecular 
oxygen, i.e. redox cycling. That deprotonation is a requisite for electron 
transfer is a well established concept [13]. 
The objective of the present study was to investigate the lack of 
redox cycling of 1,4-benzoquinone and the importance of protonation 
equilibria of its one and two electron reduced forms for the inability of 
1,4-benzoquinone to redox cycle in a NADPH-cytochrome reductase 
catalyzed reaction. 
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7.3 Materials and methods 
7.3.1 Purification of NADPH cytochrome reductase. 
NADPH-cytochrome reductase was purified from liver microsomes of 
female Wistar rats pretreated with phénobarbital (Brocacef b.v., 
Maarssen, The Netherlands) (0.1 % (w/v) in drinking water for 7 days), 
essentially as described by Yasukochi and Masters [14]. Emulgen 911 
(Kao Corporation, Tokyo, Japan) was used instead of Renex 690, and all 
buffers contained 100 |iM phenylmethanesulfonyl fluoride (Merck, 
Darmstadt, FRG) to inhibit protease activities. The preparation was made 
detergent-free as described before [15]. 
NADPH-cytochrome reductase activity was determined as 
described by Phillips and Langdon [16], using cytochrome c (Boehringer, 
Mannheim, FRG) as the final electron acceptor. One |xmol cytochrome c 
reducing activity per minute was taken as the unit to quantify the 
NADPH-cytochrome reductase activity. Protein concentrations were 
measured using the method of Lowry et al. [17] using bovine serum 
albumin (Sigma, St Louis, MO, USA) as the standard. The final 
detergent-free preparation had a specific activity of at least 35 units/mg 
protein and was homogenous as judged by SDS-PAGE, carried out as 
described by Laemmli [18]. 
7.3.2 Redox cycling of benzoquinones. 
1,4-Benzoquinone, 1,4-hydroquinone and tetramethyl-l,4-benzoquinone 
(duroquinone) were purchased from Aldrich (Steinheim, FRG). The 
redox cycling of benzoquinones was measured at room temperature in 0.1 
M potassium phosphate buffer pH 7.5 (unless indicated otherwise) 
containing 0.15 mM NADPH (final concentration). The desired 
concentrations of quinones were added as 1% (v/v) of a 100 times 
concentrated, freshly prepared solution in dimethyl sulfoxide. Reactions 
were started by addition of 0.13 units of NADPH-cytochrome reductase. 
NADPH oxidation was detected by measuring the absorption at 340 nm. 
Activities were corrected for NADPH-cytochrome reductase-independent 
NADPH oxidation which was generally between 0 and 30 % of the 
reductase dependent activity. 
Production of H2O2 was measured as described by Werringloer 
[19]. Oxygen consumption was measured using a Clark oxygen electrode 
at 25 °C. 
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7.3.3 Molecular orbital computer calculations. 
Molecular orbital calculations were performed as described before [15]. 
7.3.4 Statistical analysis of data 
The results represent the mean ± standard error of the mean. 
7.4 Results 
7.4.1 Redox cycling of the 1,4-benzoquinones. 
The redox cycling of 1,4-benzoquinone and tetramethyl-1,4-
benzoquinone (used as a well-known redox active control) was 
investigated as a function of the benzoquinone concentration. 
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Figure 7.1: NAD P H-cytochrome reductase catalyzed NADPH oxidation in the 
presence of tetramethyI-1,4-benzoquinone (o-o) or 1,4-benzoquinone 
(0-0) at pH 7.5 and increasing concentration of the benzoquinone. 
NADPH-oxidation was measured as described in 'Materials and methods'. The results 
represent the mean ± standard error of the mean of three experiments. 
From the results obtained (Figure 7.1) it follows that there is a significant 
difference in the extent to which the 1,4-benzoquinone and tetramethyl-
1,4-benzoquinone redox cycle. Whereas redox cycling of 1,4-
benzoquinone itself was hardly detectable at pH 7.5, substitution with 
four electron donating substituents (tetramethy 1-1,4-benzoquinone) 
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resulted in increased rates of redox cycling. The apparent Km and Vmax 
for the NADPH-cytochrome reductase catalyzed redox cycling of 
tetramethyl-1,4-benzoquinone derived from the data presented in Figure 
7.1 were respectively 19±1 U.M and 367+22 nmol NADPH oxidized.min-
In the presence of superoxide dismutase (0.1 mg/ml) at 
physiological pH values redox cycling of 1,4-benzoquinone was still not 
observed, indicating that elimination of superoxide anions from the 
incubation medium does not result in a shift of the equilibrium 
semiquinone + oxygen <=> quinone + superoxide anion to the right, 
initiating possibilities for redox cycling. 
7.4.2 Single electron reduction potentials of the 1,4-benzoquinones. 
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Figure 7.2: Relation between the single electron reduction potential (E(QIQ*)) for 
a series of 1,4- benzoquinones in aqueous solution and their calculated 
E-LUMO- The correlation coefficient was 0.909. 
The one electron reduction potentials in aqueous solution of the Q/Q* couples, 
indicated here as E(Q/Q*), were taken from Chambers [11]. The EnjMO values were 
calculated as described in 'Materials and methods'. BQ = 1,4-benzoquinone; MBQ= 
methyl-1,4-benzoquinone; 2,3DMBQ = 2,3-dimethyl- 1,4-benzoquinone; 2,5DMBQ = 
2,5-dimethyl- 1,4-benzoquinone; triMBQ = trimethyl-1,4-benzoquinone; TMBQ = 
tetramethyl- 1,4-benzoquinone 
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Previous studies reported in the literature, suggest a relationship between 
electronic affinities, Polarographie single electron reduction potentials 
and the energy (E) of the lowest unoccupied molecular orbital (LUMO) 
of a molecule [11,20,21,22]. The LUMO is the molecular orbital into 
which the electron will be positioned upon one electron reduction. To 
investigate whether the non redox cycling of 1,4-benzoquinone could be 
due to a deviating single electron reduction potential compared to the 
single electron reduction potential of tetramethyl- 1,4-benzoquinone, the 
ELUMO values of these and additional 1,4-benzoquinones were calculated 
and compared to data available in the literature [11,22] for their one 
electron reduction potentials. The results obtained (Figure 7.2) 
demonstrate that the calculated ELUMO values correlate with the single 
electron reduction potential of the benzoquinones (correlation coefficient 
= 0.909).The data in Figure 7.2 also demonstrate that the one electron 
reduction potential of 1,4-benzoquinone is higher than that of methyl 
substituted benzoquinones, suggesting that the reduction of 1,4-
benzoquinone (higher E1/2, lower ELUMO) *S e n e r g e t i c a ^y more 
favourable than that of tetramethyl-1,4-benzoquinone. From this it is 
concluded that the absence of redox cycling of 1,4-benzoquinone is 
unlikely to be due to an inability to accept electrons. 
7.4.3 NADPH-cytochrome reductase catalyzed reduction of 1,4-
benzoquinone. 
In Figure 7.3 data are presented that confirm that the poor redox cycling 
of 1,4-benzoquinone is not due to its inability to accept electrons. 
Immediately following the addition of NADPH-cytochrome reductase to 
a 1,4-benzoquinone containing incubation a rapid decrease in NADPH is 
observed, which levels off after a short period of time (Figure 7.3a). 
During this rapid decrease in NADPH no oxygen consumption is 
observed (data not shown). The amount of NADPH oxidized varies 
stoichiometrically with the amount of 1,4-benzoquinone added (Figure 
7.3b). From this observation it follows that two electrons are consumed 
per molecule of 1,4-benzoquinone. This implies that the 1,4-
benzoquinone can be one-electron reduced by NADPH-cytochrome 
reductase, but instead of passing its electron on to molecular oxygen, the 
semiquinone radical either disproportionates or becomes quickly reduced 
by a second electron, both processes resulting in formation of the two 
electron reduced hydroquinone. 
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Figure 7.3: Time (a) and 1,4-benzoquinone concentration (b) dependent NADPH -
cytochrome reductase catalyzed NADPH oxidation. 
Incubation conditions were as described in 'Materials and methods'. NADPH 
oxidation was determined by monitoring the absorbance at 340 nm. At the arrows in 
Figure 3 a respectively 1,4-benzoquinone (in two concentrations) and NADPH-
cytochrome reductase were added to the incubation. In Figure 3^ the relationship 
between the amount of 1,4-benzoquinone added and the amount of NADPH oxidized 
is depicted. The curve obtained fits the equation [NADPH] = 1.87 + 0.91.[HQ], 
correlation coefficient = 0.991. 
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7.4.4 Redox cycling of 1,4-benzoquinone at varying pH. 
The lack of redox cycling of 1,4-benzoquinone might be ascribed to 
efficient protonation of either its one or its two electron reduced form. 
Thus, a shift in the pH of the incubation to a value around or above the 
pKa of the one electron reduced semiquinone or the two electron reduced 
hydroquinone might result in increased possibilities for redox cycling of 
1,4-benzoquinone. Therefore, the effect of varying pH of the incubation 
mixture on the NADPH-cytochrome reductase catalyzed redox cycling of 
1,4-benzoquinone was investigated. Tetramethyl-1,4-benzoquinone was 
included in this experiment as a positive control, i.e. a compound capable 
of redox cycling at physiological pH values. From the data, presented in 
Figure 7.4, it follows that from pH 7.5 to 10.5 tetramethyl-1,4-
benzoquinone demonstrates significant redox cycling. The activity 
observed parallels the activity of NADPH-cytochrome reductase, 
demonstrating reduced activity at higher pH values (Figure 7.4). 
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Figure 7.4: pH Dependence of the NADPH-cytochrome reductase catalyzed redox 
cycling of 1,4-benzoquinone (•-•) and tetramethyl-1,4-benzoquinone 
(o-o) and of the cytochrome c reducing activity of NADPH-cytochrome 
reductase (A-A). 
Redox cycling activities in the presence of 1 uM 1,4-benzoquinone or 20 uM 
tetramethyl-1,4-benzoquinone and the cytochrome c reducing activity of NADPH-
cytochrome reductase were determined as described in 'Materials and methods'. The 
results represent the mean ± standard error of the mean of two experiments. 
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For 1,4-benzoquinone a different pattern was observed. At pH values 
below 9.0 1,4-benzoquinone appeared unable to support redox cycling. 
However, an increase in the pH from 9.0 to 10.5 results in increased 
capacities for redox cycling in spite of the relative reduction in the 
activity of the NADPH-cytochrome reductase. Additional experiments 
demonstrated that the 1,4-benzoquinone supported NADPH oxidation 
was accompanied by stoichiometric oxygen consumption and H2O2 
production (Table 7.1), indicating that the 1,4-benzoquinone supported 
NADPH oxidation at pH > 9.0 indeed represents redox cycling. 
Table 7.1: NADPH-cytochrome reductase catalyzed NADPH oxidation, H2O2 
formation and O2 consumption in the presence of 1,4-benzoquinone (BQ) 
or 1,4-hydroquinone (HQ) measured during the first two minutes of 
redox cycling atpH 10.0. 
substrate 
BQ (0.5 uM) 
HQ (0.5 uM) 
NADPH 
oxidation 
(nmol / 2 
min.Ured) 
88 ±3 
74 ±6 
H202 
formation 
(nmol / 2 
min.Ured) 
64 ±2 
62 ±4 
0 2 
consumption 
(nmol / 2 
min.Ured) 
80±1 
84 ± 2 
NADPH oxidation, H2O2 formation and O2 consumption were measured as described 
in 'Materials and methods'. The results represent the mean ± standard error of the mean 
(n=3). 
The data presented in Figure 7.4 also demonstrate that the redox cycling 
of 1,4-benzoquinone becomes significant around the pKa value of its 
hydroquinone form reported to be 9.85 [22]. The pKa of its semiquinone 
form has been reported to be 4.1 [22]. This result suggests that 1,4-
benzoquinone redox cycles from its deprotonated hydroquinone form not 
from its semiquinone form. To investigate this possibility to a further 
extent additional experiments were performed using 1,4-hydroquinone as 
a substrate for NADPH-cytochrome reductase catalyzed redox cycling. 
The results from these experiments are presented in Figures 7.5a and 
7.5D. Figure 7.5a demonstrates that the pH dependence of the 1,4-
benzoquinone and 1,4-hydroquinone supported redox cycling activities 
are similar. The 1,4-hydroquinone supported redox cycling also becomes 
significant around the pKa value of 1.4-hydroquinone, i.e. 9.85. Figure 
7.5D demonstrates that, at pH 10.0, the NADPH-cytochrome reductase 
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catalyzed redox cycling of 1,4-benzoquinone and 1,4-hydroquinone also 
show a similar dependence on the substrate concentration. 
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Figure 7.5: pH (a) and concentration (b) dependent NADPH-cytochrome 
reductase catalyzed redox cycling at pH 10.0 of 1,4-benzoquinone (*-
•) and / ,4-hydroquinone (o-o). 
Redox cycling was measured as described in 'Materials and methods'. The 
concentration of 1,4-hydroquinone and 1,4-benzoquinone used in Figure 7.5a was 1 
u.M. The results represent the mean ± standard error of the mean of two experiments. 
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Finally, the results presented in Figure 7.6 demonstrate that addition of 
the hydroquinone to an incubation without NADPH and without 
NADPH-cytochrome reductase (pH= 10.0), results in a stoichiometric 
consumption of oxygen. This implies an oxygen induced oxidation of the 
deprotonated hydroquinone. 
Together the results support the conclusion that the redox cycling 
activités observed for 1,4-benzoquinone at pH values > 9 can be ascribed 
to redox cycling of its deprotonated hydroquinone form. 
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Figure 7.6: Oxygen consumption in an incubation without NADPH and without 
NADPH-cytochrome reductase upon addition of increasing 
concentration of 1,4-hydroquinone. 
The curve obtained fits the equation O2 consumption = 0.86 + 1.02.[HQ], correlation 
coefficient = 0.999. Oxygen consumption was measured as described in 'Materials 
and methods'. The results represent the mean ± standard error of the mean of two 
experiments. 
7.5 Discussion 
In the present study the inability of 1,4-benzoquinone to support 
NADPH-cytochrome reductase catalyzed redox cycling was investigated. 
Analysis of calculated molecular orbital parameters (ELUMO) a n^ m e 
single electron reduction potentials of these and other quinone 
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derivatives, demonstrated that the non redox cycling of 1,4-benzoquinone 
can not be ascribed to a deviating single electron reduction potential of 
this molecule. Additonal experiments with 1,4-benzoquinone clearly 
demonstrated the two electron reduction of this compound by NADPH-
cytochrome reductase resulting in stoichiometric NADPH oxidation and 
formation of the hydroquinone. This result is in accordance with results 
from an experiment described by Nishibayashi et al. [23] reporting 
stoichiometric NADPH oxidation upon addition of 1,4-benzoquinone to a 
microsomal incubation. The results of the present study demonstrate that 
this reduction is not accompanied by oxygen consumption or H2O2 
formation but results in formation of the 1,4-hydroquinone. Based on 
these observations it must be concluded that the non redox cycling of 1,4-
benzoquinone at pH 7.5 must be ascribed to the inability of both its one 
electron as well as its two electron reduced form to pass their electron(s) 
on to molecular oxygen. Taking into account the pKa values reported for 
the semiquinone and hydroquinone form of 1,4-benzoquinone reported to 
be 4.1 and 9.85, respectively [22], it can be concluded that at pH 7.5 the 
semiquinone is present in its deprotonated form whereas the 
hydroquinone is present in its protonated form. Thus, the results obtained 
point at the inability of the deprotonated semiquinone and the protonated 
hydroquinone to pass electrons on to molecular oxygen. This conclusion 
is in line with the fact that the rate constant for the reaction of 1,4-
semiquinone with molecular oxygen is at least four orders in magnitude 
lower than that of the tetramethyl substituted 1,4-semiquinone [9]. 
However, the rate constant for the protonation of the one electron reduced 
1,4-benzoquinone is high compared to the rate constant for a reaction 
with molecular oxygen. Comparison of the rate constant for protonation 
of the semiquinone, reported to be 4 x 1010 M'V 1 [24], to that reported 
for the reaction of the semiquinone with molecular oxygen (0.5-4.5 x 104 
M-V1) [8,10] shows that chances for protonation of the semiquinone 
radical are 106 times higher than chances for a reaction with molecular 
oxygen. When the protonated semiquinone is efficiently reduced by a 
second electron, i.e. removed from the incubation, this will shift the 
protonation equilibrium of the semiquinone in favor of the protonated 
form, even when the pH is above its pKa. This explains why the 
semiquinone might become protonated and reduced by a second electron 
instead of passing on its electron to molecular oxygen, i.e. giving rise to 
redox cycling. Such a one electron reduction of the semiquinone to the 
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hydroquinone by NADPH-cytochrome reductase must be possible taking 
into account the one electron reduction potential of the semiquinone-
hydroquinone couple of +459 mV [22] and the midpoint potentials of the 
four one electron steps in the NADPH-cytochrome reductase reported to 
be much lower, i.e. -110 mV, -270 mV, -290 mV and -365 mV [25]. In 
addition, disproportionation of the non-protonated semiquinone radical to 
result in formation of the quinone and the two electron reduced 
hydroquinone might provide an additional and/or alternative route for the 
NADPH-cytochrome reductase initiated formation of the two electron 
reduced hydroquinone. 
Additional results of the present study demonstrate that with 
increasing pH 1,4-benzoquinone becomes capable of redox cycling. The 
actual pH at which this phenomenon occurs appears to be around the pKa 
of the hydroquinone. From this result it is concluded that the redox 
cycling observed for 1,4-benzoquinone at increased pH values results 
from redox cycling of its deprotonated hydroquinone form, present at a 
significant concentration when the pH of the medium reaches the pKa of 
the hydroquinone. This redox cycling implies electron transfer from the 
deprotonated hydroquinone to molecular oxygen, a reaction hampered at 
neutral pH by the fact that the one electron reduction potential for the 
semiquinone/hydroquinone couple might be too high, i.e. +459 mV [22], 
for an efficient one electron transfer of the hydroquinone to molecular 
oxygen. This because the reduction potential of the 02/02* couple has 
been reported to be between -155 and -330 mV [8,9,10,22]. However, the 
reduction potential of the semiquinone/hydroquinone couple will, in 
analogy to what is described for the two electron reduction potential of 
the quinone/hydroquinone couple, decline with increasing pH, facilitating 
the one electron transfer from the deprotonated hydroquinone to 
molecular oxygen. The fact that addition of superoxide dismutase did not 
inhibit the redox cycling of the (hydro)quinone at increased pH values 
(data not shown) excludes that the reaction proceeds by 02* as the 
oxidant. The stoichiometric oxygen consumption observed upon addition 
of the hydroquinone to an incubation without NADPH and without 
NADPH-cytochrome reductase further supports the 02-catalyzed 
oxidation of the hydroquinone, as depicted in Figure 7.7. 
In conclusion, the results of the present study demonstrate that the 
non redox cycling of 1,4-benzoquinone at pH 7.5 is mainly due to the low 
rate constant for the reaction of the 1,4-semiquinone with molecular oxygen 
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Figure 7.7: Schematic presentation of the pathway for redox cycling of 1,4-
benzoquinone based on the results of the present study. 
Kinetic data are derived from the literature [8,10,13]. For further explanation see text of 
the discussion section. 
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compared to the rapid protonation of the 1,4-semiquinone resulting in a 
form that can be efficiently reduced by a second electron and finally in the 
formation of the 1,4-hydroquinone. Due to its pKa value of 9.85, at 
physiological pH the 1,4-hydroquinone becomes protonated which prevents 
redox cycling of this compound. Figure 7.7 schematically presents these 
characteristics of the 1,4-benzoquinone redox cycling. The results obtained 
support that under physiological conditions 1,4-benzoquinone-induced 
toxicity must result from its nucleophilic rather than its redox cycling 
capacities. 
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Chapter 8 
Summary and Conclusions 
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The cytochrome P450 enzyme system is involved in the metabolism and 
elimination of an almost unlimited number of endogenous and exogenous 
substrates. Biotransformation by cytochromes P450 plays a role in the 
conversion xenobiotics into more hydrophilic products. Generally, this 
process of biotransformation in which cytochrome P450 reactions take 
part, leads to elimination of the xenobiotic through urine and / or faeces 
although in some cases this process can also lead to the formation of 
more toxic metabolites. Because of its significant role in the conversion 
of numerous endogenous and exogenous compounds, a complete 
understanding of the cytochrome P450 enzyme system is of importance 
in toxicology, pharmacology, anesthesiology, pathology and other related 
biomedical fields. 
Twenty-five years ago the phospholipids of the membrane of the 
endoplasmatic reticulum, to which the enzyme system is bound, appeared 
to play an important role in the in vitro cytochrome P450 enzyme system. 
Although the role of the membrane(phospholipids) in the cytochrome 
P450 system has been intensively studied since then, it has not resulted in 
a unanimous conclusion. The goal of this thesis was therefore, to gain 
further insight into the role of the membrane and membrane 
phospholipids in the cytochrome P450 system. Attention is thereby not 
only paid to the effects of the membrane and the phospholipids on 
cytochrome P450 enzymes but also to the effects on another important 
protein component of the enzyme system, namely NADPH-cytochrome 
reductase. 
In the first two chapters the cytochrome P450 enzyme system and the 
membrane(phospholipids) of the endoplasmatic reticulum are described 
respectively. In chapter 1A the structural and catalytical properties of the 
cytochrome P450 enzyme system are briefly discussed. Special attention 
is paid to the occurence, multiplicity, induction, the structure of the 
individual protein components of the enzyme system and the catalytic 
cycle of cytochromes P450. The individual steps in this catalytic cycle 
are discussed in detail. 
Chapter IB deals with the structural aspects of the membrane 
phospholipids and the membrane of the endoplasmatic reticulum. In 
addition a brief description of the different types of reconstituted systems 
used in this thesis is given. Finally, the effects of phospholipids on the 
cytochrome P450 enzyme system, reported up to now in the literature, 
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and various current hypotheses for the stimulating effect of phospholipids 
are discussed briefly. 
In chapter 2 results are described that characterise the sensitivity of 
microsomal and isolated cytochrome P450 IA1 and IIB1 for an organic 
hydroperoxide; cumene hydroperoxide (CuOOH). These data provide 
information on the difference in the way of membrane incorporation of 
these two cytochrome P450 enzymes. Up to now, very little attention has 
been paid to possible differences in sensitivity of cytochromes P450 to 
conditions of oxidative stress. A difference in sensitivity for 
(hydro)peroxides between different forms of cytochrome P450, as 
demonstrated with CuOOH in the present study, can be of importance 
from a toxicological point of view. Especially in cases in which 
conversion by one cytochrome P450 enzyme results in detoxification of 
the substrate whereas another cytochrome P450 enzyme causes 
bioactivation of the substrate, a difference in sensitivity for conditions of 
oxidative stress can then result in a shift in the metabolite pattern. 
Cytochrome P450 IIB1, embedded in the microsomal membrane is 
more sensitive towards CuOOH treatment than microsomal cytochrome 
P450 IA1. Purification of these enzymes and reconstitution in a system in 
which the proteins remain soluble results in a disappearance of the 
difference in CuOOH sensitivity between the two cytochrome P450 
enzymes. Upon incorporation of cytochrome P450 IA1 and IIB1 into an 
artificial membrane, cytochrome P450 IIB1 again appears to be more 
sensitive towards CuOOH than cytochrome P450 IA1. Furthermore, the 
EC-50 values (effective cumene hydroperoxide concentration which 
causes 50% inhibition of cytochrome P450 dependent activities) in the 
microsomal and membrane incorporated reconstituted systems are 
comparable. Based on these results it is concluded that (1) the difference 
in sensitivity between cytochrome P450 IA1 and IIB1 towards treatment 
with CuOOH originates from a difference in the way these cytochrome 
P450 enzymes are incorporated into the membrane, that (2) the purificati-
on procedure does not affect the parameters determining the way of 
incorporation of the protein into the membrane and that (3) the way of 
membrane incorporation of cytochrome P450 enzymes in microsomal 
and reconstituted systems is comparable. 
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In chapter 3 the effects of changes in the fatty acyl moiety of phosphati-
dylcholine (PC) from dilauroyl (di 12:0) to distearoyl (dil8:0) on the 
kinetics of reconstituted cytochrome P450 IA1 and IIB1 were 
investigated. So far, studies on the effect of phospholipids on the kinetics 
of cytochrome P450 dependent reactions have focussed on one P450 
enzyme or one phospholipid. Furthermore, mainly the effect on the 
activity at non-saturating substrate concentrations was investigated 
without paying much attention to the effect on the kinetic parameters Km 
and Vm a x , of a cytochrome P450 catalysed reaction. An effect of 
phospholipids on for example the Km could be of considerable 
importance especially because in living organism the substrate 
concentrations will generally be low. Furthermore, a different effect of 
phospholipids on the substrate's apparent Km of different cytochrome 
P450 enzymes - converting the substrate to different metabolites - might 
not only affect substrate conversion rates but also the metabolite pattern. 
The results presented in chapter 3 demonstrate that the Vmax of 
the cytochrome P450 dependent O-dealkylation of alkoxyresorufins and 
ethoxycoumarin for both cytochrome P450 IA1 and IIB1 is two times 
higher in the PC dil2:0 system compared to the PC dil8:0 system. The 
effect of a change in the fatty acyl moieties on the Km of the xenobiotic 
substrate however, appeared to be different for the two cytochrome P450 
enzymes. For cytochrome P450 IA1 the Km appeared to be lower in the 
PC dil2:0 system compared to the PC dil8:0 system whereas for 
cytochrome P450 IIB1 the Km was lowest in the PC dil8:0 system. 
Additional results demonstrated that the kinetic parameters were 
dependent on the PC : P450 ratio and that changing this ratio affected the 
kinetic parameters of cytochrome P450IA1 and IIB1 in a different way. 
The reason for the differential effect on the substrate apparent Km 
was further investigated in a series of experiments in which the effect of 
PC dil2:0 and PC dil8:0 on individual steps of the catalytic cycle of 
cytochrome P450, like substrate binding, oxygen binding and rate of 
electron transfer, was studied. From these experiments it was concluded 
that the higher Vm a x in the PC dil2:0 system, observed for both 
cytochrome P450 enzymes, was at least in part due to the higher affinity 
of cytochrome P450 for NADPH-cytochrome reductase in the PC dil2:0 
system. Furthermore, these experiments demonstrated that the different 
effect of a change in the fatty acyl moieties of PC on the Km of 
cytochrome P450 IA1 and IIB1 did not result from a different effect on 
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Substrate binding, oxygen binding and rate of electron transfer. This 
means that the differential effect on the Km must result from an effect on 
one or more of the other steps in the catalytic cycle such as reductive 
oxygen splitting, substrate conversion and / or product release. 
The results show that the effect of a change in the type of PC and / 
or the PC : P450 ratio on the kinetic parameters, Km and Vm a x , is 
dependent on the cytochrome P450 enzyme used in the reconstitution. 
Furthermore, in contrast to what is generally assumed and based on 
results under non-saturating substrate conditions [1-4], the addition of PC 
appears to result for some cytochrome P450 enzymes in a decrease of the 
V m a x in the reconstituted system. The results in chapter 3 also 
demonstrate that this is not reflected in lower but - in contrast - in higher 
conversion rates at non-saturating substrate concentrations (Figure 9.1), 
because the Kni is decreased simultaneously. 
In chapter 4 the existence of a preference - with respect to binding - of 
cytochrome P450 IIB1 for phospholipids with certain headgroups or fatty 
acyl moieties was investigated. The existence of "boundary" 
phospholipids (phospholipids which bind to cytochrome P450 with 
specificity and high affinity) for microsomal cytochrome P450 has been a 
topic for several studies. Nevertheless, little is known about this subject 
and unanimous conclusions have not been reached. It has been suggested 
that the composition of the membrane in the direct vicinity of cytochro-
mes P450 is different from the rest of the membrane [5] and that specific 
interactions exist between cytochrome P450 and 
phosphatidylethanolamine (PE) [6] and phosphatidic acid (PA) [7]. 
The results in chapter 4 show that the apparent binding constant 
(K(j) of a cytochrome P-450 IIB1 - phospholipid complex is dependent 
on the degree of unsaturation of the phospholipid side chains; 
demonstrating a decrease in the K^ with increasing degree of 
unsaturation, but independent of the length of the acyl chains. In addition, 
the apparent K^ appeared to be dependent on the headgroup of the 
phospholipid molecule, showing a significantly higher Kj for PE dil6:0 
compared to PC dil6:0, PS dil6:0 and PI 16:0/18:1. 
Translation of these results to the in vivo situation has to be done 
with caution because the results were obtained in a reconstituted system 
with isolated, solubilised cytochrome P450. In the membrane of the 
endoplasmatic reticulum other factors such as for example the presence 
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of other proteins can play an additional important role in the interaction 
of cytochrome P450 with phospholipids. Furthermore, the effect of the 
length and the degree of unsaturation of the fatty acyl chains on the K<j 
was determined for PC. It remains to be established whether for 
phospholipids with different headgroups similar influences of the length 
an degree of unsaturation of the acyl chains are observed. Investigations 
in this direction are however, seriously hampered by the fact that series of 
pure molecular species of PE, PS and PI are not commercially available. 
In chapter 5 the existence of specific phospholipid : protein interactions 
for NADPH-cytochrome reductase was investigated. Compared to 
cytochrome P450 very little attention has been paid to possible 
interactions between phospholipids and NADPH-cytochrome reductase 
and possible consequences of such interactions for the cytochrome P450 
system. NADPH-cytochrome reductase is a very important component of 
the cytochrome P450 enzyme system and the stimulating effect of 
phospholipids on the rate of cytochrome P450 dependent reactions may 
in part originate from an effect on NADPH-cytochrome reductase 
resulting in a more efficient electron transfer to the cytochromes P450. 
Based on the results from 31p-NMR experiments and chemical 
analysis, it was concluded that NADPH-cytochrome reductase exhibits a 
preference for the negatively charged phospholipids phosphatidylserine 
(PS) and phosphatidylinositol (PI). In addition, experiments investigating 
the possible consequences of a special interaction of NADPH-
cytochrome reductase with PS and PI demonstrated that (1) PS and PI 
had a significantly different effect on the DPH-PC dependent quenching 
of tryptophan fluorescence of NADPH-cytochrome redcutase compared 
to PE and PC and that (2) the Vmax of cytochrome P450 IIB1 dependent 
O-dealkylation of pentoxyresorufin in the presence of 1:1 mixtures of 
PS:PC and PI:PC were respectively higher and lower compared to the 
Vm a x in the presence of a 1:1 mixture of PE:PC or PC alone. These 
phenomena might best be explained by a PS and PI induced specific 
change in the conformation of NADPH-cytochrome reductase. Regarding 
the fact that the specific interaction in both cases involves a negatively 
charged phospholipid suggest a possible role of the phospholipid charge. 
However, the fact that the effects of PS and PI on the Vm a x of the 
cytochrome P450 catalysed reaction are different demonstrates that 
phospholipid charge cannot be the only factor. 
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In chapter 6 the redox cycling of 7-alkoxyresorufins and the product of 
their metabolism by cytochrome P450, resorufin, by NADPH-
cytochrome reductase is investigated. Redox cycling is a process in 
which a substrate is 1-electron reduced, in this case by NADPH-
cytochrome reductase. The electron is transfered to molecular oxygen and 
the substrate is returned to its initial state and can enter a new cycle. 
During this process reactive oxygen species are formed which can initiate 
lipidperoxidation and / or inactivate cytochrome P450. Especially in 
systems in which the NADPH-cytochrome reductase concentration is 
relatively high this process is a disturbing side-reaction, because it uses 
up reduction equivalents resulting only in the formation of reactive 
oxygen species which may cause protein inactivation and 
lipidperoxidation. In the reconstituted systems used in this thesis redox 
cycling can play an important role because the NADPH-cytochrome 
reductase : cytochrome P450 ratio is 15 to 30 times higher than in the in 
vivo situation. Furthermore, cytochrome P450 has been demonstrated to 
be very sensitive to lipidhydroperoxides - formed during 
lipidperoxidation - and reactive oxygen species. 
The results of the present chapter demonstrate that at physiological 
pH alkoxyresorufins are much better substrates for redox cycling than 
resorufin. The inability of resorufin to stimulate redox cycling originates 
from the fact that at physiological pH resorufin exists mainly in its 
deprotonated form and this form is a much worse substrate for redox 
cycling than its protonated form. AMI molecular orbital computer 
calculations demonstrated that the energy (E) of the lowest unoccupied 
molecular orbital (LUMO), i.e. the orbital into which the electron will be 
placed during redox cycling, of the deprotonated form is higher compared 
to the ELUMO °f t n e protonated form. Furhermore, one-electron 
reduction of the protonated form appeared to be energetically favorable 
by 363.5 kJ/mol over one-electron reduction of the deprotonated form. In 
addition, the computer calculations demonstrated that the one electron 
reduced resorufin is most likely to become protonated at the O-atom of 
the intramolecular semiquinone imine moiety before reduction by a 
second electron. Finally, it was demonstrated that incorporation of 
NADPH-cytochrome reductase into an artificial membrane results in an 
increased redox cycling activity of resorufin compared to solubilized 
NADPH-cytochrome reductase. This was explained by an increase in the 
protonated form in the membrane either by (1) favored partitioning of the 
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protonated form into the membrane or by (2) an effect of the membrane 
on the protonation equilibrium of resorufin in favor of the protonated 
form. This result points at the role of the membrane in concentrating 
apolar substrates of the cytochroom P450 : NADPH-cytochrome 
reductase system [8-10]. 
In chapter 7 the use of AMI MO calculations in predicting the ability of 
compounds to stimulate redox cycling, as demonstrated in chapter 6, was 
further investigated. Therefore, in addition to resorufins, the redox 
cycling ability of 1,4-benzoquinones was investigated. Quinones are 
toxic compounds that are often used in chemistry. They are also used in 
pharmacology, for example as anticancer drugs because of their toxic 
character. The mechanism through which quinones exert their toxic 
effects is believed to involve the covalent binding of quinones to cellular 
nucleophilic macromolecules and /or the quinone catalysed process of 
redox cycling. 1,4-Benzoquinone has been demonstrated to redox cycle 
very poorly. In the literature, the poor redox cycling of 1,4-benzoquinone 
has been ascribed to a very high 1-electron reduction potential. The 
results from chapter 7 demonstrate however, that, at physiological pH, 
1,4-benzoquinone is quickly 2-electron reduced by NADPH-cytochrome 
reductase to form 1,4-hydroquinone. Instead of transfering its electron on 
to molecular oxygen, the 1-electron reduced semiquinone is protonated 
and subsequently reduced by a second electron. However, at pH>9 the 
1,4-benzoquinone appears to be capable of stimulating redox cycling. 
Furthermore, the pH- and concentration-dependencies of redox cycling in 
a system with NADPH-cytochrome reductase between 1,4-benzoquinone 
and 1,4-hydroquinone are demonstrated to be similar. Based on these 
observations it was concluded that 1,4-benzoquinone is capable of redox 
cycling from its deprotonated, 2-electron reduced form at relatively high 
pH levels which ensures an adequate concentration of the deprotonated 
form. The results from chapters 6 and 7 demonstrate the importance of 
the protonation / deprotonation equilibrium of the 1- and 2-electron 
reduced forms in the redox cycling process. 
In the paragraphs above the results of the study on the role of 
phospholipids in the cytochrome P450 : NADPH-cytochrome reductase 
system as it was executed for this PhD thesis are presented. Ever since 
1968 [111 the role of phospholipids in this system has been a topic for 
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numerous studies in which many questions concerning this role have 
been answered but many new questions have also been raised. Unfortu-
nately, this thesis does not provide the answers to all these new questions 
because the cytochrome P450 system is too complex and the number of 
different phospholipids and the effects they induce is too large. 
Answering these questions will require many, many years of additional 
research. The goal of this thesis was to investigate certain aspects of 
phospholipids and the cytochrome P450 enzyme system to which up to 
now little attention has been paid in order to gain further insight into the 
role of phospholipids in the cytochrome P450 enzyme system. 
Altogether, the results of the experiments in this thesis present 
some new insightsin the role of phospholipids on the cytochrome P450 
enzyme system. Furthermore, additional evidence for already existing 
hypotheses of the stimulating effect of phospholipids are also presented. 
The conclusions of the present thesis can be summarized as follows. 
(1) Cytochromes P450 can differ in the way they are incorporated in the 
membrane which might result in differences in their sensitivity towards 
cumene hydroperoxide. 
(2) The way of incorporation of cytochrome P450 enzymes in 
microsomal and reconstituted systems is comparable. 
(3) Phospholipids influence the kinetic parameters, Km and Vmax , of 
cytochrome P450 catalysed reactions in reconstituted systems. 
(4) The result of the effect phospholipids on the kinetic parameters of 
cytochrome P450 dependent reactions is not the same for all P450 
enzymes. 
(5) The affinity of cytochrome P450 for NADPH-cytochrome reductase 
in a reconstituted system is dependent on the fatty acyl moiety of the 
phospholipid added to the system. 
(6) Phospholipids can decrease the apparent K^ of cytochromes P450 for 
their xenobiotic substrates. 
(7) The apparent Kj of cytochromes P450 for phospholipids is dependent 
on the headgroup of the phospholipid and the degree of unsaturation of 
the fatty acyl chains but independent of the length of the acyl chains of 
the PC molecule. 
(8) There is a specific interaction between NADPH-cytochrome reductase 
and the negatively charged phospholipids PS and PI. 
(9) The membrane functions as a place where apolar substrates can 
accumulate thereby decreasing the apparent Km. 
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(10) The membrane causes a shift in the overall protonation equilibrium 
of the substrate towards the protonated form. 
In addition to these conclusions a number of other interesting 
phenomena have been observed that have no bearing on the role of 
phopsholipids in the cytochrome P450 enzyme system but are also worth 
mentioning again. 
(1) The parameters determining the way of incorporation of cytochromes 
P450 in the membrane are not affected by the isolation procedure. 
(2) AMI molecular orbital calculations is a useful additional tool in 
investigating the redox cycling capacity of chemicals. 
(3) The protonationequilibria of 1- and 2-electron reduced compounds 
play an important role in their redox cycling ability. 
Finally, regarding the results of the experiments presented in this 
thesis one final conclusion must be added. The effect of phospholipids on 
the cytochrome P450 enzyme system is dependent on many factors such 
as the cytochrome P450 form, the fatty acyl moiety and headgroup of the 
phospholipid, the P450 : reductase ratio and the phospholipid : P450 
ratio. Therefore, for a complete understanding of the mechanism(s) of 
action of phospholipids in the cytochrome P450 enzyme system, a 
detailed investigation of the effects of all phospholipids (and mixtures of 
phospholipids) on all P-450 forms at several P-450 : reductase and 
phospholipid : P-450 ratio's is necessary. This requires a vast amount of 
work although some of this work has already been done in these last 
twenty-five years. Comparison of these results is , however, difficult 
because of the different conditions used in these studies. It is therefore, 
advisable to come, in analogy to the nomenclature of cytochrome P-450, 
to standardized conditions for research in order for the results of different 
laboratories to be compared. 
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Chapter 9 
Samenvatting en conclusies 
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Het cytochroom P450 enzymsysteem is van belang voor de omzetting en 
uitscheiding van een bijna oneindige hoeveelheid xenobiotica en 
endogene substraten. De omzetting door het cytochroom P450 enzym 
systeem speelt een rol bij de conversie van xenobiotica in produkten die 
goed water oplosbaar zijn en het lichaam via urine en / of faeces kunnen 
verlaten. In veel gevallen leidt het proces van biotransformatie waar 
cytochroom P450 reacties deel van zijn tot eliminatie van het 
xenobioticum, maar in sommige gevallen kan dit proces ook leiden tot de 
vorming van een meer toxisch metaboliet. Door zijn belangrijke rol bij de 
omzetting van allerlei lichaamsvreemde en lichaamseigen stoffen is een 
volledig begrip van het cytochroom P450 enzym systeem van belang in 
de toxicologie, farmacologie, anesthesiologie, pathologie en andere 
gerelateerde biomedische gebieden. 
Vijfentwintig jaar geleden bleek uit in vitro onderzoek dat de 
fosfolipiden van het membraan van het endoplasmatisch reticulum, 
waaraan het cytochroom P450 enzymsysteem gebonden is, een belang-
rijke rol heeft bij het functioneren van dit enzymsysteem. Sindsdien is 
deze rol uitvoerig onderzocht maar al dit werk heeft nog niet tot een 
eensluidende conclusie geleid omtrent de rol van membraanfosfolipiden 
in het cytochroom P450 systeem. Het doel van het in dit proefschrift 
beschreven onderzoek is het verkrijgen van meer inzicht in de rol van het 
membraan en membraanfosfolipiden bij het functioneren van het 
cytochroom P450 enzymsysteem. Hierbij wordt niet alleen aandacht 
besteed aan de effecten van het membraan en het fosfolipide op cyto-
chroom P450 enzymen maar ook aan de effecten op een andere 
belangrijke eiwit component van het enzymsysteem, nl. het NADPH-
cytochroom reductase. 
In het eerste hoofdstuk wordt respectievelijk het cytochroom P450 
enzymsysteem en het membraan(fosfolipide) van het endoplasmatisch 
reticulum nader beschreven. In hoofdstuk IA worden in het kort de 
structurele en katalytische eigenschappen van het cytochroom P450 
enzym systeem behandeld. Daarbij wordt aandacht besteed aan het 
voorkomen, de multipliciteit, inductie, de structuur van de verschillende 
eiwitcomponenten van het enzymsysteem en de katalytische cyclus van 
het cytochroom P450. De afzonderlijke stappen in deze katalytische 
cyclus worden nader beschreven. 
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Hoofdstuk IB beschrijft de structurele aspecten van membraan 
fosfolipiden en het membraan van het endoplasmatisch reticulum en geeft 
daarnaast een beknopte beschrijving van de verschillende soorten 
gereconstitueerde systemen die in dit proefschrift gebruikt zijn. Tot slot 
worden in het kort de huidige inzichten omtrent de rol van fosfolipiden in 
het cytochroom P450 systeem beschreven en de momenteel geponeerde 
hypothesen voor het stimulerend effect van fosfolipiden op het enzym-
systeem. 
Hoofdstuk 2 levert via de resultaten omtrent de gevoeligheid van 
microsomaal en gezuiverd cytochroom P450 IA1 en IIB1 voor een 
organisch hydroperoxide; cumene hydroperoxide (CuOOH), informatie 
over de (on)gelijkheid van de wijze van membraanincorporatie van deze 
twee cytochroom P450 enzymen. Tot op heden, is er weinig aandacht 
besteed aan mogelijke verschillen in gevoeligheid tussen verschillende 
cytochroom P450 enzymen voor condities van oxidatieve stress. Vanuit 
een toxicologisch oogpunt kan een verschil in gevoeligheid voor (hydro)-
peroxides tussen verschillende cytochroom P450 enzymen, zoals 
gedemonstreerd voor CuOOH in deze studie, van belang zijn. Met name 
in het geval waarin een cytochroom P450 enzym zorgt voor detoxifi-
cering terwijl een ander cytochroom P450 enzym zorgt voor bioacti-
vering, kan een verschil in gevoeligheid voor condities van oxidatieve 
stress mogelijk resulteren in een verschuiving in het metabolietpatroon en 
de toxicologische consequenties van de biotransformatie. 
De resultaten van de experimenten beschreven in hoofdstuk 2 
laten zien dat microsomaal cytochroom P450 IIB1 gevoeliger is voor 
behandeling met CuOOH dan microsomaal cytochroom P450 IA1. 
Wanneer deze enzymen gezuiverd worden en gereconstitueerd in een 
systeem waarin de eiwitten zich vrij in een waterige oplossing bevinden 
dan verdwijnt echter het verschil in CuOOH gevoeligheid tussen de twee 
cytochroom P450 enzymen. Incorporatie van cytochroom P450 IA1 en 
IIB1 in een kunstmatige membraan heeft tot gevolg dat cytochroom P450 
IIB1 wederom gevoeliger wordt voor CuOOH dan cytochroom P450 
IA1. Het blijkt dat de EC-50 waarden (de CuOOH concentratie waarbij 
de cytochroom P450 afhankelijke activiteit nog maar 50% is van de 
oorspronkelijke activiteit) in het microsomale en het gereconstitueerde 
membraan gebonden systeem vergelijkbaar zijn. Op basis van deze 
resultaten werd geconcludeerd dat (1) het verschil in gevoeligheid tussen 
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cytochroom P450 IA1 en IIB1 voor behandeling met CuOOH wordt 
veroorzaakt door een verschil in de wijzen van inbouw van de twee 
cytochroom P450 enzymen in de membraan, dat (2) de 
zuiveringsprocedure de parameters die de inbouw van het eiwit in de 
membraan bepalen niet beïnvloedt en dat (3) de manier van inbouw van 
cytochroom P450 enzymen in het microsomale en het gereconstitueerde 
vergelijkbaar is. 
In hoofdstuk 3 wordt gekeken naar het effect van een verandering in de 
vetzuurstaartsamenstelling van fosfatidylcholine (PC) van dilauroyl 
(dil2:0) naar distearoyl (dil8:0) op het kinetisch gedrag van cytochroom 
P450IA1 en IIB1. Tot dusver zijn studies naar het effect van fosfolipiden 
op de kinetiek van cytochroom P450 afhankelijke reacties vooral gericht 
geweest op één P450 enzym of maar één of enkele fosoflipide. Met name 
is er gekeken naar de activiteit (onder niet-verzadigde substraatconcen-
traties) en in slechts weinig gevallen naar het effect op de kinetische 
parameters Km en Vmax. Een effect van de fosfolipiden op bijvoorbeeld 
de Km van cytochroom P450 voor substraat kan echter van belang zijn 
met name omdat in het lichaam de substraatconcentraties over het 
algemeen laag zijn. Bovendien zou een verschillend effect van 
fosfolipiden op de Km van verschillende cytochroom P450 enzymen - die 
een substraat omzetten tot meerdere produkten - niet alleen kunnen leiden 
tot een effect op de omzettingssnelheid maar ook op het 
metabolietpatroon. 
In dit hoofdstuk wordt beschreven dat de Vmax van cytochroom 
P450 afhankelijke O-dealkylering van alkoxyresorufines en ethoxy-
coumarine voor beide cytochroom P450 enzymen twee maal zo hoog is 
in het PC dil2:0 systeem vergeleken met het PC dil8:0 systeem. Het 
effect van een verandering in de vetzuurstaarten op de substraat 
afhankelijke Km bleek echter verschillend te zijn voor de twee cyto-
chroom P450 enzymen. Voor cytochroom P450 IA1 bleek de Km in het 
PC dil2:0 systeem lager te zijn dan in het PC dil8:0 systeem terwijl voor 
cytochroom P450 IIB1 de Km in het PC dil2:0 systeem hoger is dan in 
het PC dil8:0 systeem. Additionele resultaten toonden aan dat de 
kinetische parameters afhankelijk waren van de PC : P450 verhouding en 
dat veranderingen in deze verhouding de kinetische parameters van P450 
IA1 en IIB1 verschillend beïnvloeden. 
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De reden voor dit verschillende effect op de substraat afhankelijke 
Km werd onderzocht in een serie experimenten waarin de invloed van PC 
dil2:0 en PC dil8:0 op verschillende stappen in de katalytische cyclus 
van cytochroom P450 zoals substraatbinding, zuurstofbinding en de 
snelheid van elektron overdracht werd bestudeerd. Uit deze experimenten 
bleek dat de voor beide cytochroom P450 enzymen waargenomen hogere 
Vmax in het PC dil2:0 systeem vergeleken met het PC dil8:0 systeem ten 
minste ten dele veroorzaakt wordt door een hogere affiniteit van 
cytochroom P450 voor NADPH-cytochroom reductase in het PC dil2:0 
systeem. Deze experimenten lieten echter ook zien dat het verschillende 
effect van PC dil2:0 en PC dil8:0 op de Km van cytochroom P450 IA1 
en IIB1 voor ethoxycoumarine niet bepaald wordt door een verschillend 
effect op de substraatbinding, zuurstofbinding en de snelheid van elektron 
overdracht. Dit houdt in dat het verschillend effect van de fosfolipiden op 
de Km een gevolg is van een effect op één of meerdere van de andere 
stappen in de katalytische cyclus zoals zuurstofsplitsing, 
substraatomzetting en / of produktafsplitsing. 
De resultaten laten zien dat het effect van een verandering in het 
type fosfatidylcholine en / of in de PC : P450 verhouding op de 
kinetische parameters, Km en Vmax, afhankelijk is van het cytochroom 
P450 enzym gebruikt bij de reconstitutie. Bovendien blijkt de toevoeging 
van fosfatidylcholine voor sommige cytochroom P450 enzymen te 
resulteren in een verlaging van de Vmax in een gereconstitueerd systeem, 
dit in tegenstelling tot wat over het algemeen wordt aangenomen op basis 
van resultaten onder omstandigheden van niet-substraat-verzadiging [1-
4]. Dit resulteert echter niet in een verlaging van de omzettingssnelheid 
onder niet-verzadigde substraat concentraties maar in een verhoging 
(figuur 1) omdat tegelijkertijd ook de Km wordt verlaagd. 
In hoofdstuk 4 is onderzocht of er een voorkeur bestaat - wat betreft de 
binding - van cytochroom P450 IIB1 voor fosfolipiden met een bepaalde 
kopgroep of vetzuursamenstelling. Het bestaan van zogenaamde 
"boundary" fosfolipiden (=fosfolipiden die specifiek en met hoge 
affiniteit binden aan cytochroom P450) bij microsomaal cytochroom 
P450, is onderwerp geweest van verschillende studies. 
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Desondanks is er nog maar weinig bekend en men is nog niet tot een 
eensluidende conclusie gekomen. Er is geopperd dat de samenstelling 
van de membraan in de direkte omgeving van cytochroom P450 anders is 
dan de samenstelling van de rest van de membraan [5] en dat er 
specifieke interacties bestaan tussen cytochroom P450 en phosphatidyl-
ethanolamine (PE) [6] en phosphatidezuur (PA) [7]. 
De resultaten in hoofdstuk 4 laten zien dat de bindingsconstante 
(K(j) van cytochroom P450 IIB1 voor fosfolipiden afhankelijk is van de 
graad van onverzadigdheid van de vetzuurstaarten; er werd een tendens 
waargenomen van een afnemende K^ met toenemende graad van 
onverzadigdheid. Ook bleek de bindingsconstante afhankelijk te zijn van 
de kopgroep van de fosfolipiden met een significant hogere K^ voor PE 
dil6:0 in vergelijking tot PC dil6:0, PS dil6:0 en PI16:0/18:1. De 
bindingsconstante bleek onafhankelijk van de lengte van de acylketens in 
PC. 
Vertaling van deze resultaten naar de in vivo situatie is uiterst 
riskant omdat er bij deze experimenten gebruik gemaakt is van een in 
vitro model systeem. In het membraan van het endoplasmatisch reticulum 
kunnen andere factoren zoals bijvoorbeeld de aanwezigheid van andere 
enzymen een belangrijke rol spelen bij de interactie tussen fosfolipiden 
en cytochroom P450. Bovendien is het effect van de lengte en de 
verzadigingsgraad van de vetzuurstaarten op de K^ alleen onderzocht 
voor PC. Het blijft natuurlijk de vraag of bij andere kopgroepen 
eenzelfde (on)afhankelijkheid van de lengte en verzadigingsgraad van de 
vetzuurstaarten gevonden wordt. Verder onderzoek van dit laatste aspect 
wordt echter belemmerd door het feit dat series van zuivere vormen van 
PE, PS en PI niet commercieel verkrijgbaar zijn. 
In hoofdstuk 5 werd het bestaan van specifieke fosfolipide - eiwit 
interacties van NADPH-cytochroom reductase onderzocht. Vergeleken 
met cytochroom P450 is er weinig tot geen aandacht besteed aan 
interacties tussen fosfolipiden en NADPH-cytochroom reductase en de 
mogelijke gevolgen daarvan. Toch is NADPH-cytochroom reductase een 
onmisbare component van het enzym systeem. Het stimulerend effect van 
fosfolipiden op de activiteit van cytochroom P450 afhankelijke reacties 
zou - ten dele - ook een resultaat kunnen zijn van een effect op NADPH-
cytochroom reductase, waardoor dit eiwit bijvoorbeeld efficiënter zijn 
elektronen zou kunnen overdragen aan cytochroom P450. 
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Op basis van de resultaten van 31P-NMR experimenten en 
chemische analyse werd geconcludeerd dat NADPH-cytochroom 
reductase een voorkeur heeft voor de negatief geladen fosfolipiden 
fosfatidylserine (PS) en fosfatidylinositol (PI). Bovendien bleek uit 
experimenten naar mogelijke consequenties van een speciale interactie 
van NADPH-cytochroom reductase met PS en PI dat (1) PS en PI een 
significant ander effect hadden op de quenching van de tryptofaan 
fluorescentie door DPH-PC dan PE en PC en dat (2) de Vm a x van 
cytochroom P450 IIB1 afhankelijke O-dealkylering van pentoxyreso-
rufine in aanwezigheid van 1:1 mengsels van PS : PC en PI : PC 
respectievelijk hoger en lager waren in vergelijking tot de Vmax bij een 
1:1 mengsel van PE : PC of PC alleen. Deze waarnemingen zouden het 
best te verklaren zijn door een PS en PI specifieke verandering in de 
conformatie van NADPH-cytochroom reductase. Het feit dat de 
specifieke interactie in beide gevallen negatief geladen fosfolipiden 
betreft wijst in eerste instantie naar een mogelijke rol van de lading van 
het fosfolipide. Echter, het feit dat de Vmax in aanwezigheid van PI lager 
is dan die in aanwezigheid van PC en PE terwijl in aanwezigheid van PS 
de Vm a x juist hoger is, wijst erop dat de lading in ieder geval niet de 
enige factor is die van belang is voor de invloed van fosfolipiden op 
NADPH-cytochroom reductase. 
In hoofdstuk 6 wordt de redox cycling van alkoxyresorufines en het 
produkt van hun omzetting door cytochroom P450, nl. resorufine, door 
NADPH-cytochroom reductase bestudeerd. Redox cycling is een proces 
waarbij een substraat door, in dit geval, NADPH-cytochroom reductase 
1-elektron gereduceerd wordt. Dit elektron wordt op zijn beurt weer 
overgedragen aan moleculair zuurstof en het substraat komt weer in zijn 
uitgangsvorm terug en kan aan een nieuwe cyclus deelnemen. Tijdens dit 
proces worden reactieve zuurstof tussenprodukten gevormd die 
lipidperoxidatie en / of cytochroom P450 inactivatie kunnen veroorzaken. 
Met name in systemen waarin de NADPH-cytochroom reductase 
concentratie relatief hoog is kan dit proces een storende factor worden 
door het verbruik van reductie equivalenten en de mogelijke inactivatie 
van eiwitten. In de gereconstitueerde systemen die in dit proefschrift 
gebruikt zijn kan dit proces een belangrijke rol spelen omdat de 
verhouding NADPH-cytochroom reductase : cytochroom P450 in deze 
systemen zo'n 15 tot 30 maal hoger dan in de in vivo situatie. Daar komt 
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nog bij dat cytochroom P450 gevoelig is voor lipidhydroperoxides -
gevormd tijdens lipidperoxidatie - en reactieve zuurstof species. 
Uit de resultaten blijkt dat bij fysiologische pH alkoxyresorufines 
veel betere substraten zijn voor redox cycling dan resorufine. Het 
onvermogen van resorufine om redox cycling te stimuleren bleek te 
liggen in het feit dat bij fysiologische pH resorufine hoofdzakelijk in zijn 
gedeprotoneerde vorm voorkomt en dat deze vorm veel minder dan de 
geprotoneerde vorm in staat is redox cycling te ondergaan. Met behulp 
van AMI molecuul orbitaal computer berekeningen werd aangetoond dat 
de energie (E) van de laagste niet gevulde orbitaal (LUMO = de energie 
van de orbitaal waarin het elektron wordt geplaatst tijden redox cycling) 
van de gedeprotoneerde vorm hoger is dan de E L U M O v a n de 
geprotoneerde vorm van resorufine. Tevens bleek 1-elektron reductie van 
de geprotoneerde vorm energetisch de voorkeur te hebben boven de 1-
elektron reductie van de gedeprotoneerde vorm met 363.5 kJ/mol. 
Aanvullende computerberekeningen toonden aan dat het 1-elektron 
gereduceerde resorufine wordt geprotoneerd op de zuurstof van de 
intramoleculaire semichinonimine groep voordat het wordt gereduceerd 
met een tweede elektron. Tot slot bleek dat incorporatie van NADPH-
cytochroom reductase in een kunstmatige membraan een positief effect 
had op de redox cycling van resorufine. Dit werd verklaard door een 
stijging in de concentratie van de geprotoneerde vorm in het membraan 
door (1) parti tie van de geprotoneerde vorm in het membraan en / of (2) 
een membraan geïnduceerde verschuiving in het protoneringsevenwicht 
van resorufine in het voordeel van de geprotoneerde vorm. Dit resultaat 
wijst op een rol van de membraan in het concentreren van de apolaire 
substraten van het cytochroom P450 : NADPH-cytochroom reductase 
systeem [8-10] 
In hoofdstuk 7 werd nader onderzoek gedaan naar de in hoofdstuk 7 
gevonden resultaten wat betreft de voorspellende waarde van AMI 
berekeningen voor de capaciteit van stoffen om redox cycling te 
ondergaan. Naast de redox cycling van resorufines werd gekeken naar de 
redox cycling van chinonen. Chinonen zijn toxische stoffen die veel 
gebruikt worden in de chemie. Daarnaast worden ze ook als medicijn 
gebruikt in de strijd tegen kanker vanwege hun toxische karakter. De 
toxische werking van chinonen wordt toegeschreven aan hun capaciteit 
om te binden aan cellulaire nucleofiele macromoleculen en/of hun 
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vermogen om redox cycling te stimuleren. Van 1,4-benzochinon is echter 
bekend dat het een slecht substraat is voor redox cycling. In de literatuur 
wordt als oorzaak voor de slechte redox cycling capaciteit een erg hoge 
1-elektron reductie potentiaal gegeven. Uit de resultaten van hoofdstuk 7 
blijkt echter dat bij fysiologische pH 1,4-benzochinon gemakkelijk een 
twee elektron reductie door NADPH-cytochroom reductase ondergaat 
resulterend in de vorming van 1,4-hydrochinon. In plaats van zijn 
elektron over te dragen aan moleculair zuurstof wordt het 1-elektron 
gereduceerde semichinon geprotoneerd en vervolgens gereduceerd door 
een tweede elektron. Wanneer de pH echter wordt verhoogd tot boven 9 
blijkt 1,4-benzochinon wel in staat tot redox cycling. Tevens bleek er een 
overeenkomst te bestaan tussen de pH en concentratie afhankelijkheid 
van de redox cycling in een systeem met NADPH-cytochroom reductase 
en 1,4-benzochinon ofwel 1,4-hydrochinon. Op basis van deze 
waarnemingen werd geconcludeerd dat 1,4-benzochinon in staat is om 
redox cycling te katalyseren via zijn gedeprotoneerde, twee-elektron 
gereduceerde vorm; zij het alleen bij relatief hoge pH, waarbij de 
gedeprotoneerde vorm voldoende aanwezig is. De resultaten van 
hoofdstuk 6 en 7 wijzen op het belang van het protoneringsevenwicht van 
de 1- en 2-electron gereduceerde vormen in het redox cycling proces. 
In de bovenstaande alinea's zijn in het kort de resultaten weergegeven van 
het onderzoek naar de rol van de fosfolipiden in het cytochroom P450 : 
NADPH-cytochroom reductase systeem zoals dat in het kader van dit 
proefschrift is uitgevoerd. Sinds 1968 [11] is de rol van fosfolipiden in dit 
enzymsysteem onderwerp geweest van menige studie waarin veel vragen 
werden beantwoord maar evenzoveel nieuwe vragen opgeroepen. Dit 
proefschrift levert niet de antwoorden op deze nieuwe vragen. Daarvoor 
is het cytochroom P450 enzym systeem te complex en zijn de diversiteit 
van de fosfolipiden en de effecten die ze induceren te groot. De bedoeling 
van dit onderzoek was een aantal aspecten van fosfolipiden en het 
cytochroom P450 systeem waaraan tot nu toch nog maar weinig aandacht 
is besteed verder uit te diepen en op deze manier de kennis (en het 
begrip) hierover te vergroten. 
De resultaten van de experimenten beschrijven nieuwe effecten 
van fosfolipiden op het enzym systeem. Daarnaast wordt er ook 
aanvullend bewijs geleverd voor sommige van de reeds bestaande hypo-
thesen die in hoofdstuk 2 staan vermeld. De conclusies omtrent de rol van 
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het membraan(fosfolipide) in het cytochroom P-450 enzymsysteem, zoals 
ze zijn gevonden in dit proefschrift, worden hieronder nog eens 
puntsgewijs samengevat. 
1) Cytochroom P450 enzymen kunnen verschillen in de manier waarop 
ze ingebouwd zijn in het membraan waardoor ze een verschillende 
gevoeligheid kunnen vertonen voor cumene hydroperoxide. 
2) De manier van incorporatie van cytochroom P450 enzymen in 
microsomale en gereconstitueerde systemen is vergelijkbaar. 
3) Fosfolipiden kunnen de kinetische parameters Km en Vmax van 
cytochroom P450 afhankelijke reacties in gereconstitueerde systemen 
beïnvloeden. 
4) De uitkomst van de invloed van fosfolipiden op de kinetische 
parameters van cytochroom P450 afhankelijke reacties is niet hetzelfde 
voor alle cytochroom P450 enzymen. 
5) De affiniteit van cytochroom P450 voor NADPH-cytochroom 
reductase in een gereconstitueerd systeem is afhankelijk van de 
vetzuursamenstelling van het fosfolipide molecuul dat bij reconstitutie 
wordt toegevoegd 
6) Fosfolipiden kunnen de K^ van cytochroom P450 voor het substraat 
verlagen. 
7) De K(j van cytochroom P450 enzymen voor fosfolipiden is afhankelijk 
van de kopgroep van het fosfolipide molecuul en de verzadigingsgraad 
van de vetzuurstaarten maar onafhankelijk van de lengte van de 
acylketen. 
8) Er bestaat een speciale interactie tussen NADPH-cytochroom 
reductase en de negatief geladen fosfolipiden PS en PI. 
9) Het membraan fungeert als een plaats waar apolaire substraten zich 
kunnen ophopen. 
10) Het membraan zorgt voor een verschuiving in het overall 
protoneringsevenwicht van het substraat naar de geprotoneerde kant. 
Naast deze conclusies zijn er ook nog een aantal andere 
interessante waarnemingen gedaan die geen betrekking hebben op de rol 
van fosfolipiden in het cytochroom P450 enzym systeem maar die ook de 
moeite van het vermelden waard zijn. 
(1) De parameters die de manier bepalen op welke wijze cytochroom 
P450 enzymen ingebouwd worden in het membraan worden niet 
beinvloedt door de zuiveringsprocedure. 
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(2) AMI computer berekeningen zijn zeer bruikbaar bij het onderzoek 
naar redox cycling capaciteit van chemicaliën. 
(3) De protoneringsevenwichten van 1- en 2- electron gereduceerde 
stoffen is van belang voor hun vermogen tot redox cycling. 
Tot slot, gezien de resultaten van de experimenten in dit 
proefschrift moet hier misschien nog een belangrijke conclusie aan 
toegevoegd worden. Het effect van fosfolipiden in het cytochroom P450 
enzymsysteem blijkt afhankelijk te zijn van veel factoren zoals het soort 
cytochroom P450 enzym, de vetzuurstaarten en kopgroep van het 
fosfolipide, de P450 : reductase verhouding, de fosfolipide : P450 
verhouding en het soort gereconstitueerde systeem dat gebruikt is. 
Daarom is, voor een goed begrip van het mechanisme van fosfolipide 
stimulatie van cytochroom P450-afhankelijke reacties, een gedetaileerd 
onderzoek naar het effect van alle (mengsels van) fosfolipiden op alle 
cytochroom P450 enzymen bij verschillende P450 : reductase en 
fosfolipide : P450 verhoudingen noodzakelijk. Dit vraagt een hoop tijd 
hoewel sommige zaken al (ten dele) zijn onderzocht in de afgelopen 25 
jaar. In veel gevallen zijn deze resultaten echter niet vergelijkbaar 
doordat de experimenten onder steeds verschillende condities hebben 
plaatsgevonden. Het is daarom aan te raden in de toekomst, net als voor 
de nomenclatuur van cytochroom P450, te komen tot gestandaardiseerde 
condities voor experimenten met gereconstitueerde systemen zodat de 
resultaten van verschillende laboratoria in de toekomst gemakkelijker 
vergeleken kunnen worden. 
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Chapter 10 
Uitleg voor niet-ingewijden 
211 
Omzetting van stoffen in het lichaam 
Gedurende het hele leven komt de mens in aanraking met tal van 
lichaamsvreemde stoffen van natuurlijke en niet-natuurlijke oorsprong. 
Deze lichaamsvreemde stoffen worden ook wel xenobiotica genoemd 
(xenos = vreemd, bios = leven). De xenobiotica kunnen het lichaam 
binnendringen via de natuurlijke weg zoals het maag-darm kanaal, de 
huid en de luchtwegen maar ook via kunstmatige wegen zoals via 
injecties of een infuus. Om eventuele giftige werkingen tot een minimum 
te beperken, moeten deze stoffen zo snel mogelijk het lichaam weer 
verlaten. Door het in veel gevallen vetachtige karakter van deze stoffen 
lossen ze echter slecht op in water en hebben ze de neiging zich op te 
hopen in het lichaam (met name in het vetweefsel) in plaats van 
uitgescheiden te worden via de urine of ontlasting. Gelukkig beschikt de 
mens, maar ook dieren, bacteriën, planten enz. over een machinerie die in 
staat is de chemische structuur en daarmee het karakter van deze stoffen 
dusdanig te veranderen dat ze beter oplosbaar worden in water. Dit 
proces heet biotransformatie . Het proces van biotransformatie verloopt 
in twee fasen. In de eerste fase wordt er iets aan de structuur van het 
xenobioticum veranderd (modificatie). Er wordt als het ware een "haakje" 
gecreëerd waaraan in de tweede fase een goed water-oplosbare groep kan 
worden "opgehangen" (conjugatie). 
Een belangrijk eiwit dat fase I reacties katalyseert is het 
cytochroom P450. Dit eiwit maakt met een aantal andere eiwitten, 
waarvan NADPH-cytochroom reductase de belangrijkste is, deel uit van 
het cytochroom P450 enzymsysteem. Dit enzymsysteem kan een 
lichaamsvreemde stof op tal van manieren omzetten. Over het a/.gemeen 
leidt dit tot een ontgifting (detoxificering) van het xenobioticum, doch in 
sommige gevallen kan het ook resulteren in de vorming van een 
omzettingsprodukt dat giftiger is dan de uitgangsstof (bioactivering). Het 
moge duidelijk zijn dat de verhouding van detoxificering en 
bioactivering, alsmede de snelheid waarmee het xenobioticum wordt 
omgezet van groot belang is voor de uiteindelijke giftigheid (toxiciteit ) . 
Van het belangrijkste eiwit van het cytochroom P450 enzymsysteem, het 
cytochroom P450 eiwit zelf, bestaan verschillende vormen. Deze 
verschillende vormen van cytochroom P450 onderscheiden zich van 
elkaar door verschillen in de structuur van het eiwit. Door deze 
structurele verschillen zijn deze cytochroom P450 vormen in staat om 
verschillende groepen van stoffen (substraten) om te zetten (te 
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metaboliseren). Dit is het beste duidelijk te maken met behulp van het 
"sleutel en slot" principe. De vorm van het xenobioticum, de "sleutel", 
moet overeenkomen met de vorm van het "slot", het cytochroom P450 
eiwit, anders kan het xenobioticum niet omgezet worden. Een andere 
structuur van het cytochroom P450 betekent een ander "slot" waarop 
andere "sleutels" (substraten) passen. 
Het cytochroom P450 enzymsysteem kan een grote 
verscheidenheid van reacties katalyseren. Van meer dan 250.000 
xenobiotica is het tot nu toe bekend dat ze door cytochroom P450 
omgezet worden. De meeste van deze reacties zijn zogenaamde 
monooxygenase reacties wat betekent dat een zuurstof molecuul, 
bestaande uit twee zuurstof atomen, wordt gesplitst waarbij één zuurstof 
atoom wordt ingebouwd in het substraat en het andere zuurstof atoom 
wordt ingebouwd in een water molecuul. Het in het xenobioticum 
ingebouwde zuurstof atoom is in veel gevallen het "haakje" voor de fase 
II reactie. 
Het membraan 
De omzetting van lichaamsvreemde stoffen bij zoogdieren vindt 
voornamelijk plaats in de lever. De lever is net als de rest van ons 
lichaam opgebouwd uit cellen. Iedere cel wordt omgeven door een soort 
"velletje", het membraan, die het inwendige van de cel afschermt van het 
externe milieu. Een membraan is voor een groot gedeelte opgebouwd uit 
zogenaamde fosfolipiden. De structuur van deze fosfolipiden heeft een 
tweeledig karakter; ze zijn opgebouwd uit een stuk dat goed in water 
oplost, de kopgroep, en een stuk dat slecht oplost in water, de 
vetzuurstaarten (Figuur 1). Fosfolipiden kunnen verschillende 
kopgroepen bezitten waarvan choline, ethanolamine, serine en inositol de 
meest belangrijke zijn. De fosfolipiden worden vaak ingedeeld op basis 
van het soort kopgroep dat het fosfolipide bevat. Ook de vetzuurstaarten 
van het fosfolipide molecuul zijn variabel. Doordat er twee vetzuren aan 
een fosfolipide molecuul kunnen zitten en doordat er keuze is uit veel 
verschillende vetzuren is de variatie in de vetzuurstaarten veel groter dan 
in de kopgroepen. 
Het menselijk lichaam bestaat voor ongeveer 80% uit water en in 
dit waterige milieu oriënteren de fosfolipiden zich dusdanig dat de 
vetzuurstaarten zich naar elkaar toewenden en alleen de kopgroepen, die 
goed oplossen in water, in contact komen met de waterige oplossing. In 
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de praktijk komt dit erop neer dat de fosfolipiden een dubbellaag of 
membraan vormen, waarbij het inwendige van deze dubbellaag gevormd 
wordt door de vetzuurstaarten en de buitenkant door de kopgroepen van 
de fosfolipiden (Figuur 10.1). 
Water 
• vetzuur 
staarten 
Water 
FOSFOLIPIDE DUBBELLAAG 
OF MEMBRAAN 
Figuur 10.1: Structuur van fosfolipide en membraan 
In de levercel bevinden zich een groot aantal cel organellen die elk op 
hun beurt ook weer omgeven zijn door zo'n membraan. Het cytochroom 
P450 enzymsysteem is vooral gebonden aan het membraan van één van 
deze cel organellen, namelijk het endoplasmatisch reticulum. Het 
membraan en met name de fosfolipiden, blijken van invloed te zijn op de 
werking van het cytochroom P450 enzymsysteem. 
Testsystemen 
Het onderzoek naar de omzetting van lichaamsvreemde stoffen kan om 
ethische redenen alleen in zeer speciale gevallen bij mensen worden 
verricht. Daarom wordt er gebruik gemaakt van proefdieren. In veel 
gevallen zijn dit ratten. Het onderzoek kan gebruik maken van 
verschillende testsystemen. Bij zogenaamd in vivo onderzoek wordt 
gebruik gemaakt van de dieren als zodanig. De lichaamsvreemde stof 
wordt bijvoorbeeld via het drinkwater toegediend en de urine, ontlasting 
en / of het bloed van het proefdier wordt opgevangen en geanalyseerd 
om de omzettingsprodukten te karakteriseren. Dit soort systemen worden 
veel gebruikt bij toxicologisch onderzoek. In vivo onderzoek is vaak zeer 
lastig, kostbaar en belastend voor het proefdier. Daarom wordt vaak bij 
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voorkeur gebruik gemaakt van zogenaamde in vitro testsystemen ("in de 
reageerbuis"). Bij dit soort, meer artificiële systemen wordt gebruik 
gemaakt van uit-ratten geïsoleerde levers. Het voordeel van in vitro 
systemen is dat er vele honderden of zelfs duizenden bepalingen 
uitgevoerd kunnen worden met materiaal van 1 proefdier tegenover 
slechts 1 bij in vivo onderzoek. In vitro systemen zijn dus proefdier 
besparend. Het experimentele materiaal dat uit de levers verkregen kan 
worden, kan uiteenlopen van geïsoleerde levercellen (hepatocyten), 
membranen (microsomen) tot zelfs gezuiverde eiwitten / enzymen. Van 
de verschillende in vitro systemen staat het systeem met de geïsoleerde 
levercellen het dichtst bij de originele situatie en wordt daarom net al.s 
het in vivo systeem vaak in toxicologisch onderzoek gebruikt. Het 
verkrijgen van levercellen is echter nogal bewerkelijk en de houdbaarheid 
van de levercellen is beperkt. 
Voor het bestuderen van het eigenlijke proces van de omzetting 
van een lichaamsvreemde stof door cytochroom P450 en de factoren die 
dit proces beïnvloeden kunnen in veel gevallen de andere in vitro 
testsystemen gebruikt worden. Het meest gebruikt is het systeem met 
microsomen. Dit zijn stukjes van de membraan van het endoplasmatisch 
reticulum die ontstaan via het malen van rattelever materiaal. Met behulp 
van ultracentrifuge kunnen de microsomen van ander lever weefsel 
gescheiden kunnen. In deze membraanstukjes is het cytochroom P450 
enzymsysteem ingebed. Bij andere in vitro testsystemen wordt gebruik 
gemaakt van de individuele eiwit componenten van het enzymsysteem 
die gezuiverd worden uit rattelevers. Het cytochroom P450 
enzymsysteem wordt dan weer in elkaar gezet (reconstitutie) door de 
eiwit componenten en fosfolipiden opnieuw bij elkaar te brengen. Dit 
testsysteem heeft het voordeel dat het enzymsysteem naar wens 
samengesteld kan worden en dat storende factoren tot een minimum 
beperkt kunnen worden. Een nadeel is echter dat dit systeem ver 
verwijderd is van de oorspronkelijke situatie in de levercel. Er zijn twee 
verschillende gereconstitueerde systemen te onderscheiden: (i) een 
gereconstitueerd systeem waarin de individuele eiwitcomponenten en de 
fosfolipiden in oplossing blijven en (ii) een gereconstitueerd systeem 
waarin de eiwitcomponenten zijn ingebouwd in een kunstmatige 
fosfolipide membraan. 
In dit proefschrift is met name gebruik gemaakt van microsomen 
en van de twee gereconstitueerde testsystemen omdat de mechanistische 
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invloeden van fosfolipiden op het cytochroom P450 enzymsysteem 
onderzocht werden. Voor dit soort onderzoek is het wenselijk dat de 
componenten van het enzymsysteem systematisch en gemakkelijk 
gewijzigd en beïnvloedt moeten kunnen worden. 
Doel van dit onderzoek 
Een volledig begrip van de werking van het cytochroom P450 
enzymsysteem is zeer belangrijk voor de toxicologie ("leer der 
vergiften") bij het vaststellen van de bioactivering en detoxificering van 
een lichaamsvreemde stof. Maar ook voor de geneeskunde en de 
farmacologie ("leer der geneesmiddelen") is een goede kennis van dit 
enzymsysteem van groot belang, met name omdât de werking van het 
P450 enzymsysteem mede bepalend is voor de verblijftijd van 
geneesmiddelen en zijn metabolieten in het lichaam en derhalve voor de 
benodigde dosering. Op het ogenblik wordt het cytochroom P450 
enzymsysteem al gebruikt in de farmaceutische industrie bij het screenen 
van potentiële geneesmiddelen. Ook in de organische chemie zijn er 
toepassingen beschreven voor het cytochroom P450 enzymsysteem, met 
name bij de stereo- en regioselectieve synthese van chemicaliën. 
Daarnaast zou het ook nog gebruikt kunnen worden in de strijd tegen de 
steeds maar toenemende milieuverontreiniging voor het verwijderen van 
schadelijke chemicaliën. 
De afgelopen 20 jaar is onderzoek gedaan naar de rol van de 
fosfolipiden in het cytochroom P450 enzymsysteem. Dit heeft echter nog 
altijd niet geleid tot een eensluidende conclusie over de rol en het belang 
van fosfolipiden voor het systeem mede als gevolg van de complexiteit 
van het enzymsysteem en de grote verscheidenheid aan effecten die door 
fosfolipiden geïnduceerd worden. Het doel van het onderzoek is dan ook 
om verder inzicht te verkrijgen in de rol van de membraan en 
membraanfosfolipiden bij het functioneren van het cytochroom P450 
enzymsysteem. Hierbij wordt niet alleen gekeken naar het cytochroom 
P450 eiwit zelf maar ook naar het NADPH-cytochroom reductase. 
Dit proefschrift 
In de eerste twee hoofdstukken van dit proefschrift worden in het kort de 
structurele en katalytische eigenschappen van het cytochroom P450 
enzymsysteem beschreven {Hoofdstuk IA) alsmede de structurele 
aspecten van fosfolipiden en de membraan van het endoplasmatisch 
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reticulum en hypotheses voor het stimulerende effect van fosfolipiden op 
het enzymsysteem {Hoofdstuk IB). 
In de hoofdstukken 2 tot en met 7 worden de resultaten besproken 
van de experimenten zoals die de afgelopen vier jaar zijn uitgevoerd. De 
eerste hoofdstukken (Hoofdstuk 2,3 en 4) hebben betrekking op de relatie 
cytochroom P450 - fosfolipiden, Hoofdstuk 5 heeft betrekking op de 
relatie NADPH-cytochroom reductase - fosfolipiden en de Hoofdstukken 
6 en 7 gaan over een neven reactie die tijdens cytochroom P450 
afhankelijke reacties kan optreden; de NADPH-cytochroom reductase 
afhankelijke redox cycling. Het proefschrift wordt afgesloten met een 
hoofdstuk met samenvattingen, evaluaties van de resultaten en conclusies 
(Hoofdstuk 8). 
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